0000088053-22-000160.txt : 20220225 0000088053-22-000160.hdr.sgml : 20220225 20220225122616 ACCESSION NUMBER: 0000088053-22-000160 CONFORMED SUBMISSION TYPE: N-CSR PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220225 DATE AS OF CHANGE: 20220225 EFFECTIVENESS DATE: 20220225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEUTSCHE DWS INVESTMENTS VIT FUNDS CENTRAL INDEX KEY: 0001006373 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CSR SEC ACT: 1940 Act SEC FILE NUMBER: 811-07507 FILM NUMBER: 22677189 BUSINESS ADDRESS: STREET 1: 875 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022-6225 BUSINESS PHONE: 212-454-4500 MAIL ADDRESS: STREET 1: 875 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022-6225 FORMER COMPANY: FORMER CONFORMED NAME: DEUTSCHE INVESTMENTS VIT FUNDS DATE OF NAME CHANGE: 20140811 FORMER COMPANY: FORMER CONFORMED NAME: DWS INVESTMENTS VIT FUNDS DATE OF NAME CHANGE: 20060207 FORMER COMPANY: FORMER CONFORMED NAME: SCUDDER INVESTMENTS VIT FUNDS DATE OF NAME CHANGE: 20030519 0001006373 S000006223 DWS Small Cap Index VIP C000017156 Class A C000017157 Class B N-CSR 1 ar123121scif.htm DWS SMALL CAP INDEX VIP

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

 

FORM N-CSR

 

Investment Company Act file number: 811-07507

 

Deutsche DWS Investments VIT Funds

(Exact Name of Registrant as Specified in Charter)

 

875 Third Avenue

New York, NY 10022-6225

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s Telephone Number, including Area Code: (212) 454-4500

 

Diane Kenneally

100 Summer Street

Boston, MA 02110

(Name and Address of Agent for Service)

 

Date of fiscal year end: 12/31
   
Date of reporting period: 12/31/2021

 

ITEM 1. REPORT TO STOCKHOLDERS
   
  (a)

December 31, 2021
Annual Report
Deutsche DWS Investments VIT Funds

DWS Small Cap Index VIP

Contents
    
This report must be preceded or accompanied by a prospectus. To obtain an additional prospectus or summary prospectus, if available, call (800) 728-3337 or your financial representative. We advise you to consider the Fund’s objectives, risks, charges and expenses carefully before investing. The summary prospectus and prospectus contain this and other important information about the Fund. Please read the prospectus carefully before you invest.
Stocks may decline in value. Various factors, including costs, cash flows and security selection, may cause the Fund’s performance to differ from that of the index. Smaller company stocks tend to be more volatile than medium-sized or large company stocks. The Fund may lend securities to approved institutions. Investing in derivatives entails special risks relating to liquidity, leverage and credit that may reduce returns and/or increase volatility. Please read the prospectus for details.
War, terrorism, economic uncertainty, trade disputes, public health crises (including the ongoing pandemic spread of the novel coronavirus) and related geopolitical events could lead to increased market volatility, disruption to U.S. and world economies and markets and may have significant adverse effects on the Fund and its investments.
The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc. which offers investment products or DWS Investment Management Americas, Inc. and RREEF America L.L.C. which offer advisory services.
DWS Distributors, Inc., 222 South Riverside Plaza, Chicago, IL 60606, (800) 621-1148
NOT FDIC/NCUA INSURED    NO BANK GUARANTEE    MAY LOSE VALUE
NOT A DEPOSIT    NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY
2 | DWS Small Cap Index VIP

Performance Summary December 31, 2021 (Unaudited)
Fund performance shown is historical, assumes reinvestment of all dividend and capital gain distributions, and does not guarantee future results. Investment return and principal value fluctuate with changing market conditions so that, when redeemed, shares may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. Please contact your participating insurance company for the Fund’s most recent month-end performance. Performance figures for Classes A and B differ because each class maintains a distinct expense structure. Performance does not reflect charges and fees (“contract charges”) associated with the separate account that invests in the Fund or any variable life insurance policy or variable annuity contract for which the Fund is an investment option. These charges and fees will reduce returns.
The gross expense ratios of the Fund, as stated in the fee table of the prospectus dated May 1, 2021 are 0.50% and 0.79% for Class A and Class B shares, respectively, and may differ from the expense ratios disclosed in the Financial Highlights tables in this report.
Generally accepted accounting principles require adjustments to be made to the net assets of the Fund at period end for financial reporting purposes only, and as such, the total return based on the unadjusted net asset value per share may differ from the total return reported in the financial highlights.
Growth of an Assumed $10,000 Investment

Yearly periods ended December 31
Russell 2000® Index is an unmanaged, capitalization-weighted measure of approximately 2,000 of the smallest companies in the Russell 3000® Index.
The Russell 3000® Index is an unmanaged index that measures the performance of the 3,000 largest U.S. companies based on total market capitalization, which represents approximately 98% of the investable U.S. equity market.
Index returns do not reflect any fees or expenses and it is not possible to invest directly into an index.
 

Comparative Results
DWS Small Cap Index VIP 1-Year 3-Year 5-Year 10-Year
Class A Growth of $10,000 $11,450 $17,124 $17,379 $33,875
Average annual total return 14.50% 19.64% 11.69% 12.98%
Russell 2000 Index Growth of $10,000 $11,482 $17,290 $17,639 $34,652
Average annual total return 14.82% 20.02% 12.02% 13.23%
DWS Small Cap Index VIP 1-Year 3-Year 5-Year 10-Year
Class B Growth of $10,000 $11,418 $16,980 $17,151 $32,981
Average annual total return 14.18% 19.30% 11.39% 12.67%
Russell 2000 Index Growth of $10,000 $11,482 $17,290 $17,639 $34,652
Average annual total return 14.82% 20.02% 12.02% 13.23%
The growth of $10,000 is cumulative.
DWS Small Cap Index VIP |3

Management Summary December 31, 2021 (Unaudited)
For the 12 months ended December 31, 2021, the Fund gained 14.50% (Class A shares, unadjusted for contract charges), compared with the 14.82% return of the Russell 2000® Index. The difference in performance is typically driven by transaction costs and Fund expenses. The Fund periodically invests in equity index futures in order to keep the portfolio’s exposures in line with those of the index. This strategy had a neutral impact on performance.
Small-cap stocks were helped by the backdrop of improving economic growth and robust corporate earnings brought about by the gradual resumption of normal business conditions. Monetary policy also remained supportive for most of the period, with the U.S. Federal Reserve keeping interest rates near zero and continuing its stimulative quantitative easing program. Multiple rounds of fiscal stimulus provided further fuel for investor sentiment.
The year was interesting for small caps in the sense that much of the gain for 2021 was already in the books by mid-February. The Russell 2000 Index posted impressive gains in the first six weeks of the year, when higher-risk asset classes were still in the midst of the rally that followed the first vaccine approval in late 2020. The index then proceeded to trade within a fairly defined range until November, at which point it broke out to a new high. This upswing proved to be short-lived, however, as the emergence of the omicron variant of COVID-19 caused the index to fall back into its previous range by the end of the month. After experiencing some choppiness in December, the index ultimately closed the year at the same level as where it stood in early February. Still, 2021 marked the third year in a row that the index has delivered a double-digit gain, as well as the fifth year of the past six.
Although small-cap equities produced a strong absolute return in 2021, they underperformed large caps. The shortfall stemmed primarily from the increasing dominance of a handful of mega-cap technology-related companies in the major large-company indexes. These stocks registered outsized returns as a group in 2021, leading to outperformance for the broader large-cap category.
While growth stocks outperformed value in the large-cap space, the opposite was true in small caps. The Russell 2000® Value Index rose 28.27% in 2021, far ahead of the 2.83% return for the Russell 2000® Growth Index.
At the sector level, energy was by far the top performer with a return well in excess of the Russell 2000 Index. Smaller energy companies logged significant gains as strength in oil and natural gas prices boosted their earnings and strengthened their balance sheets. However, the effect on overall performance was limited due to the sector’s modest weighting in the benchmark. The real estate, financials, and consumer discretionary sectors — all of which benefited from the acceleration in economic growth — were also top performers. On the other hand, health care was the only sector to post a negative return. The majority of stocks in the sector experienced a double-digit loss for the year, as biotechnology and pharmaceutical companies without current profits suffered sharp declines. Since health care has an index weighting of more than 20%, its weak performance was a sizable drag on returns in 2021. The defensive utilities sector, while finishing with a gain, also lagged the overall small-cap category.
Brent Reeder
Senior Vice President, Northern Trust Investments, Inc., Subadvisor to the Fund
Portfolio Manager
The views expressed reflect those of the portfolio management team only through the end of the period of the report as stated on the cover. The management team’s views are subject to change at any time based on market and other conditions and should not be construed as a recommendation. Past performance is no guarantee of future results. Current and future portfolio holdings are subject to risk.
Terms to Know
The Russell 2000 Index is an unmanaged, capitalization-weighted measure of approximately 2,000 of the smallest companies in the Russell 3000® Index.
The Russell 2000 Growth Index is an unmanaged index that measures the performance of the small-cap growth segment of the U.S. equity universe.
The Russell 2000 Value Index is an unmanaged index that measures the performance of the small-cap value segment of the U.S. equity universe.
4 | DWS Small Cap Index VIP

Portfolio Summary (Unaudited)
Asset Allocation (As a % of Investment Portfolio excluding Securities Lending Collateral) 12/31/21 12/31/20
Common Stocks 97% 99%
Cash Equivalents 3% 1%
Government & Agency Obligations 0% 0%
Warrants 0% 0%
Corporate Bonds 0%
Rights 0% 0%
  100% 100%
Sector Diversification (As a % of Common Stocks, Rights, Warrants and Corporate Bonds) 12/31/21 12/31/20
Health Care 18% 21%
Financials 16% 16%
Industrials 15% 16%
Information Technology 15% 14%
Consumer Discretionary 11% 13%
Real Estate 7% 6%
Energy 4% 2%
Materials 4% 4%
Consumer Staples 4% 3%
Communication Services 3% 2%
Utilities 3% 3%
  100% 100%
Ten Largest Equity Holdings at December 31, 2021 (3.2% of Net Assets)
 1 AMC Entertainment Holdings, Inc. 0.4%
Operator of theatrical exhibition business  
 2 Synaptics, Inc. 0.4%
Developer of custom designed user interface solutions  
 3 Lattice Semiconductor Corp. 0.3%
Manufacturer of high speed programmable logic devices  
 4 EastGroup Properties, Inc. 0.3%
Developer of industrial properties  
 5 BJ's Wholesale Club Holdings, Inc. 0.3%
Operator of warehouse club  
 6 Tetra Tech, Inc. 0.3%
Provider of management consulting and technical services  
 7 Saia, Inc. 0.3%
Provider of trucking transportation  
 8 Ovintiv, Inc. 0.3%
Producer of natural gas, oil and natural gas liquids  
 9 Tenet Healthcare Corp. 0.3%
Operator of specialty and general hospitals  
10 WillScot Mobile Mini Holdings Corp 0.3%
Provider of modular space and portable storage solutions  
Portfolio holdings and characteristics are subject to change.
For more complete details about the Fund’s investment portfolio, see page 6.
Following the Fund’s fiscal first and third quarter-end, a complete portfolio holdings listing is posted on dws.com, and is available free of charge by contacting your financial intermediary, or if you are a direct investor, by calling (800) 728-3337. In addition, the portfolio holdings listing is filed with the SEC on the Fund’s Form N-PORT and will be available on the SEC’s Web site at sec.gov. Additional portfolio holdings for the Fund are also posted on dws.com from time to time. Please see the Fund’s current prospectus for more information.
DWS Small Cap Index VIP |5

Investment Portfolio as of December 31, 2021
  Shares Value ($)
Common Stocks 96.9%  
Communication Services 3.0%  
Communications Equipment 0.0%  
EchoStar Corp. "A"*        5,658      149,088
Diversified Telecommunication Services 0.5%  
Anterix, Inc.*        1,751     102,889
ATN International, Inc.        1,608      64,240
Bandwidth, Inc. "A"*        3,540     254,030
Cogent Communications Holdings, Inc.        6,472     473,621
Consolidated Communications Holdings, Inc.*       11,043      82,602
Globalstar, Inc.* (a)       93,348     108,284
IDT Corp. "B"*        3,090     136,454
Iridium Communications, Inc.*       18,031     744,500
Liberty Latin America Ltd. "A"*        6,447      75,172
Liberty Latin America Ltd. "C"*       23,931     272,813
Ooma, Inc.*        3,382      69,128
Radius Global Infrastructure, Inc. "A"*        8,822     142,034
Telesat Corp.* (a)        2,038      58,430
      2,584,197
Entertainment 0.8%  
AMC Entertainment Holdings, Inc. "A"* (a)       78,927   2,146,814
Chicken Soup For The Soul Entertainment Inc.*          938      12,982
Cinemark Holdings, Inc.* (a)       16,748     269,978
CuriosityStream, Inc.*        4,003      23,738
Eros STX Global Corp*       49,107      11,771
IMAX Corp.*        7,513     134,032
Liberty Media Corp.-Liberty Braves "A"*        1,542      44,332
Liberty Media Corp.-Liberty Braves "C"*        5,628     158,147
Lions Gate Entertainment Corp. "A"*        8,982     149,460
Lions Gate Entertainment Corp. "B"*       18,161     279,498
LiveOne, Inc.*        7,885      10,093
Madison Square Garden Entertainment Corp.*        4,030     283,470
Marcus Corp.* (a)        3,616      64,582
      3,588,897
Interactive Media & Services 0.6%  
Cargurus, Inc.*       14,544     489,260
Cars.com, Inc.*       10,199     164,102
Eventbrite, Inc. "A"* (a)       11,754     204,990
EverQuote, Inc. "A"*        2,904      45,477
fuboTV, Inc.* (a)       20,742     321,916
  Shares Value ($)
Liberty TripAdvisor Holdings, Inc. "A"*       10,989      23,846
MediaAlpha, Inc. "A"*        3,182      49,130
Outbrain, Inc.*        1,190      16,660
QuinStreet, Inc.*        7,805     141,973
TrueCar, Inc.*       14,750      50,150
Yelp, Inc.*       10,897     394,907
Ziff Davis, Inc.*        6,690     741,653
      2,644,064
Media 1.0%  
Advantage Solutions, Inc.*       11,747      94,211
AMC Networks, Inc. "A"*        4,486     154,498
Boston Omaha Corp. "A"*        3,081      88,517
Cardlytics, Inc.*        4,952     327,278
Clear Channel Outdoor Holdings, Inc.*       55,887     184,986
comScore, Inc.*       10,039      33,530
Daily Journal Corp.*          192      68,492
Emerald Holding, Inc.*        4,554      18,079
Entercom Communications Corp.*       18,721      48,113
Entravision Communications Corp. "A"        9,050      61,359
Fluent, Inc.*        6,063      12,065
Gannett Co., Inc.*       21,472     114,446
Gray Television, Inc.       13,235     266,818
Hemisphere Media Group, Inc.*        2,187      15,899
iHeartMedia, Inc. "A"*       17,264     363,234
Integral Ad Science Holding Corp.*        2,543      56,480
John Wiley & Sons, Inc. "A"        6,651     380,903
Magnite, Inc.*       20,095     351,662
National CineMedia, Inc.        9,195      25,838
Scholastic Corp.        4,101     163,876
Sinclair Broadcast Group, Inc. "A"        7,140     188,710
Stagwell, Inc.*        9,625      83,449
TechTarget, Inc.*        3,986     381,301
TEGNA, Inc.       34,003     631,096
The E.W. Scripps Co. "A"*        8,901     172,234
Thryv Holdings, Inc.*        1,189      48,904
WideOpenWest, Inc.*        8,138     175,130
      4,511,108
Wireless Telecommunication Services 0.1%  
Gogo, Inc.* (a)        9,006     121,851
Shenandoah Telecommunications Co.        7,551     192,551
Telephone & Data Systems, Inc.       15,667     315,690
U.S. Cellular Corp.*        2,389      75,301
      705,393
 
The accompanying notes are an integral part of the financial statements.
6 | DWS Small Cap Index VIP

  Shares Value ($)
Consumer Discretionary 11.0%  
Auto Components 1.4%  
Adient PLC*       14,454     692,057
American Axle & Manufacturing Holdings, Inc.*       17,200     160,476
Cooper-Standard Holdings, Inc.*        2,638      59,118
Dana, Inc.       22,180     506,148
Dorman Products, Inc.*        4,027     455,091
Fox Factory Holding Corp.*        6,460   1,098,846
Gentherm, Inc.*        5,144     447,014
Goodyear Tire & Rubber Co.*       42,208     899,875
LCI Industries        3,821     595,579
Modine Manufacturing Co.*        7,327      73,929
Motorcar Parts of America, Inc.*        2,880      49,162
Patrick Industries, Inc.        3,452     278,542
Standard Motor Products, Inc.        3,189     167,072
Stoneridge, Inc.*        3,879      76,571
Tenneco, Inc. "A"*       10,149     114,684
Visteon Corp.*        4,237     470,900
XL Fleet Corp.*        5,927      19,618
XPEL, Inc.*        2,780     189,818
      6,354,500
Automobiles 0.3%  
Arcimoto, Inc.*        4,223      32,855
Canoo, Inc.* (a)       16,539     127,681
Fisker, Inc.* (a)       25,221     396,727
Lordstown Motors Corp. "A"* (a)       24,080      83,076
Winnebago Industries, Inc.        5,012     375,499
Workhorse Group, Inc.* (a)       17,984      78,410
      1,094,248
Distributors 0.0%  
Funko, Inc. "A"*        4,202      78,998
Greenlane Holdings, Inc. "A"*        1,386       1,336
      80,334
Diversified Consumer Services 0.6%  
2U, Inc.*       11,164     224,061
Adtalem Global Education, Inc.*        7,540     222,882
American Public Education, Inc.*        2,855      63,524
Carriage Services, Inc.        2,348     151,305
Coursera, Inc.* (a)       11,236     274,608
European Wax Center, Inc. "A"*        2,067      62,733
Graham Holdings Co. "B"          578     364,042
Houghton Mifflin Harcourt Co.* (a)       19,654     316,429
Laureate Education, Inc. "A"       15,498     189,696
  Shares Value ($)
OneSpaWorld Holdings Ltd.* (a)        8,077      80,932
Perdoceo Education Corp.*       10,462     123,033
PowerSchool Holdings, Inc. "A"* (a)        8,225     135,466
Regis Corp.*        6,746      11,738
StoneMor, Inc.*        4,918      11,213
Strategic Education, Inc.        3,721     215,223
Stride, Inc.*        6,324     210,779
Udemy, Inc.*        2,163      42,265
Vivint Smart Home, Inc.*       14,094     137,839
WW International, Inc.*        8,087     130,443
      2,968,211
Hotels, Restaurants & Leisure 2.3%  
Accel Entertainment, Inc.*        8,865     115,422
Bally's Corp.*        5,081     193,383
Biglari Holdings, Inc. "B"*          102      14,542
BJ's Restaurants, Inc.*        3,459     119,508
Bloomin' Brands, Inc.*       13,451     282,202
Bluegreen Vacations Holding Corp*        2,149      75,430
Brinker International, Inc.*        6,895     252,288
Carrols Restaurant Group, Inc.        5,337      15,798
Century Casinos, Inc.* (a)        4,231      51,534
Chuy's Holdings, Inc.*        3,124      94,095
Cracker Barrel Old Country Store, Inc.        3,664     471,337
Dave & Buster's Entertainment, Inc.*        6,605     253,632
Del Taco Restaurants, Inc.        4,606      57,345
Denny's Corp.*        9,363     149,808
Dine Brands Global, Inc.        2,500     189,525
Drive Shack, Inc.*       12,654      18,095
El Pollo Loco Holdings, Inc.*        2,711      38,469
Esports Technologies, Inc.*        1,631      33,533
Everi Holdings, Inc.*       13,284     283,613
F45 Training Holdings, Inc.*        2,851      31,047
Fiesta Restaurant Group, Inc.*        2,630      28,956
First Watch Restaurant Group, Inc.*        1,712      28,693
Full House Resorts, Inc.*        4,990      60,429
GAN Ltd.*        6,162      56,629
Golden Entertainment, Inc.*        2,583     130,519
Golden Nugget Online Gaming, Inc.*        5,957      59,272
Hall of Fame Resort & Entertainment Co.*        8,403      12,773
Hilton Grand Vacations, Inc.*       13,120     683,683
International Game Technology PLC       15,409     445,474
Jack in the Box, Inc.        3,295     288,247
Krispy Kreme, Inc. (a)        3,451      65,293
Kura Sushi USA, Inc. "A"*          598      48,342
Life Time Group Holdings, Inc.* (a)        5,840     100,506
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |7

  Shares Value ($)
Lindblad Expeditions Holdings, Inc.* (a)        4,676      72,946
Monarch Casino & Resort, Inc.*        2,053     151,819
Nathan's Famous, Inc.          497      29,020
NEOGAMES SA*        1,592      44,226
Noodles & Co.*        6,217      56,388
Papa John's International, Inc.        5,090     679,362
PlayAGS, Inc.*        3,774      25,625
Portillo's, Inc. "A"* (a)        3,583     134,506
RCI Hospitality Holdings, Inc.        1,237      96,338
Red Robin Gourmet Burgers, Inc.*        2,426      40,102
Red Rock Resorts, Inc. "A" (a)        9,036     497,070
Rush Street Interactive, Inc.*        7,985     131,753
Ruth's Hospitality Group, Inc.*        5,173     102,943
Scientific Games Corp. "A"* (a)       14,712     983,203
SeaWorld Entertainment, Inc.*        7,922     513,821
Shake Shack, Inc. "A"*        5,737     413,982
Target Hospitality Corp.*        4,513      16,066
Texas Roadhouse, Inc.       10,659     951,636
The Cheesecake Factory, Inc.*        7,141     279,570
The ONE Group Hospitality, Inc.*        2,972      37,477
Wingstop, Inc.        4,556     787,277
Xponential Fitness, Inc. "A"*        1,406      28,739
      10,823,291
Household Durables 1.9%  
Aterian, Inc.*        3,809      15,655
Bassett Furniture Industries, Inc.        1,442      24,182
Beazer Homes U.S.A., Inc.*        4,420     102,632
Casper Sleep, Inc.*        4,361      29,131
Cavco Industries, Inc.*        1,428     453,604
Century Communities, Inc.        4,598     376,070
Ethan Allen Interiors, Inc.        3,341      87,835
Flexsteel Industries, Inc.        1,032      27,720
GoPro, Inc. "A"*       19,479     200,829
Green Brick Partners, Inc.*        4,763     144,462
Hamilton Beach Brands Holding Co. "A"        1,206      17,318
Helen of Troy Ltd.*        3,677     898,916
Hooker Furniture Corp.        1,785      41,555
Hovnanian Enterprises, Inc. "A"*          785      99,923
Installed Building Products, Inc.        3,657     510,956
iRobot Corp.*        4,095     269,779
KB Home       12,137     542,888
Landsea Homes Corp.*        1,234       9,033
  Shares Value ($)
La-Z-Boy, Inc.        6,641     241,135
Legacy Housing Corp.*        1,257      33,273
LGI Homes, Inc.*        3,308     511,020
Lifetime Brands, Inc.        1,845      29,465
Lovesac Co.*        1,963     130,068
M.D.C. Holdings, Inc.        8,780     490,187
M/I Homes, Inc.*        4,341     269,923
Meritage Homes Corp.*        5,635     687,808
Purple Innovation, Inc.* (a)        8,614     114,308
Skyline Champion Corp.*        8,045     635,394
Snap One Holdings Corp.* (a)        1,939      40,874
Sonos, Inc.*       18,361     547,158
Taylor Morrison Home Corp.*       18,348     641,446
Traeger, Inc.*        3,324      40,420
Tri Pointe Home, Inc.*       17,020     474,688
Tupperware Brands Corp.*        7,422     113,482
Universal Electronics, Inc.*        1,953      79,585
VOXX International Corp.*        2,409      24,500
Vuzix Corp.* (a)        9,012      78,134
Weber, Inc. "A" (a)        2,523      32,622
      9,067,978
Internet & Direct Marketing Retail 0.5%  
1-800-Flowers.com, Inc. "A"* (a)        3,967      92,709
1stdibs.com, Inc.*          937      11,722
aka Brands Holding Corp.*        1,491      13,792
CarParts.com, Inc.* (a)        7,281      81,547
Duluth Holdings, Inc. "B"*        1,836      27,870
Groupon, Inc.* (a)        3,528      81,709
Lands' End, Inc.*        2,303      45,208
Liquidity Services, Inc.*        4,107      90,683
Lulu's Fashion Lounge Holdings, Inc.*          888       9,084
Overstock.com, Inc.*        6,622     390,764
PetMed Express, Inc. (a)        3,112      78,609
Porch Group, Inc.*       11,914     185,739
Quotient Technology, Inc.*       13,994     103,836
RealReal, Inc.* (a)       12,086     140,318
Rent the Runway, Inc. "A"* (a)        2,654      21,630
Revolve Group, Inc.* (a)        5,540     310,462
Shutterstock, Inc.        3,605     399,722
Stitch Fix, Inc. "A"* (a)       12,458     235,705
Xometry, Inc. "A"*        1,190      60,988
      2,382,097
Leisure Products 0.5%  
Acushnet Holdings Corp.        5,277     280,103
American Outdoor Brands, Inc.*        2,073      41,315
AMMO, Inc.* (a)       13,274      72,343
Callaway Golf Co.*       17,722     486,292
Clarus Corp.        4,061     112,571
Escalade, Inc.        1,389      21,932
The accompanying notes are an integral part of the financial statements.
8 | DWS Small Cap Index VIP

  Shares Value ($)
Genius Brands International, Inc.* (a)       43,490      45,665
Johnson Outdoors, Inc. "A"          824      77,201
Latham Group, Inc.* (a)        4,879     122,121
Malibu Boats, Inc. "A"*        3,156     216,912
Marine Products Corp.        1,244      15,550
MasterCraft Boat Holdings, Inc.*        2,878      81,534
Nautilus, Inc.* (a)        4,789      29,357
Smith & Wesson Brands, Inc.        7,178     127,768
Solo Brands, Inc. "A"* (a)        1,797      28,087
Sturm, Ruger & Co., Inc.        2,661     181,001
Vista Outdoor, Inc.*        8,861     408,226
      2,347,978
Multiline Retail 0.4%  
Big Lots, Inc.        4,881     219,889
Dillard's, Inc. "A" (a)          890     218,068
Franchise Group, Inc.        4,352     227,000
Macy's, Inc. (a)       48,011   1,256,928
      1,921,885
Specialty Retail 2.4%  
Aaron's Co., Inc.        4,713     116,175
Abercrombie & Fitch Co. "A"*        8,911     310,370
Academy Sports & Outdoors, Inc.*       11,962     525,132
American Eagle Outfitters, Inc. (a)       23,245     588,563
America's Car-Mart, Inc.*          955      97,792
Arko Corp.*       18,744     164,385
Asbury Automotive Group, Inc.*        3,536     610,773
Barnes & Noble Education, Inc.*        6,909      47,050
Bed Bath & Beyond, Inc.* (a)       15,522     226,311
Big 5 Sporting Goods Corp.        3,195      60,737
Boot Barn Holdings, Inc.*        4,467     549,664
Caleres, Inc.        5,779     131,068
Camping World Holdings, Inc. "A" (a)        6,364     257,106
CarLotz, Inc.* (a)       11,785      26,752
Cato Corp. "A"        3,028      51,960
Chico's FAS, Inc.* (a)       18,718     100,703
Citi Trends, Inc.* (a)        1,358     128,671
Conn's, Inc.* (a)        2,742      64,492
Designer Brands, Inc. "A"*        9,226     131,101
Genesco, Inc.*        2,289     146,885
Group 1 Automotive, Inc.        2,709     528,851
GrowGeneration Corp.*        8,491     110,808
Guess?, Inc.        6,159     145,845
Haverty Furniture Companies, Inc.        2,470      75,508
Hibbett, Inc.        2,252     161,986
JOANN, Inc.        1,803      18,715
Kirkland's, Inc.*        2,145      32,025
  Shares Value ($)
Lazydays Holdings, Inc.*        1,141      24,577
Lumber Liquidators Holdings, Inc.*        4,179      71,336
MarineMax, Inc.*        3,229     190,640
Monro, Inc.        5,056     294,613
Murphy USA, Inc.        3,707     738,583
National Vision Holdings, Inc.*       12,481     598,963
ODP Corp.*        7,034     276,296
OneWater Marine, Inc. "A"        1,502      91,577
Party City Holdco, Inc.* (a)       16,985      94,606
Rent-A-Center, Inc.       10,069     483,715
Sally Beauty Holdings, Inc.*       17,377     320,779
Shift Technologies, Inc.*        9,544      32,545
Shoe Carnival, Inc.        2,749     107,431
Signet Jewelers Ltd.        8,035     699,286
Sleep Number Corp.*        3,374     258,448
Sonic Automotive, Inc. "A"        3,368     166,548
Sportsman's Warehouse Holdings, Inc.*        6,490      76,582
The Buckle, Inc.        4,603     194,753
The Children's Place, Inc.*        2,164     171,584
The Container Store Group, Inc.*        5,172      51,617
Tilly's, Inc. "A"        3,686      59,381
Torrid Holdings, Inc.*        1,821      17,991
TravelCenters of America, Inc.*        1,914      98,801
Urban Outfitters, Inc.*       10,565     310,188
Winmark Corp.          538     133,580
Zumiez, Inc.*        3,231     155,056
      11,128,904
Textiles, Apparel & Luxury Goods 0.7%  
Crocs, Inc.*        8,898   1,140,901
Fossil Group, Inc.*        7,423      76,383
G-III Apparel Group Ltd.*        6,769     187,095
Kontoor Brands, Inc.        7,994     409,692
Movado Group, Inc. (a)        2,398     100,308
Oxford Industries, Inc.        2,444     248,115
PLBY Group, Inc.* (a)        4,422     117,802
Rocky Brands, Inc.          982      39,084
Steven Madden Ltd.       12,308     571,953
Superior Group of Companies, Inc.        1,660      36,420
Unifi, Inc.*        2,113      48,916
Vera Bradley, Inc.*        3,992      33,972
Wolverine World Wide, Inc.       12,418     357,763
      3,368,404
Consumer Staples 3.3%  
Beverages 0.4%  
Celsius Holdings, Inc.*        8,246     614,904
Coca-Cola Consolidated, Inc.          723     447,674
MGP Ingredients, Inc. (a)        2,217     188,423
National Beverage Corp.        3,615     163,868
NewAge, Inc.*       20,525      21,141
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |9

  Shares Value ($)
Primo Water Corp.       24,275     427,968
The Duckhorn Portfolio, Inc.* (a)        5,467     127,600
Zevia PBC "A"*        1,654      11,661
      2,003,239
Food & Staples Retailing 1.0%  
BJ's Wholesale Club Holdings, Inc.*       20,907   1,400,142
HF Foods Group, Inc.*        5,299      44,829
Ingles Markets, Inc. "A"        2,193     189,344
MedAvail Holdings, Inc.*        1,808       2,531
Natural Grocers by Vitamin Cottage, Inc.        1,516      21,603
Performance Food Group Co.*       23,182   1,063,822
PriceSmart, Inc.        3,633     265,827
Rite Aid Corp.*        8,323     122,265
SpartanNash Co.        5,608     144,462
Sprouts Farmers Market, Inc.*       17,105     507,676
The Andersons, Inc.        4,869     188,479
The Chefs' Warehouse, Inc.* (a)        4,817     160,406
United Natural Foods, Inc.*        8,604     422,284
Village Super Market, Inc. "A"        1,112      26,010
Weis Markets, Inc.        2,548     167,862
      4,727,542
Food Products 0.9%  
AppHarvest, Inc.* (a)       10,332      40,191
B&G Foods, Inc. (a)        9,863     303,090
Calavo Growers, Inc.        2,600     110,240
Cal-Maine Foods, Inc.        6,125     226,564
Fresh Del Monte Produce, Inc.        5,166     142,582
Hostess Brands, Inc.*       20,912     427,023
J & J Snack Foods Corp.        2,227     351,777
John B. Sanfilippo & Son, Inc.        1,320     119,011
Laird Superfood, Inc.*          947      12,349
Lancaster Colony Corp.        2,916     482,890
Landec Corp.*        3,778      41,936
Limoneira Co.        2,398      35,970
Mission Produce, Inc.* (a)        5,709      89,631
Sanderson Farms, Inc.        3,122     596,552
Seneca Foods Corp. "A"*        1,003      48,094
Simply Good Foods Co.*       12,925     537,292
Sovos Brands, Inc.*        3,809      57,325
Tattooed Chef, Inc.* (a)        7,188     111,701
The Vita Coco Co., Inc*        1,549      17,302
Tootsie Roll Industries, Inc. (a)        2,252      81,590
TreeHouse Foods, Inc.*        8,013     324,767
Utz Brands, Inc. (a)        8,990     143,390
  Shares Value ($)
Vital Farms, Inc.* (a)        3,928      70,940
Whole Earth Brands, Inc.*        5,755      61,809
      4,434,016
Household Products 0.3%  
Central Garden & Pet Co.*        1,483      78,050
Central Garden & Pet Co. "A"*        6,167     295,091
Energizer Holdings, Inc.       10,530     422,253
Oil-Dri Corp. of America          876      28,672
WD-40 Co. (a)        2,108     515,701
      1,339,767
Personal Products 0.6%  
BellRing Brands, Inc. "A"* (a)        6,214     177,285
Edgewell Personal Care Co.        8,364     382,319
elf Beauty, Inc.*        7,396     245,621
Inter Parfums, Inc.        2,769     296,006
Medifast, Inc.        1,751     366,712
Nature's Sunshine Products, Inc.        1,954      36,149
Nu Skin Enterprises, Inc. "A" (a)        7,678     389,659
Revlon, Inc. "A"*        1,271      14,413
The Beauty Health Co.* (a)       13,153     317,777
The Honest Co., Inc.* (a)       13,147     106,359
Thorne HealthTech, Inc.*        1,033       6,415
USANA Health Sciences, Inc.*        1,791     181,249
Veru, Inc.*       10,144      59,748
      2,579,712
Tobacco 0.1%  
22nd Century Group, Inc.* (a)       23,177      71,617
Turning Point Brands, Inc.        2,242      84,703
Universal Corp.        3,615     198,536
Vector Group Ltd.       22,132     254,075
      608,931
Energy 4.2%  
Energy Equipment & Services 0.7%  
Archrock, Inc.       20,442     152,906
Aspen Aerogels, Inc.*        3,420     170,282
Bristow Group, Inc.*        3,543     112,207
Cactus, Inc. "A"        8,500     324,105
ChampionX Corp.*       31,009     626,692
DMC Global, Inc.*        2,865     113,483
Dril-Quip, Inc.*        5,357     105,426
Expro Group Holdings NV*        7,095     101,813
FTS International, Inc. "A"*        1,373      36,041
Helix Energy Solutions Group, Inc.*       22,524      70,275
Helmerich & Payne, Inc.       16,053     380,456
Liberty Oilfield Services, Inc. "A"*       14,177     137,517
Nabors Industries Ltd.*        1,047      84,901
The accompanying notes are an integral part of the financial statements.
10 | DWS Small Cap Index VIP

  Shares Value ($)
National Energy Services Reunited Corp.*        5,594      52,863
Newpark Resources, Inc.*       13,210      38,837
NexTier Oilfield Solutions, Inc.*       25,809      91,622
Oceaneering International, Inc.*       15,587     176,289
Oil States International, Inc.*        9,159      45,520
Patterson-UTI Energy, Inc.       28,491     240,749
ProPetro Holding Corp.*       12,735     103,154
RPC, Inc.*       10,769      48,891
Select Energy Services, Inc. "A"*        9,966      62,088
Solaris Oilfield Infrastructure, Inc. "A"        4,525      29,639
TETRA Technologies, Inc.*       18,938      53,784
Tidewater, Inc.*        6,541      70,054
U.S. Silica Holdings, Inc.*       11,041     103,786
      3,533,380
Oil, Gas & Consumable Fuels 3.5%  
Aemetis, Inc.* (a)        4,015      49,385
Alto Ingredients, Inc.*       10,918      52,516
Altus Midstream Co. "A"          497      30,471
Antero Resources Corp.*       43,697     764,697
Arch Resources, Inc.        2,337     213,415
Berry Corp.       10,275      86,516
Brigham Minerals, Inc. "A"        6,686     141,008
California Resources Corp. (a)       12,372     528,408
Callon Petroleum Co.* (a)        7,270     343,507
Centennial Resource Development, Inc. "A"*       27,810     166,304
Centrus Energy Corp. "A"*        1,450      72,370
Chesapeake Energy Corp.       16,023   1,033,804
Civitas Resources, Inc.        6,634     324,867
Clean Energy Fuels Corp.*       24,156     148,076
CNX Resources Corp.*       31,968     439,560
Comstock Resources, Inc.*       14,081     113,915
CONSOL Energy, Inc.*        5,268     119,636
Crescent Energy, Inc. "A"* (a)        4,508      57,161
CVR Energy, Inc.        4,322      72,653
Delek U.S. Holdings, Inc.*       10,070     150,949
Denbury, Inc.*        7,773     595,334
DHT Holdings, Inc.       21,001     108,995
Dorian LPG Ltd.        4,570      57,993
Earthstone Energy, Inc. "A"*        3,555      38,892
Energy Fuels, Inc.* (a)       23,689     180,747
Equitrans Midstream Corp.       62,591     647,191
Falcon Minerals Corp.        6,307      30,715
Frontline Ltd.* (a)       17,813     125,938
Gevo, Inc.* (a)       29,928     128,092
Golar LNG Ltd.*       15,740     195,019
Green Plains, Inc.*        7,380     256,529
HighPeak Energy, Inc.        1,035      15,152
International Seaways, Inc.        7,390     108,485
  Shares Value ($)
Kosmos Energy Ltd.*       68,689     237,664
Laredo Petroleum, Inc.* (a)        1,935     116,352
Magnolia Oil & Gas Corp. "A"       21,984     414,838
Matador Resources Co. (a)       16,906     624,170
Murphy Oil Corp.       22,329     583,010
Nordic American Tankers Ltd. (a)       27,030      45,681
Northern Oil and Gas, Inc.        8,179     168,324
Oasis Petroleum, Inc.        3,012     379,482
Ovintiv, Inc.       40,010   1,348,337
Par Pacific Holdings, Inc.*        6,929     114,259
PBF Energy, Inc. "A"*       14,796     191,904
PDC Energy, Inc.       14,861     724,920
Peabody Energy Corp.*       13,571     136,660
Range Resources Corp.*       36,521     651,169
Ranger Oil Corp. "A"*        3,255      87,625
Renewable Energy Group, Inc.*        6,909     293,218
REX American Resources Corp.*          771      74,016
Riley Exploration Permian, Inc.          352       6,801
Scorpio Tankers, Inc.        7,493      95,985
SFL Corp. Ltd.       19,057     155,315
SM Energy Co.       18,494     545,203
Southwestern Energy Co.*      155,454     724,416
Talos Energy, Inc.*        5,678      55,644
Teekay Corp.*       10,677      33,526
Teekay Tankers Ltd. "A"*        3,658      39,872
Tellurian, Inc.* (a)       56,978     175,492
Uranium Energy Corp.* (a)       39,270     131,554
Ur-Energy, Inc.*       27,710      33,806
W&T Offshore, Inc.*       13,889      44,861
Whiting Petroleum Corp.*        6,078     393,125
World Fuel Services Corp.        9,656     255,594
      16,281,123
Financials 15.6%  
Banks 8.2%  
1st Source Corp.        2,629     130,398
Allegiance Bancshares, Inc.        2,840     119,876
Amalgamated Financial Corp.        1,860      31,192
Amerant Bancorp, Inc.        4,054     140,066
American National Bankshares, Inc.        1,579      59,497
Ameris Bancorp.       10,264     509,916
Arrow Financial Corp.        2,099      73,948
Associated Banc-Corp       22,556     509,540
Atlantic Capital Bancshares, Inc.*        2,911      83,749
Atlantic Union Bankshares Corp.       11,424     426,001
Banc of California, Inc.        8,229     161,453
BancFirst Corp.        2,639     186,208
Bank First Corp. (a)          968      69,928
Bank of Marin Bancorp.        2,457      91,474
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |11

  Shares Value ($)
Bank of NT Butterfield & Son Ltd.        7,790     296,877
BankUnited, Inc.       13,511     571,650
Banner Corp.        5,145     312,147
Bar Harbor Bankshares        2,246      64,977
Berkshire Hills Bancorp., Inc.        7,622     216,693
Blue Ridge Bankshares, Inc.        2,701      48,348
Brookline Bancorp., Inc.       11,478     185,829
Bryn Mawr Bank Corp.        3,127     140,746
Business First Bancshares, Inc.        3,115      88,186
Byline Bancorp., Inc. (a)        3,729     101,988
Cadence Bank       28,820     858,548
Cambridge Bancorp.        1,049      98,176
Camden National Corp.        2,310     111,250
Capital Bancorp., Inc        1,139      29,842
Capital City Bank Group, Inc.        1,984      52,378
Capstar Financial Holdings, Inc.        3,154      66,329
Carter Bankshares, Inc.*        4,127      63,515
Cathay General Bancorp.       11,240     483,208
CBTX, Inc.        2,740      79,460
Central Pacific Financial Corp.        4,254     119,835
CIT Group, Inc.       15,166     778,622
Citizens & Northern Corp.        2,252      58,822
City Holding Co.        2,228     182,228
Civista Bancshares, Inc.        2,320      56,608
CNB Financial Corp.        2,323      61,560
Coastal Financial Corp.*        1,361      68,894
Columbia Banking System, Inc.       12,087     395,487
Community Bank System, Inc.        8,187     609,768
Community Trust Bancorp., Inc.        2,422     105,623
ConnectOne Bancorp., Inc.        5,692     186,185
CrossFirst Bankshares, Inc.* (a)        7,198     112,361
Customers Bancorp., Inc.*        4,574     299,002
CVB Financial Corp.       19,867     425,353
Dime Community Bancshares, Inc.        5,303     186,454
Eagle Bancorp., Inc.        4,759     277,640
Eastern Bankshares, Inc.       26,368     531,843
Enterprise Bancorp., Inc.        1,527      68,593
Enterprise Financial Services Corp.        5,405     254,521
Equity Bancshares, Inc. "A" (a)        2,118      71,864
Farmers National Banc Corp.        4,637      86,016
FB Financial Corp.        5,016     219,801
Fidelity D&D Bancorp, Inc.          606      35,754
Financial Institutions, Inc.        2,348      74,666
First BanCorp.       30,680     422,770
First BanCorp. - North Carolina        5,321     243,276
First Bancorp., Inc.        1,499      47,069
  Shares Value ($)
First Bancshares, Inc.        3,234     124,897
First Bank        2,559      37,131
First Busey Corp.        7,787     211,183
First Commonwealth Financial Corp.       14,640     235,558
First Community Bancshares, Inc.        2,637      88,129
First Financial Bancorp.       13,996     341,223
First Financial Bankshares, Inc.       19,953   1,014,411
First Financial Corp.        1,803      81,658
First Foundation, Inc.        6,003     149,235
First Internet Bancorp.        1,408      66,232
First Interstate BancSystem, Inc. "A"        6,299     256,180
First Merchants Corp.        8,619     361,050
First Mid Bancshares, Inc.        2,576     110,227
First Midwest Bancorp., Inc.       17,630     361,062
First of Long Island Corp.        3,509      75,759
Five Star Bancorp.        1,951      58,530
Flushing Financial Corp.        4,686     113,870
Fulton Financial Corp.       24,255     412,335
German American Bancorp., Inc.        3,720     145,006
Glacier Bancorp., Inc.       16,921     959,421
Great Southern Bancorp., Inc.        1,572      93,141
Great Western Bancorp., Inc.        8,567     290,935
Guaranty Bancshares, Inc.        1,115      41,902
Hancock Whitney Corp.       13,289     664,716
Hanmi Financial Corp.        4,802     113,711
HarborOne Bancorp, Inc.        7,619     113,066
HBT Financial, Inc.        1,633      30,586
Heartland Financial U.S.A., Inc.        6,245     316,059
Heritage Commerce Corp.        9,092     108,559
Heritage Financial Corp.        5,418     132,416
Hilltop Holdings, Inc.        9,345     328,383
Home BancShares, Inc.       23,394     569,644
HomeTrust Bancshares, Inc.        2,310      71,564
Hope Bancorp., Inc.       17,402     255,983
Horizon Bancorp, Inc.        6,633     138,298
Howard Bancorp., Inc.*        1,839      40,072
Independent Bank Corp.       10,281     650,757
Independent Bank Group, Inc.        5,699     411,183
International Bancshares Corp.        8,303     351,964
Investors Bancorp., Inc.       35,117     532,023
Lakeland Bancorp., Inc.        7,276     138,171
Lakeland Financial Corp.        3,768     301,968
Live Oak Bancshares, Inc.        4,853     423,618
Macatawa Bank Corp.        4,472      39,443
Mercantile Bank Corp.        2,444      85,613
Metrocity Bankshares, Inc.        2,877      79,204
Metropolitan Bank Holding Corp.*        1,496     159,369
The accompanying notes are an integral part of the financial statements.
12 | DWS Small Cap Index VIP

  Shares Value ($)
Mid Penn Bancorp, Inc.        2,185      69,352
Midland States Bancorp., Inc.        3,289      81,534
MidWestOne Financial Group, Inc.        2,243      72,606
MVB Financial Corp.        1,471      61,076
National Bank Holdings Corp. "A"        4,512     198,257
NBT Bancorp., Inc.        6,560     252,691
Nicolet Bankshares, Inc.*        1,927     165,240
Northrim BanCorp., Inc.          890      38,679
OceanFirst Financial Corp.        9,047     200,843
OFG Bancorp. (a)        7,432     197,394
Old National Bancorp.       25,219     456,968
Old Second Bancorp., Inc.        4,268      53,734
Origin Bancorp, Inc. (a)        3,352     143,868
Orrstown Financial Services, Inc.        1,526      38,455
Pacific Premier Bancorp., Inc.       14,315     573,029
Park National Corp. (a)        2,187     300,297
Peapack-Gladstone Financial Corp.        2,769      98,023
Peoples Bancorp., Inc.        3,800     120,878
Peoples Financial Services Corp.        1,001      52,743
Preferred Bank        2,076     149,036
Primis Financial Corp.        3,621      54,460
QCR Holdings, Inc.        2,337     130,872
RBB Bancorp.        2,025      53,055
Red River Bancshares, Inc.          726      38,841
Reliant Bancorp., Inc.        2,240      79,520
Renasant Corp.        8,246     312,936
Republic Bancorp., Inc. "A"        1,404      71,379
Republic First Bancorp., Inc.*        7,485      27,844
S&T Bancorp., Inc.        5,917     186,504
Sandy Spring Bancorp., Inc.        6,757     324,877
Seacoast Banking Corp. of Florida        7,854     277,953
ServisFirst Bancshares, Inc.        7,681     652,424
Sierra Bancorp. (a)        2,103      57,096
Silvergate Capital Corp. "A"*        4,238     628,072
Simmons First National Corp. "A"       17,266     510,728
SmartFinancial, Inc.        1,986      54,337
South Plains Financial, Inc.        1,510      41,993
South State Corp.       10,735     859,981
Southern First Bancshares, Inc.*        1,130      70,614
Southside Bancshares, Inc.        4,805     200,945
Spirit of Texas Bancshares, Inc.        1,968      56,639
Stock Yards Bancorp., Inc.        3,736     238,656
Summit Financial Group, Inc.        1,881      51,633
Texas Capital Bancshares, Inc.*        7,825     471,456
The Bancorp, Inc.*        8,133     205,846
  Shares Value ($)
Third Coast Bancshares, Inc.*          604      15,692
Tompkins Financial Corp.        2,210     184,712
TowneBank       10,134     320,133
TriCo Bancshares        4,307     185,029
TriState Capital Holdings, Inc.*        4,412     133,507
Triumph Bancorp., Inc.*        3,628     432,022
Trustmark Corp.        9,596     311,486
UMB Financial Corp.        6,702     711,149
United Bankshares, Inc.       20,057     727,668
United Community Banks, Inc.       13,569     487,670
Univest Financial Corp.        4,311     128,985
Valley National Bancorp.       61,384     844,030
Veritex Holdings, Inc.        7,269     289,161
Washington Trust Bancorp., Inc.        2,584     145,660
WesBanco, Inc.        9,269     324,322
West BanCorp, Inc.        2,459      76,401
Westamerica BanCorp.        4,050     233,807
      38,664,251
Capital Markets 1.6%  
Artisan Partners Asset Management, Inc. "A"        8,948     426,283
AssetMark Financial Holdings, Inc.*        2,837      74,358
Associated Capital Group, Inc. "A"          276      11,868
B. Riley Financial, Inc.        3,115     276,799
BGC Partners, Inc. "A"       48,138     223,842
Blucora, Inc.*        7,670     132,844
Brightsphere Investment Group, Inc. (a)        8,874     227,174
Cohen & Steers, Inc.        3,817     353,111
Cowen, Inc. "A"        3,965     143,136
Diamond Hill Investment Group, Inc.          476      92,453
Donnelley Financial Solutions, Inc.*        4,554     214,676
Federated Hermes, Inc.       14,121     530,667
Focus Financial Partners, Inc. "A"*        9,185     548,528
GAMCO Investors, Inc. "A"          754      18,835
GCM Grosvenor, Inc. "A"        6,716      70,518
Greenhill & Co., Inc.        2,070      37,115
Hamilton Lane, Inc. "A"        5,305     549,704
Houlihan Lokey, Inc.        7,829     810,458
Moelis & Co. "A"        9,407     588,032
Open Lending Corp. "A"*       16,083     361,546
Oppenheimer Holdings, Inc. "A"        1,444      66,958
Piper Sandler Companies        2,694     480,906
PJT Partners, Inc. "A"        3,566     264,205
Pzena Investment Management, Inc. "A"        2,623      24,840
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |13

  Shares Value ($)
Sculptor Capital Management, Inc.        3,240      69,174
StepStone Group, Inc. "A"        6,151     255,697
StoneX Group, Inc.*        2,587     158,454
Value Line, Inc.          187       8,755
Virtus Investment Partners, Inc.        1,128     335,129
WisdomTree Investments, Inc.       20,907     127,951
      7,484,016
Consumer Finance 0.8%  
Atlanticus Holdings Corp.*          764      54,488
Curo Group Holdings Corp.        3,151      50,448
Encore Capital Group, Inc.* (a)        4,419     274,464
Enova International, Inc.*        5,574     228,311
EZCORP, Inc. "A"*        7,130      52,548
FirstCash Holdings, Inc.        6,124     458,136
Green Dot Corp. "A"*        8,275     299,886
LendingClub Corp.*       15,082     364,683
LendingTree, Inc.*        1,805     221,293
Navient Corp.       24,075     510,872
Nelnet, Inc. "A"        2,606     254,554
Oportun Financial Corp.*        3,124      63,261
PRA Group, Inc.* (a)        6,536     328,173
PROG Holdings, Inc. (a)        9,936     448,213
Regional Management Corp.        1,129      64,872
World Acceptance Corp.*          646     158,548
      3,832,750
Diversified Financial Services 0.2%  
Alerus Financial Corp.        2,359      69,071
A-Mark Precious Metals, Inc.        1,346      82,240
Banco Latinoamericano de Comercio Exterior SA "E"        4,821      80,029
Cannae Holdings, Inc.*       12,891     453,119
Marlin Business Services Corp.        1,215      28,285
      712,744
Insurance 1.9%  
Ambac Financial Group, Inc.*        7,119     114,260
American Equity Investment Life Holding Co.       12,755     496,425
American National Group, Inc.        1,125     212,445
AMERISAFE, Inc.        2,944     158,475
Argo Group International Holdings Ltd.        4,924     286,134
Bright Health Group, Inc.* (a)        7,937      27,303
BRP Group, Inc. "A"*        7,141     257,861
Citizens, Inc.* (a)        7,521      39,936
CNO Financial Group, Inc.       18,649     444,592
Crawford & Co. "A"        2,763      20,695
Donegal Group, Inc. "A"        2,103      30,052
eHealth, Inc.*        3,751      95,650
  Shares Value ($)
Employers Holdings, Inc.        4,341     179,631
Enstar Group Ltd.*        1,913     473,640
Genworth Financial, Inc. "A"*       78,211     316,755
Goosehead Insurance, Inc. "A"        2,736     355,899
Greenlight Capital Re Ltd. "A"*        3,838      30,090
HCI Group, Inc.          869      72,596
Heritage Insurance Holdings, Inc.        3,614      21,250
Horace Mann Educators Corp.        6,496     251,395
Independence Holding Co.          589      33,385
Investors Title Co.          183      36,078
James River Group Holdings Ltd.        5,512     158,801
Kinsale Capital Group, Inc.        3,286     781,707
Maiden Holdings, Ltd.*       10,666      32,638
MBIA, Inc.* (a)        7,480     118,109
MetroMile, Inc.*       14,851      32,524
National Western Life Group, Inc. "A"          401      85,990
NI Holdings, Inc.*        1,084      20,498
Palomar Holdings, Inc.*        3,805     246,450
ProAssurance Corp.        8,202     207,511
RLI Corp.        6,139     688,182
Safety Insurance Group, Inc. (a)        2,230     189,617
Selective Insurance Group, Inc.        9,132     748,276
Selectquote, Inc.*       20,795     188,403
SiriusPoint Ltd.*       13,573     110,348
State Auto Financial Corp.        2,693     139,201
Stewart Information Services Corp.        4,105     327,292
Tiptree, Inc.        3,292      45,528
Trean Insurance Group, Inc.*        2,703      24,084
Trupanion, Inc.*        5,845     771,715
United Fire Group, Inc.        3,279      76,040
United Insurance Holdings Corp.        3,590      15,581
Universal Insurance Holdings, Inc.        4,357      74,069
      9,037,111
Mortgage Real Estate Investment Trusts (REITs) 1.3%  
AFC Gamma, Inc.        1,934      44,018
Angel Oak Mortgage, Inc. (a)        1,143      18,722
Apollo Commercial Real Estate Finance, Inc.       21,376     281,308
Arbor Realty Trust, Inc. (a)       22,078     404,469
Ares Commercial Real Estate Corp.        7,046     102,449
ARMOUR Residential REIT, Inc. (a)       13,134     128,845
Blackstone Mortgage Trust, Inc. "A"       24,084     737,452
BrightSpire Capital, Inc.       12,535     128,609
The accompanying notes are an integral part of the financial statements.
14 | DWS Small Cap Index VIP

  Shares Value ($)
Broadmark Realty Capital, Inc.       19,670     185,488
Chimera Investment Corp.       36,008     543,001
Douglas Elliman, Inc.       11,066     127,259
Dynex Capital, Inc. (a)        5,534      92,473
Ellington Financial, Inc.        8,392     143,419
Franklin BSP Realty Trust, Inc.        5,502      82,200
Granite Point Mortgage Trust, Inc.        8,072      94,523
Great Ajax Corp.        3,079      40,520
Hannon Armstrong Sustainable Infrastructure Capital, Inc.       11,812     627,453
Invesco Mortgage Capital, Inc. (a)       48,232     134,085
KKR Real Estate Finance Trust, Inc.        5,406     112,607
Ladder Capital Corp.       17,207     206,312
MFA Financial, Inc.       67,542     307,991
New York Mortgage Trust, Inc.       58,084     216,072
Orchid Island Capital, Inc.       21,787      98,041
PennyMac Mortgage Investment Trust (a)       15,017     260,245
Ready Capital Corp.        9,248     144,546
Redwood Trust, Inc.       17,642     232,698
TPG RE Finance Trust, Inc.        9,611     118,408
Two Harbors Investment Corp.       52,193     301,154
      5,914,367
Thrifts & Mortgage Finance 1.6%  
Axos Financial, Inc.*        8,792     491,561
Blue Foundry Bancorp.*        4,078      59,661
Bridgewater Bancshares, Inc.*        3,349      59,244
Capitol Federal Financial, Inc.       20,062     227,303
Columbia Financial, Inc.*        6,187     129,061
Enact Holdings, Inc.        2,127      43,965
Essent Group Ltd.       16,523     752,292
Federal Agricultural Mortgage Corp. "C"        1,417     175,609
Finance of America Companies, Inc. "A"*        2,660      10,560
Flagstar Bancorp., Inc.        8,045     385,677
FS Bancorp, Inc.        1,014      34,101
Hingham Institution For Savings The          217      91,114
Home Bancorp., Inc.        1,080      44,831
Home Point Capital, Inc.        1,180       5,310
HomeStreet, Inc.        3,121     162,292
Kearny Financial Corp.       10,233     135,587
Luther Burbank Corp.        2,316      32,517
Merchants Bancorp.        1,465      69,338
Meta Financial Group, Inc.        4,880     291,141
Mr Cooper Group, Inc.*        9,390     390,718
NMI Holdings, Inc. "A"*       12,789     279,440
  Shares Value ($)
Northfield Bancorp., Inc.        6,945     112,231
Northwest Bancshares, Inc.       18,954     268,389
Ocwen Financial Corp.*        1,261      50,402
PCSB Financial Corp.        2,106      40,098
PennyMac Financial Services, Inc.        4,760     332,153
Pioneer Bancorp., Inc.*        1,979      22,402
Premier Financial Corp.        5,607     173,312
Provident Bancorp, Inc.        2,529      47,039
Provident Financial Services, Inc.       11,423     276,665
Radian Group, Inc.       27,408     579,131
Southern Missouri Bancorp., Inc.        1,107      57,752
TrustCo Bank Corp. NY        2,827      94,167
Velocity Financial, Inc.*        1,318      18,057
Walker & Dunlop, Inc.        4,494     678,055
Washington Federal, Inc.        9,802     327,191
Waterstone Financial, Inc.        3,353      73,297
WSFS Financial Corp.        7,270     364,372
      7,386,035
Health Care 17.5%  
Biotechnology 8.2%  
2seventy bio, Inc.* (a)        3,457      88,603
4D Molecular Therapeutics, Inc.* (a)        4,326      94,912
89bio, Inc.*        1,368      17,880
ACADIA Pharmaceuticals, Inc.*       18,359     428,499
Acumen Pharmaceuticals, Inc.*        1,346       9,099
Adagio Therapeutics, Inc.* (a)        3,164      22,971
Adicet Bio, Inc.*        3,171      55,461
Aduro Biotech Holding Europe BV        2,328           0
Adverum Biotechnologies, Inc.* (a)       14,257      25,092
Aeglea BioTherapeutics, Inc.*        5,803      27,564
Aerovate Therapeutics, Inc.*        1,460      17,213
Affimed NV*       18,122     100,033
Agenus, Inc.* (a)       32,612     105,011
Agios Pharmaceuticals, Inc.*        8,334     273,939
Akebia Therapeutics, Inc.*       25,679      58,035
Akero Therapeutics, Inc.*        3,939      83,310
Akouos, Inc.* (a)        3,481      29,588
Albireo Pharma, Inc.*        2,658      61,905
Aldeyra Therapeutics, Inc.* (a)        7,426      29,704
Alector, Inc.*        8,845     182,649
Aligos Therapeutics, Inc.* (a)        3,087      36,643
Alkermes PLC*       24,536     570,707
Allakos, Inc.*        5,431      53,169
Allogene Therapeutics, Inc.*       10,654     158,958
Allovir, Inc.*        4,336      56,108
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |15

  Shares Value ($)
Alpine Immune Sciences, Inc.*        1,727      23,919
Altimmune, Inc.*        6,189      56,691
ALX Oncology Holdings, Inc.*        2,652      56,991
Amicus Therapeutics, Inc.*       40,334     465,858
AnaptysBio, Inc.*        2,936     102,026
Anavex Life Sciences Corp.* (a)       10,291     178,446
Anika Therapeutics, Inc.*        2,197      78,718
Annexon, Inc.*        4,786      54,991
Apellis Pharmaceuticals, Inc.*       10,952     517,811
Applied Molecular Transport, Inc.*        3,792      53,012
Applied Therapeutics, Inc.*        2,831      25,337
AquaBounty Technologies, Inc.*        8,030      16,863
Arbutus Biopharma Corp.*       11,933      46,419
Arcturus Therapeutics Holdings, Inc.* (a)        3,239     119,875
Arcus Biosciences, Inc.* (a)        6,875     278,231
Arcutis Biotherapeutics, Inc.*        4,241      87,958
Ardelyx, Inc.*       12,958      14,254
Arena Pharmaceuticals, Inc.*        9,499     882,837
Arrowhead Pharmaceuticals, Inc.*       15,524   1,029,241
Atara Biotherapeutics, Inc.*       13,399     211,168
Athenex, Inc.*       13,245      18,013
Athersys, Inc.* (a)       33,481      30,220
Atossa Therapeutics, Inc.*       17,955      28,728
Atreca, Inc. "A"* (a)        3,654      11,072
Aura Biosciences, Inc.*          867      14,722
Avid Bioservices, Inc.* (a)        9,264     270,324
Avidity Biosciences, Inc.*        5,917     140,647
Avita Medical, Inc.*        3,660      43,847
Avrobio, Inc.*        5,779      22,249
Beam Therapeutics, Inc.* (a)        7,843     625,009
Beyondspring, Inc.*        3,302      14,958
BioAtla, Inc.*        2,438      47,858
BioCryst Pharmaceuticals, Inc.* (a)       27,607     382,357
Biohaven Pharmaceutical Holding Co., Ltd.*        8,530   1,175,519
Biomea Fusion, Inc.*        3,411      25,412
Bioxcel Therapeutics, Inc.* (a)        2,532      51,476
Black Diamond Therapeutics, Inc.*        3,653      19,470
Bluebird Bio, Inc.*       10,373     103,626
Blueprint Medicines Corp.*        8,953     958,956
Bolt Biotherapeutics, Inc.* (a)        3,361      16,469
Bridgebio Pharma, Inc.* (a)       16,298     271,851
Brooklyn ImmunoTherapeutics, Inc.*        4,354      18,156
  Shares Value ($)
C4 Therapeutics, Inc.* (a)        5,950     191,590
Cardiff Oncology, Inc.*        5,505      33,085
CareDx, Inc.*        7,753     352,606
Caribou Biosciences, Inc.*        3,142      47,413
Catalyst Pharmaceuticals, Inc.*       15,196     102,877
Celcuity, Inc.*        1,379      18,189
Celldex Therapeutics, Inc.* (a)        7,144     276,044
CEL-SCI Corp*        5,598      39,746
Century Therapeutics, Inc.*        1,725      27,358
Cerevel Therapeutics Holdings, Inc.*        6,233     202,074
ChemoCentryx, Inc.*        8,375     304,934
Chimerix, Inc.*       11,169      71,817
Chinook Therapeutics, Inc.*        6,025      98,268
Clene Inc.* (a)        3,513      14,403
Clovis Oncology, Inc.* (a)       16,566      44,894
Codiak Biosciences, Inc.*        2,408      26,825
Cogent Biosciences, Inc.* (a)        5,680      48,734
Coherus Biosciences, Inc.*       10,137     161,787
Cortexyme, Inc.* (a)        2,979      37,595
Crinetics Pharmaceuticals, Inc.* (a)        7,081     201,171
Cue Biopharma, Inc.*        4,881      55,204
Cullinan Oncology, Inc* (a)        3,842      59,282
Curis, Inc.*       13,236      63,003
Cytokinetics, Inc.* (a)       12,143     553,478
CytomX Therapeutics, Inc.*       10,055      43,538
Day One Biopharmaceuticals, Inc.*        1,606      27,061
Deciphera Pharmaceuticals, Inc.*        5,918      57,819
Denali Therapeutics, Inc.*       13,919     620,787
DermTech, Inc.* (a)        3,638      57,480
Design Therapeutics, Inc.* (a)        4,126      88,338
Dynavax Technologies Corp.* (a)       16,746     235,616
Dyne Therapeutics, Inc.* (a)        4,605      54,753
Eagle Pharmaceuticals, Inc.*        1,729      88,041
Editas Medicine, Inc.* (a)       10,611     281,722
Eiger BioPharmaceuticals, Inc.*        5,072      26,324
Eliem Therapeutics, Inc.* (a)        1,019      10,659
Emergent BioSolutions, Inc.*        7,598     330,285
Enanta Pharmaceuticals, Inc.*        3,007     224,863
Entrada Therapeutics, Inc.*        1,448      24,790
Epizyme, Inc.*       13,419      33,547
Erasca, Inc.* (a)        3,048      47,488
Evelo Biosciences, Inc.* (a)        4,653      28,244
Fate Therapeutics, Inc.*       12,443     728,040
FibroGen, Inc.*       13,123     185,034
Finch Therapeutics Group, Inc.*        1,151      11,475
The accompanying notes are an integral part of the financial statements.
16 | DWS Small Cap Index VIP

  Shares Value ($)
Foghorn Therapeutics, Inc.*        2,986      68,290
Forma Therapeutics Holdings, Inc.* (a)        5,013      71,285
Forte Biosciences, Inc.*        1,729       3,700
Fortress Biotech, Inc.*       10,826      27,065
Frequency Therapeutics, Inc.* (a)        5,090      26,112
G1 Therapeutics, Inc.* (a)        6,012      61,383
Gemini Therapeutics, Inc.*        3,333       9,699
Generation Bio Co.*        6,531      46,239
Geron Corp.* (a)       46,692      56,964
Global Blood Therapeutics, Inc.*        9,345     273,528
Gossamer Bio, Inc.*        9,395     106,257
Graphite Bio, Inc.*        2,369      29,447
Greenwich Lifesciences, Inc.*          614      14,939
Gritstone bio, Inc.* (a)        6,179      79,462
GT Biopharma, Inc.*        2,456       7,491
Halozyme Therapeutics, Inc.*       21,135     849,838
Harpoon Therapeutics, Inc.*        2,916      22,016
Heron Therapeutics, Inc.* (a)       13,963     127,482
Homology Medicines, Inc.*        6,738      24,526
Hookipa Pharma, Inc.*        3,395       7,910
Humanigen, Inc.*        6,874      25,571
iBio, Inc.*       34,708      19,055
Icosavax, Inc.* (a)        1,981      45,325
Ideaya Biosciences, Inc.*        5,065     119,737
IGM Biosciences, Inc.*        1,223      35,871
Imago Biosciences, Inc.*        1,424      33,763
Immuneering Corp. "A"*        1,194      19,307
Immunic, Inc.*        3,075      29,428
ImmunityBio, Inc.* (a)       10,244      62,284
ImmunoGen, Inc.*       30,408     225,627
Immunovant, Inc.*        6,133      52,253
Impel Neuropharma, Inc.*          723       6,239
Infinity Pharmaceuticals, Inc.*       13,364      30,069
Inhibrx, Inc.* (a)        4,285     187,126
Inovio Pharmaceuticals, Inc.* (a)       32,211     160,733
Inozyme Pharma, Inc.*        1,975      13,469
Insmed, Inc.*       18,147     494,324
Instil Bio, Inc.* (a)        8,309     142,167
Intellia Therapeutics, Inc.*       10,675   1,262,212
Intercept Pharmaceuticals, Inc.* (a)        3,857      62,831
Invitae Corp.* (a)       30,759     469,690
Ironwood Pharmaceuticals, Inc.*       22,713     264,834
iTeos Therapeutics, Inc.*        2,990     139,214
IVERIC bio, Inc.*       17,623     294,657
Janux Therapeutics, Inc.* (a)        1,948      38,434
Jounce Therapeutics, Inc.*        5,032      42,017
KalVista Pharmaceuticals, Inc.*        3,116      41,225
  Shares Value ($)
Karuna Therapeutics, Inc.*        3,406     446,186
Karyopharm Therapeutics, Inc.* (a)       11,474      73,778
Keros Therapeutics, Inc.* (a)        2,392     139,956
Kezar Life Sciences, Inc.* (a)        5,428      90,756
Kiniksa Pharmaceuticals Ltd. "A"*        4,174      49,128
Kinnate Biopharma, Inc.*        3,767      66,751
Kodiak Sciences, Inc.* (a)        5,137     435,515
Kronos Bio, Inc.*        5,952      80,888
Krystal Biotech, Inc.*        2,747     192,153
Kura Oncology, Inc.*        9,577     134,078
Kymera Therapeutics, Inc.* (a)        5,333     338,592
Lexicon Pharmaceuticals, Inc.*       10,380      40,897
Ligand Pharmaceuticals, Inc.* (a)        2,333     360,355
Lineage Cell Therapeutics, Inc.* (a)       18,562      45,477
Lyell Immunopharma, Inc.*        3,440      26,626
MacroGenics, Inc.*        9,391     150,726
Madrigal Pharmaceuticals, Inc.* (a)        1,821     154,312
Magenta Therapeutics, Inc.*        4,575      20,267
MannKind Corp.* (a)       38,562     168,516
MaxCyte, Inc.*       14,821     151,026
MEI Pharma, Inc.* (a)       15,242      40,696
MeiraGTx Holdings PLC*        4,590     108,967
Mersana Therapeutics, Inc.*       10,564      65,708
MiMedx Group, Inc.* (a)       17,052     102,994
Mirum Pharmaceuticals, Inc.*          287       4,578
Molecular Templates, Inc.*        5,730      22,462
Monte Rosa Therapeutics, Inc.*        1,696      34,632
Morphic Holding, Inc.*        3,238     153,416
Mustang Bio, Inc.*       11,045      18,335
Myriad Genetics, Inc.*       12,117     334,429
Neoleukin Therapeutics, Inc.*        5,089      24,529
NexImmune, Inc.*        2,574      11,866
Nkarta, Inc.*        2,156      33,095
Nurix Therapeutics, Inc.* (a)        4,806     139,134
Nuvalent, Inc. "A"*        1,585      30,178
Ocugen, Inc.* (a)       28,302     128,774
Olema Pharmaceuticals, Inc.* (a)        3,732      34,932
Omega Therapeutics, Inc.*        1,055      11,953
Oncocyte Corp.*       10,247      22,236
Oncorus, Inc.*        3,123      16,458
Oncternal Therapeutics, Inc.*        6,739      15,298
OPKO Health, Inc.* (a)       61,943     297,946
Organogenesis Holdings, Inc.*        5,846      54,017
ORIC Pharmaceuticals, Inc.* (a)        4,704      69,149
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |17

  Shares Value ($)
Outlook Therapeutics, Inc.*       13,336      18,137
Oyster Point Pharma, Inc.*        1,696      30,969
Passage Bio, Inc.*        5,678      36,055
PMV Pharmaceuticals, Inc.* (a)        4,022      92,908
Portage Biotech, Inc.*          548       5,880
Poseida Therapeutics, Inc.*        4,323      29,440
Praxis Precision Medicines, Inc.* (a)        5,162     101,691
Precigen, Inc.*       14,534      53,921
Precision BioSciences, Inc.*        7,836      57,986
Prelude Therapeutics, Inc.* (a)        1,618      20,144
Prometheus Biosciences, Inc.* (a)        4,609     182,240
Protagonist Therapeutics, Inc.* (a)        6,778     231,808
Prothena Corp. PLC*        5,538     273,577
PTC Therapeutics, Inc.*       10,687     425,663
Puma Biotechnology, Inc.*        4,810      14,622
Pyxis Oncology, Inc.*        1,727      18,945
Radius Health, Inc.* (a)        7,334      50,751
Rallybio Corp.*          955       9,111
RAPT Therapeutics, Inc.*        3,292     120,915
Recursion Pharmaceuticals, Inc. "A"* (a)       17,684     302,927
REGENXBIO, Inc.*        6,176     201,955
Relay Therapeutics, Inc.*       10,728     329,457
Reneo Pharmaceuticals, Inc.*        1,096       9,371
Replimune Group, Inc.*        4,653     126,096
REVOLUTION Medicines, Inc.* (a)        9,148     230,255
Rhythm Pharmaceuticals, Inc.*        6,753      67,395
Rigel Pharmaceuticals, Inc.*       25,327      67,117
Rocket Pharmaceuticals, Inc.*        6,212     135,608
Rubius Therapeutics, Inc.* (a)        6,913      66,918
Sana Biotechnology, Inc.* (a)       13,425     207,819
Sangamo Therapeutics, Inc.*       18,637     139,777
Scholar Rock Holding Corp.* (a)        4,350     108,054
Selecta Biosciences, Inc.*       13,726      44,747
Sensei Biotherapeutics, Inc.*        3,114      18,061
Sera Prognostics, Inc. "A"*          516       3,545
Seres Therapeutics, Inc.*       10,676      88,931
Sesen Bio, Inc.*       26,218      21,368
Shattuck Labs, Inc.*        4,078      34,704
Sigilon Therapeutics, Inc.*        2,035       5,617
Silverback Therapeutics, Inc.* (a)        3,308      22,031
Solid Biosciences, Inc.*        9,102      15,928
Sorrento Therapeutics, Inc.* (a)       45,820     213,063
  Shares Value ($)
Spectrum Pharmaceuticals, Inc.*       24,947      31,683
Spero Therapeutics, Inc.*        3,443      55,122
SpringWorks Therapeutics, Inc.*        4,482     277,794
Spruce Biosciences, Inc.* (a)        1,143       5,098
SQZ Biotechnologies Co.* (a)        3,478      31,059
Stoke Therapeutics, Inc.*        2,923      70,123
Summit Therapeutics, Inc.*        3,405       9,159
Surface Oncology, Inc.*        5,050      24,139
Sutro Biopharma, Inc.*        6,637      98,759
Syndax Pharmaceuticals, Inc.*        6,894     150,910
Syros Pharmaceuticals, Inc.*        8,330      27,156
Talaris Therapeutics, Inc.*        3,330      50,916
Taysha Gene Therapies, Inc.* (a)        3,409      39,715
TCR2 Therapeutics, Inc.*        4,733      22,056
Tenaya Therapeutics, Inc.* (a)        2,043      38,715
TG Therapeutics, Inc.*       19,868     377,492
Tonix Pharmaceuticals Holding Corp.* (a)       70,128      25,085
Travere Therapeutics, Inc.*        9,045     280,757
Trevena, Inc.*       25,031      14,581
Turning Point Therapeutics, Inc.*        7,063     336,905
Twist Bioscience Corp.* (a)        7,237     560,071
Tyra Biosciences, Inc.*        1,915      26,944
UroGen Pharma Ltd.* (a)        3,025      28,768
Vanda Pharmaceuticals, Inc.*        8,210     128,815
Vaxart, Inc.* (a)       18,328     114,917
Vaxcyte, Inc.* (a)        6,100     145,119
VBI Vaccines, Inc.* (a)       28,377      66,402
Vera Therapeutics, Inc.*        1,560      41,683
Veracyte, Inc.*       10,342     426,090
Verastem, Inc.*       27,171      55,701
Vericel Corp.* (a)        7,109     279,384
Verve Therapeutics, Inc.* (a)        2,355      86,829
Viking Therapeutics, Inc.*       10,059      46,271
Vincerx Pharma, Inc.*        2,632      26,820
Vir Biotechnology, Inc.*        9,210     385,623
Viracta Therapeutics, Inc.*        5,563      20,305
VistaGen Therapeutics, Inc.* (a)       29,306      57,147
Vor BioPharma, Inc.*        2,768      32,164
Werewolf Therapeutics, Inc.*        4,104      48,879
XBiotech, Inc.        2,119      23,584
Xencor, Inc.*        8,682     348,322
Xilio Therapeutics, Inc.*        1,210      19,360
XOMA Corp.*        1,030      21,475
Y-mAbs Therapeutics, Inc.*        5,362      86,918
The accompanying notes are an integral part of the financial statements.
18 | DWS Small Cap Index VIP

  Shares Value ($)
Zentalis Pharmaceuticals, Inc.*        5,556     467,037
ZIOPHARM Oncology, Inc.* (a)       30,832      33,607
      38,370,745
Health Care Equipment & Supplies 3.1%  
Accelerate Diagnostics, Inc.* (a)        5,301      27,671
Accuray, Inc.*       14,218      67,820
Acutus Medical, Inc.*        2,691       9,176
Alphatec Holdings, Inc.*       10,554     120,632
AngioDynamics, Inc.*        5,792     159,743
Apyx Medical Corp.*        4,922      63,100
Asensus Surgical, Inc.* (a)       35,936      39,889
Aspira Women's Health, Inc.*       11,120      19,682
AtriCure, Inc.*        6,848     476,141
Atrion Corp.          210     148,029
Avanos Medical, Inc.*        7,346     254,686
Axogen, Inc.*        5,986      56,089
Axonics, Inc.*        7,034     393,904
BioLife Solutions, Inc.*        1,594      59,408
Bioventus, Inc. "A"*        4,604      66,712
Butterfly Network, Inc.* (a)       19,203     128,468
Cardiovascular Systems, Inc.*        6,171     115,891
Cerus Corp.*       26,336     179,348
ClearPoint Neuro, Inc.*        2,881      32,325
CONMED Corp.        4,419     626,437
CryoLife, Inc.*        5,766     117,338
CryoPort, Inc.*        6,275     371,292
Cue Health, Inc.*        2,323      31,151
Cutera, Inc.*        2,722     112,473
CVRx, Inc.* (a)        1,270      15,532
CytoSorbents Corp.*        6,431      26,946
DarioHealth Corp.*        2,068      26,822
Eargo, Inc.*        4,821      24,587
Glaukos Corp.*        6,964     309,480
Haemonetics Corp.*        7,791     413,235
Heska Corp.* (a)        1,520     277,385
Inari Medical, Inc.*        5,257     479,806
Inogen, Inc.*        2,986     101,524
Integer Holdings Corp.*        5,079     434,712
Intersect ENT, Inc.*        5,217     142,476
Invacare Corp.*        5,137      13,973
iRadimed Corp.*        1,016      46,949
iRhythm Technologies, Inc.*        4,557     536,313
Lantheus Holdings, Inc.*       10,285     297,134
LeMaitre Vascular, Inc.        2,860     143,658
LivaNova PLC*        8,171     714,391
Meridian Bioscience, Inc.*        6,361     129,764
Merit Medical Systems, Inc.*        7,794     485,566
Mesa Laboratories, Inc.          773     253,614
Natus Medical, Inc.*        5,043     119,670
Neogen Corp.*       16,565     752,217
  Shares Value ($)
Neuronetics, Inc.*        3,831      17,086
NeuroPace, Inc.*        1,062      10,705
Nevro Corp.*        5,296     429,347
NuVasive, Inc.*        8,015     420,627
OraSure Technologies, Inc.*       10,660      92,635
Ortho Clinical Diagnostics Holdings PLC*       18,314     391,736
Orthofix Medical, Inc.*        2,868      89,166
OrthoPediatrics Corp.*        2,118     126,783
Outset Medical, Inc.* (a)        7,097     327,101
Paragon 28, Inc.*        1,382      24,448
PAVmed, Inc.*       10,684      26,283
PROCEPT BioRobotics Corp.*        1,158      28,962
Pulmonx Corp.* (a)        3,897     124,977
Pulse Biosciences, Inc.* (a)        2,153      31,886
Quotient Ltd.*       12,092      31,318
Retractable Technologies, Inc.* (a)        2,526      17,505
RxSight, Inc.*        1,538      17,303
SeaSpine Holdings Corp.*        4,869      66,316
Senseonics Holdings, Inc.* (a)       67,153     179,299
Shockwave Medical, Inc.*        5,166     921,253
SI-BONE, Inc.*        4,922     109,318
Sientra, Inc.*        8,318      30,527
Sight Sciences, Inc.*        1,580      27,761
Silk Road Medical, Inc.*        5,302     225,918
STAAR Surgical Co.*        7,265     663,295
Stereotaxis, Inc.*        7,906      49,017
Surmodics, Inc.*        2,093     100,778
Tactile Systems Technology, Inc.*        2,930      55,758
Talis Biomedical Corp.*        2,153       8,634
TransMedics Group, Inc.*        4,014      76,908
Treace Medical Concepts, Inc.*        4,636      86,415
Utah Medical Products, Inc.          540      54,000
Vapotherm, Inc.*        3,510      72,692
Varex Imaging Corp.*        5,958     187,975
ViewRay, Inc.*       21,404     117,936
Zynex, Inc.*        3,097      30,877
      14,695,704
Health Care Providers & Services 2.9%  
1Life Healthcare, Inc.*       17,918     314,819
Accolade, Inc.*        7,912     208,560
AdaptHealth Corp.*       11,075     270,895
Addus HomeCare Corp.*        2,391     223,582
Agiliti, Inc.* (a)        3,464      80,226
AirSculpt Technologies, Inc.*        1,105      18,995
Alignment Healthcare, Inc.*       12,157     170,927
AMN Healthcare Services, Inc.*        7,197     880,409
Apollo Medical Holdings, Inc.* (a)        5,808     426,772
Apria, Inc.*        2,974      96,952
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |19

  Shares Value ($)
Aveanna Healthcare Holdings, Inc.*        5,986      44,296
Biodesix, Inc.*        1,882       9,956
Brookdale Senior Living, Inc.*       28,385     146,467
Castle Biosciences, Inc.*        3,180     136,327
Community Health Systems, Inc.*       19,163     255,060
CorVel Corp.* (a)        1,368     284,544
Covetrus, Inc.*       15,822     315,965
Cross Country Healthcare, Inc.*        5,540     153,790
Exagen, Inc.*        1,684      19,585
Fulgent Genetics, Inc.* (a)        3,184     320,279
Hanger, Inc.*        5,604     101,601
HealthEquity, Inc.*       12,622     558,397
InfuSystems Holdings, Inc.*        2,777      47,292
Innovage Holding Corp.*        2,834      14,170
LHC Group, Inc.*        4,652     638,394
LifeStance Health Group, Inc.* (a)        6,906      65,745
Magellan Health, Inc.*        3,591     341,109
MEDNAX, Inc.*       11,791     320,833
ModivCare, Inc.*        1,926     285,607
National HealthCare Corp.        1,872     127,184
National Research Corp.        2,056      85,365
Ontrack, Inc.*        1,246       7,837
Option Care Health, Inc.*       24,297     691,007
Owens & Minor, Inc.       11,165     485,677
Patterson Companies, Inc.       13,170     386,539
PetIQ, Inc.* (a)        4,056      92,112
Privia Health Group, Inc.*        2,462      63,692
Progyny, Inc.*        9,847     495,796
R1 RCM, Inc.*       18,329     467,206
RadNet, Inc.*        6,929     208,632
Select Medical Holdings Corp.       16,810     494,214
Sharps Compliance Corp.*        2,351      16,763
SOC Telemed, Inc.*        8,632      11,049
Surgery Partners, Inc.*        5,187     277,038
Tenet Healthcare Corp.*       16,199   1,323,296
The Ensign Group, Inc.        8,002     671,848
The Joint Corp.*        2,095     137,621
The Pennant Group, Inc.*        3,857      89,020
Tivity Health, Inc.*        6,608     174,716
Triple-S Management Corp.*        3,406     121,526
U.S. Physical Therapy, Inc. (a)        1,953     186,609
Viemed Healthcare, Inc.*        5,371      28,037
      13,394,338
Health Care Technology 1.1%  
Allscripts Healthcare Solutions, Inc.*       18,477     340,901
American Well Corp. "A"*       28,538     172,369
Castlight Health, Inc. "B"*       18,342      28,247
Computer Programs & Systems, Inc.*        2,115      61,969
  Shares Value ($)
Convey Health Solutions Holdings, Inc.*        2,195      18,350
Evolent Health, Inc. "A"*       12,192     337,353
Forian, Inc.*        2,788      25,148
Health Catalyst, Inc.*        8,040     318,545
HealthStream, Inc.*        3,730      98,323
iCAD, Inc.*        3,128      22,522
Inspire Medical Systems, Inc.*        4,117     947,157
Multiplan Corp.* (a)       58,315     258,335
NantHealth, Inc.*        5,014       5,290
NextGen Healthcare, Inc.*        8,795     156,463
Omnicell, Inc.*        6,675   1,204,437
OptimizeRx Corp.*        2,669     165,771
Phreesia, Inc.*        7,587     316,074
Schrodinger, Inc.* (a)        7,065     246,074
Simulations Plus, Inc. (a)        2,381     112,621
Tabula Rasa HealthCare, Inc.* (a)        3,409      51,135
Vocera Communications, Inc.*        5,295     343,328
      5,230,412
Life Sciences Tools & Services 0.8%  
Absci Corp.* (a)        1,959      16,064
Akoya Biosciences, Inc.*        2,127      32,564
Alpha Teknova, Inc.*        1,002      20,521
Berkeley Lights, Inc.* (a)        7,366     133,914
Bionano Genomics, Inc.* (a)       43,832     131,058
ChromaDex Corp.*        7,696      28,783
Codex DNA, Inc.*        1,043      11,264
Codexis, Inc.*        9,220     288,309
Cytek Biosciences, Inc.*        2,392      39,037
Fluidigm Corp.*       11,244      44,077
Harvard Bioscience, Inc.*        6,434      45,360
Inotiv, Inc.* (a)        2,267      95,373
IsoPlexis Corp.*        1,320      12,131
Medpace Holdings, Inc.*        4,423     962,622
NanoString Technologies, Inc.*        7,064     298,313
NeoGenomics, Inc.*       17,358     592,255
Pacific Biosciences of California, Inc.*       29,762     608,931
Personalis, Inc.*        5,460      77,914
Quanterix Corp.*        4,816     204,198
Rapid Micro Biosystems, Inc. "A"*        1,116      11,874
Seer, Inc.* (a)        6,224     141,969
Singular Genomics Systems Inc.*        1,677      19,386
      3,815,917
Pharmaceuticals 1.4%  
9 Meters Biopharma, Inc.*       32,519      31,826
Aclaris Therapeutics, Inc.* (a)        7,772     113,005
Aerie Pharmaceuticals, Inc.* (a)        6,490      45,560
The accompanying notes are an integral part of the financial statements.
20 | DWS Small Cap Index VIP

  Shares Value ($)
Amneal Pharmaceuticals, Inc.*       15,449      74,001
Amphastar Pharmaceuticals, Inc.*        5,776     134,523
Ampio Pharmaceuticals, Inc.*       28,996      16,528
Angion Biomedica Corp.*        3,126       9,065
ANI Pharmaceuticals, Inc.*        1,679      77,368
Antares Pharma, Inc.*       25,905      92,481
Arvinas, Inc.*        7,213     592,476
Atea Pharmaceuticals, Inc.*        9,649      86,262
Athira Pharma, Inc.* (a)        4,925      64,173
Avalo Therapeutics, Inc.*        8,757      14,887
Axsome Therapeutics, Inc.* (a)        4,264     161,094
BioDelivery Sciences International, Inc.*       13,810      42,811
Cara Therapeutics, Inc.*        6,518      79,389
Cassava Sciences, Inc.* (a)        5,938     259,491
Citius Pharmaceuticals, Inc.* (a)       17,411      26,813
Collegium Pharmaceutical, Inc.*        5,452     101,843
Corcept Therapeutics, Inc.* (a)       14,605     289,179
CorMedix, Inc.*        6,430      29,256
Cymabay Therapeutics, Inc.*       10,657      36,021
Cyteir Therapeutics, Inc.*        1,192      13,553
DICE Therapeutics, Inc.*        2,170      54,923
Durect Corp.*       36,276      35,765
Edgewise Therapeutics, Inc.* (a)        5,966      91,160
Endo International PLC*       35,462     133,337
Esperion Therapeutics, Inc.*        4,147      20,735
Evolus, Inc.*        4,943      32,179
EyePoint Pharmaceuticals, Inc.*        3,227      39,498
Fulcrum Therapeutics, Inc.* (a)        3,956      69,982
Harmony Biosciences Holdings, Inc.*        3,434     146,426
Ikena Oncology, Inc.*        4,321      54,185
Innoviva, Inc.*        6,876     118,611
Intra-Cellular Therapies, Inc.* (a)       10,836     567,156
Kala Pharmaceuticals, Inc.*        7,896       9,554
Kaleido Biosciences, Inc.*        2,389       5,710
KemPharm, Inc.*        4,383      38,176
Landos Biopharma, Inc.*          617       2,962
Marinus Pharmaceuticals, Inc.*        5,675      67,419
Mind Medicine MindMed, Inc.* (a)       51,517      71,093
NGM Biopharmaceuticals, Inc.*        4,818      85,327
Nuvation Bio, Inc.* (a)       24,388     207,298
Ocular Therapeutix, Inc.*       11,617      80,970
  Shares Value ($)
Omeros Corp.* (a)        8,907      57,272
Oramed Pharmaceuticals, Inc.*        4,497      64,217
Pacira BioSciences, Inc.*        6,798     409,036
Paratek Pharmaceuticals, Inc.*        6,988      31,376
Phathom Pharmaceuticals, Inc.* (a)        3,105      61,075
Phibro Animal Health Corp. "A"        3,142      64,160
Pliant Therapeutics, Inc.*        3,531      47,668
Prestige Consumer Healthcare, Inc.*        7,588     460,212
Provention Bio, Inc.* (a)        8,664      48,692
Rain Therapeutics, Inc.*        2,513      32,367
Reata Pharmaceuticals, Inc. "A"* (a)        4,257     112,257
Relmada Therapeutics, Inc.*        2,318      52,225
Revance Therapeutics, Inc.*       11,009     179,667
Seelos Therapeutics, Inc.*       13,947      22,734
SIGA Technologies, Inc.*        7,275      54,708
Supernus Pharmaceuticals, Inc.*        7,513     219,079
Tarsus Pharmaceuticals, Inc.*        1,379      31,027
Terns Pharmaceuticals, Inc.*        1,924      13,603
TherapeuticsMD, Inc.* (a)       54,921      19,524
Theravance Biopharma, Inc.*        9,299     102,754
Theseus Pharmaceuticals, Inc.* (a)        1,848      23,433
Ventyx Biosciences, Inc.* (a)        1,638      32,531
Verrica Pharmaceuticals, Inc.*        2,141      19,612
WaVe Life Sciences Ltd.*        5,506      17,289
Zogenix, Inc.*        9,001     146,266
      6,646,855
Industrials 14.8%  
Aerospace & Defense 0.6%  
AAR Corp.*        5,141     200,653
Aerojet Rocketdyne Holdings, Inc.       11,546     539,891
AeroVironment, Inc.*        3,487     216,299
AerSale Corp.*        1,422      25,226
Astronics Corp.*        3,430      41,160
Byrna Technologies, Inc.*        2,742      36,606
Cadre Holdings, Inc.*          947      24,073
Ducommun, Inc.*        1,690      79,041
Kaman Corp.        4,241     182,999
Kratos Defense & Security Solutions, Inc.*       18,755     363,847
Maxar Technologies, Inc.       11,065     326,749
Moog, Inc. "A"        4,373     354,082
National Presto Industries, Inc.          791      64,886
PAE, Inc.*       10,705     106,301
Park Aerospace Corp.        2,688      35,481
Parsons Corp.*        4,038     135,879
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |21

  Shares Value ($)
Triumph Group, Inc.*        9,930     184,003
Vectrus, Inc.*        1,813      82,981
      3,000,157
Air Freight & Logistics 0.4%  
Air Transport Services Group, Inc.*        9,004     264,538
Atlas Air Worldwide Holdings, Inc.*        4,437     417,610
Forward Air Corp.        4,081     494,168
Hub Group, Inc. "A"*        5,097     429,371
Radiant Logistics, Inc.*        5,654      41,218
      1,646,905
Airlines 0.3%  
Allegiant Travel Co.*        2,352     439,918
Frontier Group Holdings, Inc.*        5,328      72,301
Hawaiian Holdings, Inc.*        7,822     143,690
Mesa Air Group, Inc.*        5,331      29,854
SkyWest, Inc.*        7,703     302,728
Spirit Airlines, Inc.*       15,236     332,906
Sun Country Airlines Holdings, Inc.*        4,752     129,492
      1,450,889
Building Products 1.3%  
AAON, Inc.        6,463     513,356
American Woodmark Corp.*        2,528     164,826
Apogee Enterprises, Inc.        3,839     184,848
Caesarstone Ltd.        3,272      37,104
Cornerstone Building Brands, Inc.*        8,433     147,071
CSW Industrials, Inc.        2,304     278,461
Gibraltar Industries, Inc.*        5,075     338,401
Griffon Corp.        7,041     200,528
Insteel Industries, Inc.        2,877     114,533
JELD-WEN Holding, Inc.*       13,846     364,981
Masonite International Corp.*        3,606     425,328
PGT Innovations, Inc.*        8,782     197,507
Quanex Building Products Corp.        4,928     122,116
Resideo Technologies, Inc.*       22,094     575,107
Simpson Manufacturing Co., Inc.        6,685     929,683
UFP Industries, Inc.        9,228     849,068
View, Inc.* (a)       21,465      83,928
Zurn Water Solutions Corp.       18,680     679,952
      6,206,798
Commercial Services & Supplies 1.7%  
ABM Industries, Inc.       10,339     422,348
ACCO Brands Corp.       14,690     121,339
Aris Water Solution, Inc. "A"*        3,035      39,303
Brady Corp. "A"        7,251     390,829
BrightView Holdings, Inc.*        6,014      84,677
Casella Waste Systems, Inc. "A"*        7,559     645,690
  Shares Value ($)
CECO Environmental Corp.*        4,425      27,568
Cimpress PLC*        2,616     187,332
CompX International, Inc.          256       5,752
CoreCivic, Inc.*       18,400     183,448
Deluxe Corp.        6,525     209,518
Ennis, Inc.        4,003      78,179
Harsco Corp.* (a)       12,241     204,547
Healthcare Services Group, Inc. (a)       11,585     206,097
Heritage-Crystal Clean, Inc.*        2,491      79,762
HNI Corp.        6,711     282,198
Interface, Inc.        8,677     138,398
KAR Auction Services, Inc.*       18,340     286,471
Kimball International, Inc. "B"        5,579      57,073
Matthews International Corp. "A"        4,690     171,982
MillerKnoll, Inc.       11,470     449,509
Montrose Environmental Group, Inc.*        3,993     281,546
NL Industries, Inc.        1,487      11,004
Pitney Bowes, Inc.       26,549     176,020
RR Donnelley & Sons Co.*       10,908     122,824
SP Plus Corp.*        3,660     103,285
Steelcase, Inc. "A"       12,921     151,434
Team, Inc.*        3,398       3,704
Tetra Tech, Inc.        8,225   1,396,605
The Brink's Co.        7,305     478,989
U.S. Ecology, Inc.*        4,825     154,111
UniFirst Corp.        2,317     487,497
Viad Corp.*        3,035     129,868
VSE Corp.        1,559      95,005
      7,863,912
Construction & Engineering 1.5%  
Ameresco, Inc. "A"*        4,757     387,410
API Group Corp. 144A*       30,748     792,376
Arcosa, Inc.        7,331     386,344
Argan, Inc.        2,205      85,312
Comfort Systems U.S.A., Inc.        5,481     542,290
Concrete Pumping Holdings, Inc.*        3,639      29,840
Construction Partners, Inc. "A"*        4,412     129,757
Dycom Industries, Inc.*        4,493     421,264
EMCOR Group, Inc.        8,175   1,041,413
Fluor Corp.*       21,873     541,794
Granite Construction, Inc.        7,103     274,886
Great Lakes Dredge & Dock Corp.*       10,147     159,511
IES Holdings, Inc.*        1,268      64,212
Infrastructure and Energy Alternatives, Inc.*        4,068      37,426
INNOVATE Corp.*        6,830      25,271
Matrix Service Co.*        4,083      30,704
MYR Group, Inc.*        2,553     282,234
Northwest Pipe Co.*        1,413      44,933
The accompanying notes are an integral part of the financial statements.
22 | DWS Small Cap Index VIP

  Shares Value ($)
NV5 Global, Inc.*        2,009     277,483
Primoris Services Corp.        8,337     199,921
Sterling Construction Co., Inc.*        4,316     113,511
Tutor Perini Corp.*        6,512      80,553
WillScot Mobile Mini Holdings Corp*       32,225   1,316,069
      7,264,514
Electrical Equipment 1.0%  
Advent Technologies Holdings, Inc.*        2,624      18,394
Allied Motion Technologies, Inc.        1,884      68,747
American Superconductor Corp.*        4,125      44,880
Array Technologies, Inc.*       19,702     309,124
Atkore, Inc.*        7,040     782,778
AZZ, Inc.        3,738     206,674
Babcock & Wilcox Enterprises, Inc.*        8,521      76,859
Beam Global*        1,351      25,129
Blink Charging Co.* (a)        5,606     148,615
Bloom Energy Corp. "A"* (a)       21,776     477,548
Encore Wire Corp.        3,006     430,159
EnerSys        6,522     515,629
Eos Energy Enterprises, Inc.*        6,349      47,745
FTC Solar, Inc.*        2,958      22,362
FuelCell Energy, Inc.* (a)       56,663     294,648
GrafTech International, Ltd.       30,518     361,028
Powell Industries, Inc.        1,308      38,573
Preformed Line Products Co.          404      26,139
Romeo Power, Inc.* (a)       20,015      73,055
Stem, Inc.* (a)       17,485     331,690
Thermon Group Holdings, Inc.*        5,197      87,985
TPI Composites, Inc.*        5,491      82,145
Vicor Corp.*        3,265     414,590
      4,884,496
Machinery 3.7%  
AgEagle Aerial Systems, Inc.*       10,273      16,129
Alamo Group, Inc.        1,491     219,445
Albany International Corp. "A"        4,657     411,912
Altra Industrial Motion Corp.       10,001     515,752
Astec Industries, Inc.        3,457     239,466
Barnes Group, Inc.        7,151     333,165
Blue Bird Corp.*        2,368      37,036
Chart Industries, Inc.* (a)        5,574     888,997
CIRCOR International, Inc.*        2,832      76,974
Columbus McKinnon Corp.        4,274     197,715
Commercial Vehicle Group, Inc.*        4,934      39,768
Desktop Metal, Inc. "A"* (a)       29,120     144,144
Douglas Dynamics, Inc.        3,379     131,984
  Shares Value ($)
Energy Recovery, Inc.*        6,511     139,921
Enerpac Tool Group Corp.        9,255     187,691
EnPro Industries, Inc.        3,186     350,683
ESCO Technologies, Inc.        3,897     350,691
Evoqua Water Technologies Corp.*       17,641     824,717
Federal Signal Corp.        9,264     401,502
Franklin Electric Co., Inc.        7,094     670,809
Gorman-Rupp Co.        3,377     150,445
Greenbrier Companies, Inc.        4,963     227,752
Helios Technologies, Inc.        4,979     523,641
Hillenbrand, Inc.       11,246     584,680
Hydrofarm Holdings Group, Inc.* (a)        6,022     170,362
Hyliion Holdings Corp.* (a)       18,034     111,811
Hyster-Yale Materials Handling, Inc.        1,567      64,404
Ideanomics, Inc.* (a)       67,752      81,302
John Bean Technologies Corp.        4,830     741,695
Kadant, Inc.        1,746     402,418
Kennametal, Inc.       12,889     462,844
Lindsay Corp.        1,696     257,792
Luxfer Holdings PLC        4,440      85,736
Mayville Engineering Co., Inc.*        1,165      17,370
Meritor, Inc.*       10,528     260,884
Miller Industries, Inc.        1,713      57,214
Mueller Industries, Inc.        8,606     510,852
Mueller Water Products, Inc. "A"       23,786     342,518
Nikola Corp.* (a)       34,811     343,585
NN, Inc.*        7,174      29,413
Omega Flex, Inc.          450      57,128
Park-Ohio Holdings Corp.        1,208      25,573
Proto Labs, Inc.*        4,311     221,370
RBC Bearings, Inc.*        4,267     861,806
REV Group, Inc.        4,423      62,585
Shyft Group, Inc.        5,242     257,539
SPX Corp.*        6,761     403,496
SPX FLOW, Inc.        6,333     547,678
Standex International Corp.        1,860     205,828
Tennant Co.        2,818     228,371
Terex Corp.       10,550     463,673
The Manitowoc Co., Inc.*        5,321      98,917
Titan International, Inc.*        7,771      85,170
TriMas Corp.        6,626     245,162
Trinity Industries, Inc.       11,678     352,676
Wabash National Corp.        7,648     149,289
Watts Water Technologies, Inc. "A"        4,215     818,427
Welbilt, Inc.*       20,192     479,964
      17,169,871
Marine 0.2%  
Costamare, Inc.        7,787      98,506
Eagle Bulk Shipping, Inc.        1,283      58,376
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |23

  Shares Value ($)
Genco Shipping & Trading Ltd.        4,947      79,152
Matson, Inc.        6,323     569,260
Safe Bulkers, Inc.*        9,520      35,890
      841,184
Professional Services 1.7%  
Acacia Research Corp.*        7,472      38,331
ASGN, Inc.*        7,752     956,597
Atlas Technical Consultants, Inc.*        2,067      17,404
Barrett Business Services, Inc.        1,203      83,079
CBIZ, Inc.*        7,384     288,862
CRA International, Inc.        1,072     100,082
Exponent, Inc.        7,982     931,739
First Advantage Corp.*        8,373     159,422
Forrester Research, Inc.*        1,718     100,898
Franklin Covey Co.*        1,926      89,289
Heidrick & Struggles International, Inc.        3,033     132,633
HireQuest, Inc.          779      15,705
HireRight Holdings Corp.*        3,335      53,360
Huron Consulting Group, Inc.*        3,241     161,726
ICF International, Inc.        2,871     294,421
Insperity, Inc.        5,588     659,999
KBR, Inc.       21,541   1,025,783
Kelly Services, Inc. "A"        5,377      90,172
Kforce, Inc.        3,096     232,881
Korn Ferry        8,186     619,926
ManTech International Corp. "A"        4,214     307,327
Mistras Group, Inc.*        2,950      21,919
Resources Connection, Inc.        4,683      83,545
Sterling Check Corp.*        2,432      49,880
TriNet Group, Inc.*        6,227     593,184
TrueBlue, Inc.*        5,326     147,370
Upwork, Inc.*       18,052     616,656
Willdan Group, Inc.*        1,623      57,130
      7,929,320
Road & Rail 0.9%  
ArcBest Corp.        3,899     467,295
Avis Budget Group, Inc.*        6,320   1,310,578
Covenant Logistics Group, Inc.*        1,733      45,803
Daseke, Inc.*        5,765      57,881
Heartland Express, Inc.        7,189     120,919
HyreCar, Inc.*        2,692      12,679
Marten Transport Ltd.        8,921     153,084
P.A.M. Transportation Services, Inc.*          527      37,422
Saia, Inc.*        4,051   1,365,309
U.S. Xpress Enterprises, Inc. "A"*        4,479      26,292
Universal Logistics Holdings, Inc.        1,353      25,518
  Shares Value ($)
Werner Enterprises, Inc.        9,348     445,526
Yellow Corp.*        7,738      97,421
      4,165,727
Trading Companies & Distributors 1.5%  
Alta Equipment Group, Inc.*        2,939      43,027
Applied Industrial Technologies, Inc.        5,839     599,665
Beacon Roofing Supply, Inc.*        8,618     494,242
BlueLinx Holdings, Inc.*        1,378     131,957
Boise Cascade Co.        6,059     431,401
Custom Truck One Source, Inc.*        6,878      55,024
DXP Enterprises, Inc.* (a)        2,623      67,332
EVI Industries, Inc.*          839      26,202
GATX Corp. (a)        5,364     558,875
Global Industrial Co.        2,010      82,209
GMS, Inc.*        6,607     397,147
H&E Equipment Services, Inc.        4,875     215,816
Herc Holdings, Inc.        3,809     596,299
Karat Packaging, Inc.*          711      14,369
Lawson Products, Inc.*          770      42,158
McGrath RentCorp.        3,679     295,277
MRC Global, Inc.*       12,309      84,686
NOW, Inc.*       16,588     141,662
Rush Enterprises, Inc. "A"        6,523     362,940
Rush Enterprises, Inc. "B"          956      51,595
Textainer Group Holdings Ltd. (a)        7,183     256,505
Titan Machinery, Inc.*        2,927      98,611
Transcat, Inc.*        1,066      98,530
Triton International Ltd.       10,275     618,863
Veritiv Corp.*        2,180     267,203
WESCO International, Inc.*        6,785     892,838
Willis Lease Finance Corp.*          491      18,486
      6,942,919
Information Technology 14.1%  
Communications Equipment 0.8%  
ADTRAN, Inc.        7,559     172,572
Aviat Networks, Inc.*        1,649      52,900
CalAmp Corp.*        5,260      37,136
Calix, Inc.*        8,502     679,905
Cambium Networks Corp.*        1,570      40,239
Casa Systems, Inc.*        4,292      24,336
Clearfield, Inc.*        1,783     150,521
Comtech Telecommunications Corp.        3,836      90,875
Digi International, Inc.* (a)        5,256     129,140
DZS, Inc.*        2,494      40,453
EMCORE Corp.*        5,639      39,360
Extreme Networks, Inc.*       19,202     301,471
Harmonic, Inc.*       13,845     162,817
Infinera Corp.* (a)       28,143     269,891
Inseego Corp.* (a)       12,848      74,904
The accompanying notes are an integral part of the financial statements.
24 | DWS Small Cap Index VIP

  Shares Value ($)
KVH Industries, Inc.*        2,389      21,955
NETGEAR, Inc.*        4,579     133,752
NetScout Systems, Inc.*       10,812     357,661
Plantronics, Inc.*        6,550     192,177
Ribbon Communications, Inc.*       10,566      63,924
Viavi Solutions, Inc.*       36,603     644,945
      3,680,934
Electronic Equipment, Instruments & Components 2.3%  
908 Devices, Inc.* (a)        2,913      75,359
Advanced Energy Industries, Inc.        5,772     525,598
Aeva Technologies, Inc.* (a)       16,288     123,137
Akoustis Technologies, Inc.* (a)        6,877      45,938
Arlo Technologies, Inc.*       12,589     132,059
Badger Meter, Inc.        4,441     473,233
Belden, Inc.        6,821     448,344
Benchmark Electronics, Inc. (a)        5,510     149,321
CTS Corp.        4,830     177,358
Daktronics, Inc.*        4,972      25,109
ePlus, Inc.*        4,072     219,399
Fabrinet*        5,689     673,976
FARO Technologies, Inc.*        2,796     195,776
Identiv, Inc.*        3,177      89,401
II-VI, Inc.* (a)       16,206   1,107,356
Insight Enterprises, Inc.*        5,234     557,944
Iteris, Inc.*        6,737      26,948
Itron, Inc.*        6,908     473,336
Kimball Electronics, Inc.*        3,594      78,205
Knowles Corp.*       13,533     315,996
Luna Innovations, Inc.*        4,492      37,913
Methode Electronics, Inc. (a)        5,915     290,841
MicroVision, Inc.* (a)       25,603     128,271
Napco Security Technologies, Inc.*        2,158     107,857
nLight, Inc.*        6,535     156,513
Novanta, Inc.*        5,388     950,066
OSI Systems, Inc.*        2,544     237,101
Ouster, Inc.* (a)       24,153     125,596
PAR Technology Corp.* (a)        3,813     201,212
PC Connection, Inc.        1,727      74,486
Plexus Corp.*        4,319     414,149
Rogers Corp.*        2,858     780,234
Sanmina Corp.*        9,605     398,223
ScanSource, Inc.*        3,955     138,741
TTM Technologies, Inc.*       15,648     233,155
Velodyne Lidar, Inc.*       10,869      50,432
Vishay Intertechnology, Inc.       20,484     447,985
Vishay Precision Group, Inc.*        1,914      71,048
      10,757,616
  Shares Value ($)
IT Services 1.5%  
BigCommerce Holdings, Inc.*        7,480     264,568
Brightcove, Inc.*        6,293      64,314
Cantaloupe, Inc.*        8,950      79,476
Cass Information Systems, Inc.        2,092      82,257
Conduent, Inc.*       25,797     137,756
CSG Systems International, Inc.        5,016     289,022
DigitalOcean Holdings, Inc.*        7,762     623,521
EVERTEC, Inc.        9,213     460,466
Evo Payments, Inc. "A"*        7,196     184,218
ExlService Holdings, Inc.*        5,047     730,654
Flywire Corp.* (a)        9,642     366,975
GreenBox POS*        2,667      11,201
Grid Dynamics Holdings, Inc.*        6,960     264,271
I3 Verticals, Inc. "A"*        3,295      75,093
IBEX Holdings Ltd.*          973      12,542
International Money Express, Inc.*        4,656      74,310
Limelight Networks, Inc.*       18,485      63,404
LiveRamp Holdings, Inc.*       10,196     488,898
Maximus, Inc.        9,390     748,101
MoneyGram International, Inc.*       13,368     105,474
Paya Holdings, Inc.*       12,650      80,201
Perficient, Inc.*        4,956     640,761
Priority Technology Holdings, Inc.*        1,214       8,595
Rackspace Technology, Inc.* (a)        8,261     111,276
Remitly Global, Inc.*        1,909      39,364
Repay Holdings Corp.*       13,294     242,881
StarTek, Inc.*        2,999      15,655
The Hackett Group, Inc.        3,809      78,199
TTEC Holdings, Inc.        2,795     253,087
Tucows, Inc. "A"* (a)        1,493     125,143
Unisys Corp.*        9,937     204,404
Verra Mobility Corp.*       21,939     338,519
      7,264,606
Semiconductors & Semiconductor Equipment 3.7%  
Alpha & Omega Semiconductor Ltd.*        3,278     198,516
Ambarella, Inc.*        5,389   1,093,374
Amkor Technology, Inc.       15,729     389,922
Atomera, Inc.* (a)        2,972      59,797
Axcelis Technologies, Inc.*        5,160     384,729
AXT, Inc.*        6,078      53,547
CEVA, Inc.*        3,529     152,594
CMC Materials, Inc.        4,344     832,701
Cohu, Inc.*        7,438     283,313
Diodes, Inc.*        6,702     735,947
FormFactor, Inc.* (a)       11,994     548,366
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |25

  Shares Value ($)
Ichor Holdings Ltd.*        4,310     198,389
Impinj, Inc.*        2,869     254,480
Kopin Corp.* (a)       11,919      48,749
Kulicke & Soffa Industries, Inc.        9,429     570,832
Lattice Semiconductor Corp.*       20,719   1,596,606
MACOM Technology Solutions Holdings, Inc.*        7,507     587,798
MaxLinear, Inc.*       10,853     818,208
Meta Materials, Inc.* (a)       31,319      77,045
NeoPhotonics Corp.*        7,981     122,668
NVE Corp.          734      50,132
Onto Innovation, Inc.*        7,431     752,240
PDF Solutions, Inc.*        4,558     144,899
Photronics, Inc.*        9,072     171,007
Power Integrations, Inc.        9,209     855,424
Rambus, Inc.*       16,618     488,403
Semtech Corp.*        9,861     876,939
Silicon Laboratories, Inc.*        6,090   1,257,098
SiTime Corp.*        2,437     712,920
SkyWater Technology, Inc.*        1,213      19,675
SMART Global Holdings, Inc.*        2,685     190,608
SunPower Corp.* (a)       12,318     257,077
Synaptics, Inc.*        5,993   1,735,033
Ultra Clean Holdings, Inc.*        6,852     393,031
Veeco Instruments, Inc.*        7,500     213,525
      17,125,592
Software 5.5%  
8x8, Inc.*       17,226     288,708
A10 Networks, Inc.        9,328     154,658
ACI Worldwide, Inc.*       18,154     629,944
Agilysys, Inc.*        3,280     145,829
Alarm.com Holdings, Inc.*        7,231     613,261
Alkami Technology, Inc.*        4,412      88,505
Altair Engineering, Inc. "A"*        7,015     542,400
American Software, Inc. "A"        4,694     122,842
Appfolio, Inc. "A"*        2,905     351,679
Appian Corp.*        6,075     396,151
Arteris, Inc.*          800      16,888
Asana, Inc. "A"*       10,899     812,520
Avaya Holdings Corp.*       12,801     253,460
AvidXchange Holdings, Inc.*        3,914      58,945
Benefitfocus, Inc.*        3,761      40,092
Blackbaud, Inc.* (a)        7,310     577,344
Blackline, Inc.*        8,287     858,036
Bottomline Technologies DE, Inc.*        6,849     386,763
Box, Inc. "A"*       21,372     559,733
BTRS Holdings, Inc. "A"*        9,562      74,775
Cerence, Inc.* (a)        5,839     447,501
ChannelAdvisor Corp.*        4,451     109,851
Cleanspark, Inc.* (a)        5,029      47,876
CommVault Systems, Inc.*        6,989     481,682
  Shares Value ($)
Consensus Cloud Solutions, Inc.*        2,452     141,897
CoreCard Corp.* (a)        1,035      40,158
Couchbase, Inc.*        1,413      35,268
CS Disco, Inc.*        1,198      42,828
Digimarc Corp.* (a)        1,872      73,907
Digital Turbine, Inc.* (a)       13,888     847,029
Domo, Inc. "B"*        4,277     212,139
E2open Parent Holdings, Inc.* (a)       30,452     342,889
Ebix, Inc.        4,039     122,786
eGain Corp.*        2,965      29,591
Enfusion, Inc. "A"* (a)        3,338      69,898
EngageSmart, Inc.*        2,464      59,432
Envestnet, Inc.*        8,286     657,411
EverCommerce, Inc.* (a)        2,453      38,635
GTY Technology Holdings, Inc.*        4,948      33,152
Instructure Holdings, Inc.*        1,756      42,109
Intapp, Inc.*        1,485      37,363
InterDigital, Inc.        4,718     337,950
JFrog Ltd.*        8,220     244,134
Kaltura, Inc.*        2,543       8,570
LivePerson, Inc.*       10,051     359,022
Marathon Digital Holdings, Inc.* (a)       14,613     480,183
MeridianLink, Inc.*        1,846      39,837
MicroStrategy, Inc. "A"* (a)        1,295     705,114
Mimecast Ltd.*        9,298     739,842
Mitek Systems, Inc.*        6,455     114,576
Model N, Inc.*        5,459     163,934
Momentive Global, Inc.*       19,895     420,779
ON24, Inc.* (a)        4,000      69,400
OneSpan, Inc.*        5,357      90,694
PagerDuty, Inc.*       12,542     435,834
Ping Identity Holding Corp.*        9,257     211,800
Progress Software Corp.        6,791     327,802
PROS Holdings, Inc.*        6,210     214,183
Q2 Holdings, Inc.*        8,382     665,866
Qualys, Inc.*        5,246     719,856
Rapid7, Inc.*        8,581   1,009,898
Rekor Systems, Inc.*        4,802      31,453
Rimini Street, Inc.*        6,723      40,136
Riot Blockchain, Inc.* (a)       13,608     303,867
Sailpoint Technologies Holdings, Inc.*       13,999     676,712
Sapiens International Corp. NV        4,762     164,051
SecureWorks Corp. "A"*        1,587      25,344
ShotSpotter, Inc.*        1,228      36,251
Smith Micro Software, Inc.*        7,445      36,629
Sprout Social, Inc. "A"*        6,917     627,303
SPS Commerce, Inc.*        5,511     784,491
Stronghold Digital Mining, Inc. "A"*        1,158      14,880
Sumo Logic, Inc.*       13,460     182,518
Telos Corp.*        5,981      92,227
The accompanying notes are an integral part of the financial statements.
26 | DWS Small Cap Index VIP

  Shares Value ($)
Tenable Holdings, Inc.*       14,144     778,910
Upland Software, Inc.*        4,242      76,101
Varonis Systems, Inc.*       16,371     798,577
Verint Systems, Inc.*        9,932     521,529
Veritone, Inc.* (a)        4,312      96,934
Viant Technology, Inc. "A"*        1,751      16,993
VirnetX Holding Corp.*        9,845      25,597
Vonage Holdings Corp.*       36,948     768,149
Weave Communications, Inc.*          767      11,643
Workiva, Inc.*        6,545     854,057
Xperi Holding Corp.       16,242     307,136
Yext, Inc.*       17,486     173,461
Zuora, Inc. "A"*       17,084     319,129
      26,009,287
Technology Hardware, Storage & Peripherals 0.3%  
3D Systems Corp.*       18,996     409,174
Avid Technology, Inc.*        5,556     180,959
Corsair Gaming, Inc.* (a)        4,136      86,897
Diebold Nixdorf, Inc.* (a)       11,507     104,138
Eastman Kodak Co.*        6,917      32,372
Quantum Corp.*        8,574      47,328
Super Micro Computer, Inc.*        6,674     293,322
Turtle Beach Corp.*        2,183      48,594
      1,202,784
Materials 3.6%  
Chemicals 1.9%  
AdvanSix, Inc.        4,114     194,387
American Vanguard Corp.        4,486      73,526
Amyris, Inc.* (a)       27,143     146,844
Avient Corp.       13,847     774,740
Balchem Corp.        4,953     835,076
Cabot Corp.        8,592     482,870
Chase Corp.        1,180     117,481
Danimer Scientific, Inc.* (a)       13,879     118,249
Ecovyst, Inc.        7,905      80,947
Ferro Corp.*       12,509     273,071
FutureFuel Corp.        3,994      30,514
GCP Applied Technologies, Inc.*        7,644     242,009
H.B. Fuller Co.        7,971     645,651
Hawkins, Inc.        2,832     111,722
Ingevity Corp.*        6,018     431,491
Innospec, Inc.        3,705     334,710
Intrepid Potash, Inc.*        1,624      69,394
Koppers Holdings, Inc.* (a)        3,245     101,569
Kraton Corp.*        4,859     225,069
Kronos Worldwide, Inc.        3,404      51,094
Livent Corp.* (a)       24,744     603,259
Marrone Bio Innovations, Inc.*       16,520      11,898
Minerals Technologies, Inc.        5,016     366,920
Orion Engineered Carbons SA*        9,240     169,646
  Shares Value ($)
PureCycle Technologies, Inc.* (a)        8,218      78,646
Quaker Chemical Corp.        2,077     479,330
Rayonier Advanced Materials, Inc.*        9,680      55,273
Sensient Technologies Corp.        6,481     648,489
Stepan Co.        3,308     411,151
Tredegar Corp.        4,170      49,289
Trinseo PLC        6,011     315,337
Tronox Holdings PLC "A"       17,682     424,898
Valhi, Inc.          416      11,960
Zymergen, Inc.* (a)       12,370      82,755
      9,049,265
Construction Materials 0.2%  
Forterra, Inc.*        4,539     107,937
Summit Materials, Inc. "A"*       18,277     733,639
United States Lime & Minerals, Inc.          300      38,706
      880,282
Containers & Packaging 0.2%  
Greif, Inc. "A"        3,950     238,461
Greif, Inc. "B"          852      50,933
Myers Industries, Inc.        5,301     106,073
O-I Glass, Inc*       24,429     293,881
Pactiv Evergreen, Inc.        6,850      86,858
Ranpak Holdings Corp.*        5,809     218,302
UFP Technologies, Inc.*        1,043      73,281
      1,067,789
Metals & Mining 1.2%  
Allegheny Technologies, Inc.*       19,487     310,428
Arconic Corp.*       16,249     536,379
Carpenter Technology Corp.        7,295     212,941
Century Aluminum Co.*        7,661     126,866
Coeur Mining, Inc.*       39,742     200,300
Commercial Metals Co.       18,504     671,510
Compass Minerals International, Inc.        5,284     269,907
Constellium SE*       18,950     339,394
Ferroglobe Representation & Warranty Insurance Trust       12,466           0
Gatos Silver, Inc.*        6,925      71,882
Haynes International, Inc.        1,818      73,320
Hecla Mining Co.       82,079     428,452
Kaiser Aluminum Corp.        2,451     230,247
Materion Corp.        3,141     288,784
MP Materials Corp.* (a)       11,585     526,191
Novagold Resources, Inc.*       36,873     252,949
Olympic Steel, Inc.        1,578      37,083
Perpetua Resources Corp.*        4,104      19,494
PolyMet Mining Corp.*        4,457      11,143
Ryerson Holding Corp.        2,428      63,249
Schnitzer Steel Industries, Inc. "A"        3,942     204,669
SunCoke Energy, Inc.       12,238      80,648
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |27

  Shares Value ($)
TimkenSteel Corp.*        7,129     117,628
Warrior Met Coal, Inc.        7,958     204,600
Worthington Industries, Inc.        4,976     271,988
      5,550,052
Paper & Forest Products 0.1%  
Clearwater Paper Corp.*        2,553      93,619
Glatfelter Corp.        6,822     117,338
Neenah, Inc. (a)        2,508     116,070
Schweitzer-Mauduit International, Inc.        4,916     146,989
Verso Corp. "A"        3,966     107,161
      581,177
Real Estate 7.2%  
Equity Real Estate Investment Trusts (REITs) 6.5%  
Acadia Realty Trust       13,274     289,771
Agree Realty Corp.       10,526     751,135
Alexander & Baldwin, Inc.*       11,034     276,843
Alexander's, Inc.          337      87,721
American Assets Trust, Inc.        7,593     284,965
American Finance Trust, Inc.       18,808     171,717
Apartment Investment and Management Co. "A"*       22,957     177,228
Apple Hospitality REIT, Inc.       32,765     529,155
Armada Hoffler Properties, Inc.        9,083     138,243
Ashford Hospitality Trust, Inc.*        2,493      23,933
Braemar Hotels & Resorts, Inc.*        8,901      45,395
Brandywine Realty Trust       26,184     351,389
Broadstone Net Lease, Inc. (a)       23,990     595,432
BRT Apartments Corp.        1,764      42,318
CareTrust REIT, Inc.       14,787     337,587
CatchMark Timber Trust, Inc. "A"        7,559      65,839
Centerspace        2,184     242,206
Chatham Lodging Trust*        7,225      99,127
City Office REIT, Inc.        6,317     124,571
Clipper Realty, Inc.        1,682      16,719
Community Healthcare Trust, Inc.        3,559     168,234
CorePoint Lodging, Inc.*        6,156      96,649
Corporate Office Properties Trust       17,352     485,335
CTO Realty Growth, Inc.          866      53,190
DiamondRock Hospitality Co.*       32,179     309,240
DigitalBridge Group, Inc.* (a)       74,745     622,626
Diversified Healthcare Trust       35,482     109,639
Easterly Government Properties, Inc.       13,246     303,598
EastGroup Properties, Inc.        6,164   1,404,467
Empire State Realty Trust, Inc. "A"       22,234     197,883
  Shares Value ($)
Equity Commonwealth*       17,977     465,604
Essential Properties Realty Trust, Inc.       18,571     535,402
Farmland Partners, Inc.        4,375      52,281
Four Corners Property Trust, Inc.       11,888     349,626
Franklin Street Properties Corp.       15,870      94,427
Getty Realty Corp.        6,287     201,750
Gladstone Commercial Corp.        5,823     150,059
Gladstone Land Corp.        4,809     162,352
Global Medical REIT, Inc.        9,506     168,732
Global Net Lease, Inc.       15,867     242,448
Healthcare Realty Trust, Inc.       22,437     709,907
Hersha Hospitality Trust*        4,795      43,970
Independence Realty Trust, Inc.       16,205     418,575
Indus Realty Trust, Inc.          910      73,765
Industrial Logistics Properties Trust       10,106     253,155
Innovative Industrial Properties, Inc. (a)        3,626     953,312
iStar, Inc. (a)       10,222     264,034
Kite Realty Group Trust       33,102     720,962
LTC Properties, Inc.        5,899     201,392
LXP Industrial Trust       42,478     663,506
Monmouth Real Estate Investment Corp.       14,735     309,582
National Health Investors, Inc.        6,673     383,497
National Storage Affiliates Trust       12,439     860,779
NETSTREIT Corp.        6,114     140,011
NexPoint Residential Trust, Inc.        3,429     287,453
Office Properties Income Trust        7,214     179,196
One Liberty Properties, Inc.        2,425      85,554
Outfront Media, Inc.       22,411     601,063
Paramount Group, Inc.       28,882     240,876
Pebblebrook Hotel Trust       19,887     444,872
Phillips Edison & Co., Inc. (a)        2,758      91,124
Physicians Realty Trust       33,542     631,596
Piedmont Office Realty Trust, Inc. "A"       19,147     351,922
Plymouth Industrial REIT, Inc.        4,846     155,072
Postal Realty Trust, Inc. "A"        1,871      37,046
PotlatchDeltic Corp.       10,141     610,691
Preferred Apartment Communities, Inc.        7,967     143,884
PS Business Parks, Inc.        3,073     565,954
Retail Opportunity Investments Corp.       18,075     354,270
Retail Value, Inc.        2,634      16,910
RLJ Lodging Trust       25,305     352,499
RPT Realty       12,665     169,458
The accompanying notes are an integral part of the financial statements.
28 | DWS Small Cap Index VIP

  Shares Value ($)
Ryman Hospitality Properties, Inc.*        8,231     756,923
Sabra Health Care REIT, Inc.       34,835     471,666
Safehold, Inc.        3,196     255,201
Saul Centers, Inc.        1,829      96,974
Seritage Growth Properties "A"* (a)        5,449      72,308
Service Properties Trust       25,508     224,215
SITE Centers Corp.       26,254     415,601
STAG Industrial, Inc.       26,913   1,290,748
Summit Hotel Properties, Inc.*       15,986     156,023
Sunstone Hotel Investors, Inc.*       33,271     390,269
Tanger Factory Outlet Centers, Inc. (a)       15,775     304,142
Terreno Realty Corp.       11,232     957,977
The GEO Group, Inc. (a)       18,122     140,446
The Macerich Co. (a)       32,940     569,203
UMH Properties, Inc.        6,508     177,864
Uniti Group, Inc.       29,936     419,403
Universal Health Realty Income Trust        1,912     113,707
Urban Edge Properties       17,575     333,925
Urstadt Biddle Properties, Inc. "A"        4,590      97,767
Veris Residential, Inc.*       13,409     246,457
Washington Real Estate Investment Trust       13,057     337,523
Whitestone REIT        6,984      70,748
Xenia Hotels & Resorts, Inc.*       17,418     315,440
      30,355,253
Real Estate Management & Development 0.7%  
Cushman & Wakefield PLC*       21,285     473,378
eXp World Holdings, Inc. (a)        9,680     326,119
Fathom Holdings, Inc.*          795      16,266
Forestar Group, Inc.*        2,712      58,986
FRP Holdings, Inc.*          975      56,355
Kennedy-Wilson Holdings, Inc.       18,095     432,109
Marcus & Millichap, Inc.*        3,644     187,520
Newmark Group, Inc. "A"       23,035     430,755
Rafael Holdings, Inc. "B"*        1,432       7,303
RE/MAX Holdings, Inc. "A"        2,916      88,909
Realogy Holdings Corp.*       17,796     299,151
Redfin Corp.* (a)       15,723     603,606
Tejon Ranch Co.*        3,265      62,296
The RMR Group, Inc. "A"        2,384      82,677
The St. Joe Co.        5,136     267,329
      3,392,759
Utilities 2.6%  
Electric Utilities 0.6%  
ALLETE, Inc.        8,078     535,975
MGE Energy, Inc.        5,518     453,855
  Shares Value ($)
Otter Tail Corp.        6,329     452,017
PNM Resources, Inc.       13,155     600,000
Portland General Electric Co.       13,773     728,867
Via Renewables, Inc.        2,030      23,203
      2,793,917
Gas Utilities 0.9%  
Brookfield Infrastructure Corp. "A" (a)        9,435     644,033
Chesapeake Utilities Corp.        2,605     379,835
New Jersey Resources Corp.       14,875     610,767
Northwest Natural Holding Co.        4,578     223,315
ONE Gas, Inc.        8,079     626,850
South Jersey Industries, Inc.       15,833     413,558
Southwest Gas Holdings, Inc.*        9,182     643,199
Spire, Inc.        7,763     506,303
      4,047,860
Independent Power & Renewable Electricity Producers 0.3%  
Clearway Energy, Inc. "A"        5,403     180,893
Clearway Energy, Inc. "C"       12,540     451,816
Ormat Technologies, Inc. (a)        6,984     553,831
Sunnova Energy International, Inc.*       13,312     371,671
      1,558,211
Multi-Utilities 0.4%  
Avista Corp.       10,692     454,303
Black Hills Corp.        9,678     682,976
NorthWestern Corp.        7,978     456,023
Unitil Corp.        2,299     105,731
      1,699,033
Water Utilities 0.4%  
American States Water Co.        5,683     587,849
Artesian Resources Corp. "A"        1,330      61,619
Cadiz, Inc.*        2,735      10,557
California Water Service Group        7,931     569,922
Global Water Resources, Inc.        2,087      35,688
Middlesex Water Co.        2,624     315,667
Pure Cycle Corp.*        3,151      46,005
SJW Group        4,177     305,756
York Water Co.        2,056     102,348
      2,035,411
Total Common Stocks (Cost $341,993,375) 454,832,052
Rights 0.0%  
Health Care  
GTX, Inc.* (a) (b)          123         252
Tobira Therapeutics, Inc.* (b)        1,687         101
Total Rights (Cost $355)     353
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |29

  Shares Value ($)
Warrants 0.0%  
Energy  
Nabors Industries Ltd., Expiration Date 6/11/2026* (Cost $0)          450        1,679
  Principal
Amount ($)
Value ($)
Corporate Bonds 0.0%  
Financials  
GAMCO Investors, Inc., Step-Up Coupon, 4.0% to 06/15/2022, 5.0% to 06/15/2023 (Cost $1,000)        1,000          990
Government & Agency Obligations 0.3%
U.S. Treasury Obligations  
U.S. Treasury Bills, 0.038% (c), 1/27/2022 (Cost $1,519,959)    1,520,000    1,519,972
  Shares Value ($)
Securities Lending Collateral 8.7%
DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares", 0.01% (d) (e)
(Cost $40,582,540)
  40,582,540 40,582,540
Cash Equivalents 2.5%
DWS Central Cash Management Government Fund, 0.05% (d) (Cost $11,652,393)   11,652,393 11,652,393
    % of
Net Assets
Value ($)
Total Investment Portfolio (Cost $395,749,622)   108.4 508,589,979
Other Assets and Liabilities, Net   (8.4) (39,352,889)
Net Assets   100.0 469,237,090
A summary of the Fund’s transactions with affiliated investments during the year ended December 31, 2021 are as follows:
Value ($) at
12/31/2020
Purchases
Cost ($)
Sales
Proceeds ($)
Net Realized
Gain/
(Loss) ($)
Net Change in
Unrealized
Appreciation
(Depreciation) ($)
Income ($) Capital Gain
Distributions ($)
Number
of Shares
at
12/31/2021
Value ($) at
12/31/2021
Securities Lending Collateral 8.7%
DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares", 0.01% (d) (e)
21,733,499 18,849,041 (f) 228,125 40,582,540 40,582,540
Cash Equivalents 2.5%
DWS Central Cash Management Government Fund, 0.05% (d)
1,628,225 116,473,539 106,449,371 3,231 11,652,393 11,652,393
23,361,724 135,322,580 106,449,371 231,356 52,234,933 52,234,933
* Non-income producing security.
(a) All or a portion of these securities were on loan. In addition, "Other Assets and Liabilities, Net" may include pending sales that are also on loan. The value of securities loaned at December 31, 2021 amounted to $40,072,032, which is 8.5% of net assets.
(b) Investment was valued using significant unobservable inputs.
(c) Annualized yield at time of purchase; not a coupon rate.
(d) Affiliated fund managed by DWS Investment Management Americas, Inc. The rate shown is the annualized seven-day yield at period end.
(e) Represents cash collateral held in connection with securities lending. Income earned by the Fund is net of borrower rebates. In addition, the Fund held non-cash U.S. Treasury securities collateral having a value of $1,864,058.
(f) Represents the net increase (purchase cost) or decrease (sales proceeds) in the amount invested in cash collateral for the year ended December 31, 2021.
    
144A: Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers.
At December 31, 2021, open futures contracts purchased were as follows:
Futures Currency Expiration
Date
Contracts Notional
Amount ($)
Notional
Value ($)
Unrealized
Appreciation ($)
Russell E-Mini 2000 Index USD 3/18/2022 121 13,415,025 13,568,940 153,915
Currency Abbreviation(s)

USD United States Dollar
The accompanying notes are an integral part of the financial statements.
30 | DWS Small Cap Index VIP

For information on the Fund’s policy and additional disclosures regarding futures contracts, please refer to the Derivatives section of Note B in the accompanying Notes to Financial Statements.
Fair Value Measurements
Various inputs are used in determining the value of the Fund's investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds and credit risk). Level 3 includes significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments). The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities.
The following is a summary of the inputs used as of December 31, 2021 in valuing the Fund's investments. For information on the Fund's policy regarding the valuation of investments, please refer to the Security Valuation section of Note A in the accompanying Notes to Financial Statements.
Assets Level 1 Level 2 Level 3 Total
Common Stocks (a) $ 454,832,052        $  —  $  — $ 454,832,052
Rights        — 353         353
Warrants 1,679        —  —       1,679
Corporate Bonds       990  —         990
Government & Agency Obligations 1,519,972  —   1,519,972
Short-Term Investments (a) 52,234,933        —  —  52,234,933
Derivatives (b)        
Futures Contracts     153,915        —  —     153,915
Total $ 507,222,579 $1,520,962 $353 $ 508,743,894
(a) See Investment Portfolio for additional detailed categorizations.
(b) Derivatives include unrealized appreciation (depreciation) on open futures contracts.
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |31

Statement of Assets and Liabilities
as of December 31, 2021

Assets  
Investments in non-affiliated securities, at value (cost $343,514,689) — including $40,072,032 of securities loaned $ 456,355,046
Investment in DWS Government & Agency Securities Portfolio (cost $40,582,540)* 40,582,540
Investment in DWS Central Cash Management Government Fund (cost $11,652,393) 11,652,393
Cash 18,425
Receivable for investments sold 477,163
Receivable for Fund shares sold 729,166
Dividends receivable 362,044
Interest receivable 13,722
Other assets 7,838
Total assets 510,198,337
Liabilities  
Payable upon return of securities loaned 40,582,540
Payable for investments purchased 45,358
Payable for Fund shares redeemed 63,221
Payable for variation margin on futures contracts 24,762
Accrued management fee 102,439
Accrued Trustees' fees 4,170
Other accrued expenses and payables 138,757
Total liabilities 40,961,247
Net assets, at value $ 469,237,090
Net Assets Consist of  
Distributable earnings (loss) 173,639,702
Paid-in capital 295,597,388
Net assets, at value $ 469,237,090
Net Asset Value  
Class A  
Net Asset Value, offering and redemption price per share ($425,942,723 ÷ 22,857,220 outstanding shares of beneficial interest, no par value, unlimited number of shares authorized) $  18.63
Class B  
Net Asset Value, offering and redemption price per share ($43,294,367 ÷ 2,324,391 outstanding shares of beneficial interest, no par value, unlimited number of shares authorized) $  18.63
* Represents collateral on securities loaned. In addition, the Fund held non-cash collateral having a value of $1,864,058.
Statement of Operations
for the year ended December 31, 2021

Investment Income  
Income:  
Dividends (net of foreign taxes withheld of $6,818) $  4,790,327
Interest 843
Income distributions — DWS Central Cash Management Government Fund 3,231
Securities lending income, net of borrower rebates 228,125
Total income 5,022,526
Expenses:  
Management fee 1,542,103
Administration fee 450,572
Services to shareholders 3,272
Record keeping fee (Class B) 17,675
Distribution service fee (Class B) 105,471
Custodian fee 28,320
Professional fees 67,482
Reports to shareholders 44,770
Trustees' fees and expenses 17,297
Other 21,812
Total expenses before expense reductions 2,298,774
Expense reductions (368,033)
Total expenses after expense reductions 1,930,741
Net investment income 3,091,785
Realized and Unrealized Gain (Loss)  
Net realized gain (loss) from:  
Investments 65,310,777
Futures (59,141)
  65,251,636
Change in net unrealized appreciation (depreciation) on:  
Investments (9,626,071)
Futures 88,310
  (9,537,761)
Net gain (loss) 55,713,875
Net increase (decrease) in net assets resulting from operations $58,805,660
 
The accompanying notes are an integral part of the financial statements.
32 | DWS Small Cap Index VIP

Statements of Changes in Net Assets
  Years Ended December 31,
Increase (Decrease) in Net Assets 2021 2020
Operations:    
Net investment income $  3,091,785 $  3,304,892
Net realized gain (loss) 65,251,636 24,331,163
Change in net unrealized appreciation
(depreciation)
(9,537,761) 44,444,817
Net increase (decrease) in net assets resulting from operations 58,805,660 72,080,872
Distributions to shareholders:    
Class A (27,860,902) (36,874,155)
Class B (2,609,130) (3,407,812)
Total distributions (30,470,032) (40,281,967)
Fund share transactions:    
Class A    
Proceeds from shares sold 98,120,413 97,628,393
Reinvestment of distributions 27,860,902 36,874,155
Payments for shares redeemed (112,716,499) (129,334,937)
Net increase (decrease) in net assets from Class A share transactions 13,264,816 5,167,611
Class B    
Proceeds from shares sold 9,013,498 4,372,633
Reinvestment of distributions 2,609,130 3,407,812
Payments for shares redeemed (8,406,842) (6,383,154)
Net increase (decrease) in net assets from Class B share transactions 3,215,786 1,397,291
Increase (decrease) in net assets 44,816,230 38,363,807
Net assets at beginning of period 424,420,860 386,057,053
Net assets at end of period $ 469,237,090 $ 424,420,860
   
Other Information    
Class A    
Shares outstanding at beginning of period   22,246,452   20,802,116
Shares sold 5,142,943 7,293,317
Shares issued to shareholders in reinvestment of distributions 1,466,363 3,475,415
Shares redeemed (5,998,538) (9,324,396)
Net increase (decrease) in Class A shares      610,768    1,444,336
Shares outstanding at end of period 22,857,220 22,246,452
Class B    
Shares outstanding at beginning of period    2,154,282    1,943,200
Shares sold 474,075 340,656
Shares issued to shareholders in reinvestment of distributions 137,106 320,584
Shares redeemed (441,072) (450,158)
Net increase (decrease) in Class B shares      170,109      211,082
Shares outstanding at end of period 2,324,391 2,154,282
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |33

Financial Highlights
DWS Small Cap Index VIP Class A
  Years Ended December 31,
  2021 2020 2019 2018 2017
Selected Per Share Data
Net asset value, beginning of period $17.39 $16.97 $14.97 $18.29 $16.78
Income (loss) from investment operations:          
Net investment incomea .13 .14 .17 .19 .17
Net realized and unrealized gain (loss) 2.41 2.03 3.49 (2.06) 2.16
Total from investment operations 2.54 2.17 3.66 (1.87) 2.33
Less distributions from:          
Net investment income (.16) (.17) (.18) (.18) (.17)
Net realized gains (1.14) (1.58) (1.48) (1.27) (.65)
Total distributions (1.30) (1.75) (1.66) (1.45) (.82)
Net asset value, end of period $18.63 $17.39 $16.97 $14.97 $18.29
Total Return (%)b 14.50 19.43 25.22 (11.23) 14.33
Ratios to Average Net Assets and Supplemental Data
Net assets, end of period ($ millions) 426 387 353 308 360
Ratio of expenses before expense reductions (%)c .47 .50 .53 .51 .51
Ratio of expenses after expense reductions (%)c .39 .39 .39 .41 .44
Ratio of net investment income (%) .69 .99 1.04 1.03 1.00
Portfolio turnover rate (%) 26 23 22 17 15
a Based on average shares outstanding during the period.
b Total return would have been lower had certain expenses not been reduced.
c Expense ratio does not reflect charges and fees associated with the separate account that invests in the Fund or any variable life insurance policy or variable annuity contract for which the Fund is an investment option.
    
The accompanying notes are an integral part of the financial statements.
34 | DWS Small Cap Index VIP

DWS Small Cap Index VIP Class B
  Years Ended December 31,
  2021 2020 2019 2018 2017
Selected Per Share Data          
Net asset value, beginning of period $17.39 $16.97 $14.97 $18.28 $16.77
Income (loss) from investment operations:          
Net investment incomea .08 .10 .12 .14 .13
Net realized and unrealized gain (loss) 2.41 2.04 3.49 (2.05) 2.15
Total from investment operations 2.49 2.14 3.61 (1.91) 2.28
Less distributions from:          
Net investment income (.11) (.14) (.13) (.13) (.12)
Net realized gains (1.14) (1.58) (1.48) (1.27) (.65)
Total distributions (1.25) (1.72) (1.61) (1.40) (.77)
Net asset value, end of period $18.63 $17.39 $16.97 $14.97 $18.28
Total Return (%)b 14.18 19.09 24.87 (11.42) 14.03
Ratios to Average Net Assets and Supplemental Data
Net assets, end of period ($ millions) 43 37 33 28 35
Ratio of expenses before expense reductions (%)c .76 .79 .81 .80 .78
Ratio of expenses after expense reductions (%)c .67 .66 .65 .67 .70
Ratio of net investment income (%) .42 .71 .76 .77 .76
Portfolio turnover rate (%) 26 23 22 17 15
a Based on average shares outstanding during the period.
b Total return would have been lower had certain expenses not been reduced.
c Expense ratio does not reflect charges and fees associated with the separate account that invests in the Fund or any variable life insurance policy or variable annuity contract for which the Fund is an investment option.
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP |35

Notes to Financial Statements
A. Organization and Significant Accounting Policies
Deutsche DWS Investments VIT Funds (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust is organized as a Massachusetts business trust. DWS Small Cap Index VIP (the “Fund”) is a diversified series of the Trust offered to investors. The Fund is an underlying investment vehicle for variable annuity contracts and variable life insurance policies to be offered by the separate accounts of certain life insurance companies (“Participating Insurance Companies”).
Multiple Classes of Shares of Beneficial Interest. The Fund offers two classes of shares (Class A shares and Class B shares). Class B shares are subject to Rule 12b-1 distribution fees under the 1940 Act and recordkeeping fees equal to an annual rate of up to 0.25% and of up to 0.15%, respectively, of the average daily net assets of the Class B shares of the Fund. Class A shares are not subject to such fees.
Investment income, realized and unrealized gains and losses, and certain fund-level expenses and expense reductions, if any, are borne pro rata on the basis of relative net assets by the holders of all classes of shares, except that each class bears certain expenses unique to that class (including the applicable 12b-1 distribution fees). Differences in class-level expenses may result in payment of different per share dividends by class. All shares have equal rights with respect to voting subject to class-specific arrangements.
The Fund's financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) which require the use of management estimates. Actual results could differ from those estimates. The Fund qualifies as an investment company under Topic 946 of Accounting Standards Codification of U.S. GAAP. The policies described below are followed consistently by the Fund in the preparation of its financial statements.
Security Valuation. Investments are stated at value determined as of the close of regular trading on the New York Stock Exchange on each day the exchange is open for trading.
Various inputs are used in determining the value of the Fund’s investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds and credit risk). Level 3 includes significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments). The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities.
Equity securities are valued at the most recent sale price or official closing price reported on the exchange (U.S. or foreign) or over-the-counter market on which they trade. Securities for which no sales are reported are valued at the calculated mean between the most recent bid and asked quotations on the relevant market or, if a mean cannot be determined, at the most recent bid quotation. Equity securities are generally categorized as Level 1.
Debt securities are valued at prices supplied by independent pricing services approved by the Fund’s Board. If the pricing services are unable to provide valuations, securities are valued at the most recent bid quotation or evaluated price, as applicable, obtained from one or more broker-dealers. Such services may use various pricing techniques which take into account appropriate factors such as yield, quality, coupon rate, maturity, type of issue, trading characteristics and other data, as well as broker quotes. These securities are generally categorized as Level 2.
Investments in open-end investment companies are valued at their net asset value each business day and are categorized as Level 1.
Futures contracts are generally valued at the settlement prices established each day on the exchange on which they are traded and are categorized as Level 1.
Securities and other assets for which market quotations are not readily available or for which the above valuation procedures are deemed not to reflect fair value are valued in a manner that is intended to reflect their fair value as determined in accordance with procedures approved by the Board and are generally categorized as Level 3. In accordance with the Fund’s valuation procedures, factors considered in determining value may include, but are not limited to, the type of the security; the size of the holding; the initial cost of the security; the existence of any contractual restrictions on the security’s disposition; the price and extent of public trading in similar securities of the issuer or of comparable companies; quotations or evaluated prices from broker-dealers and/or pricing services; information obtained from the issuer, analysts, and/or the appropriate stock exchange (for exchange-traded securities); an analysis of the company’s or
36 | DWS Small Cap Index VIP

issuer’s financial statements; an evaluation of the forces that influence the issuer and the market(s) in which the security is purchased and sold; and with respect to debt securities, the maturity, coupon, creditworthiness, currency denomination and the movement of the market in which the security is normally traded. The value determined under these procedures may differ from published values for the same securities.
Disclosure about the classification of fair value measurements is included in a table following the Fund's Investment Portfolio.
Securities Lending. Brown Brothers Harriman & Co., as lending agent, lends securities of the Fund to certain financial institutions under the terms of its securities lending agreement. During the term of the loans, the Fund continues to receive interest and dividends generated by the securities and to participate in any changes in their market value. The Fund requires the borrowers of the securities to maintain collateral with the Fund consisting of cash and/or U.S. Treasury Securities having a value at least equal to the value of the securities loaned. When the collateral falls below specified amounts, the lending agent will use its best efforts to obtain additional collateral on the next business day to meet required amounts under the securities lending agreement. During the year ended December 31, 2021, the Fund invested the cash collateral into a joint trading account in DWS Government & Agency Securities Portfolio, an affiliated money market fund managed by DWS Investment Management Americas, Inc. DWS Investment Management Americas, Inc. receives a management/administration fee (0.04% annualized effective rate as of December 31, 2021) on the cash collateral invested in DWS Government & Agency Securities Portfolio. The Fund receives compensation for lending its securities either in the form of fees or by earning interest on invested cash collateral net of borrower rebates and fees paid to a lending agent. Either the Fund or the borrower may terminate the loan at any time, and the borrower, after notice, is required to return borrowed securities within a standard time period. There may be risks of delay and costs in recovery of securities or even loss of rights in the collateral should the borrower of the securities fail financially. If the Fund is not able to recover securities lent, the Fund may sell the collateral and purchase a replacement investment in the market, incurring the risk that the value of the replacement security is greater than the value of the collateral. The Fund is also subject to all investment risks associated with the reinvestment of any cash collateral received, including, but not limited to, interest rate, credit and liquidity risk associated with such investments.
As of December 31, 2021, the Fund had securities on loan. The value of the related collateral exceeded the value of the securities loaned at period end.
Remaining Contractual Maturity of the Agreements as of December 31, 2021

  Overnight
and
Continuous
<30 days Between 30
& 90 days
>90 days Total
Securities Lending Transactions 
Common Stocks $ 40,582,496 $ — $ 45,510 $ 1,818,548 $ 42,446,554
Rights 44 44
Total Borrowings $ 40,582,540 $  $ 45,510 $ 1,818,548 $ 42,446,598
Gross amount of recognized liabilities and non-cash collateral for securities lending transactions: $ 42,446,598
Federal Income Taxes. The Fund’s policy is to comply with the requirements of the Internal Revenue Code, as amended, which are applicable to regulated investment companies, and to distribute all of its taxable income to its shareholders.
The Fund has reviewed the tax positions for the open tax years as of December 31, 2021 and has determined that no provision for income tax and/or uncertain tax positions is required in the Fund's financial statements. The Fund's federal tax returns for the prior three fiscal years remain open subject to examination by the Internal Revenue Service.
Distribution of Income and Gains. Distributions from net investment income of the Fund, if any, are declared and distributed to shareholders annually. Net realized gains from investment transactions, in excess of available capital loss carryforwards, would be taxable to the Fund if not distributed, and, therefore, will be distributed to shareholders at least annually. The Fund may also make additional distributions for tax purposes if necessary.
The timing and characterization of certain income and capital gain distributions are determined annually in accordance with federal tax regulations which may differ from accounting principles generally accepted in the
DWS Small Cap Index VIP |37

United States of America. These differences primarily relate to income received from passive foreign investment companies, investments in futures contracts, certain securities sold at a loss, and the realized tax character on distributions from certain securities. As a result, net investment income (loss) and net realized gain (loss) on investment transactions for a reporting period may differ significantly from distributions during such period. Accordingly, the Fund may periodically make reclassifications among certain of its capital accounts without impacting the net asset value of the Fund.
At December 31, 2021, the Fund's components of distributable earnings (accumulated losses) on a net tax basis were as follows:
Undistributed ordinary income* $  9,340,236
Undistributed long-term capital gains $  58,223,175
Net unrealized appreciation (depreciation) on investments $ 105,932,350
At December 31, 2021, the aggregate cost of investments for federal income tax purposes was $402,657,629. The net unrealized appreciation for all investments based on tax cost was $105,932,350. This consisted of aggregate gross unrealized appreciation for all investments for which there was an excess of value over tax cost of $157,496,708 and aggregate gross unrealized depreciation for all investments for which there was an excess of tax cost over value of $51,564,358.
In addition, the tax character of distributions paid to shareholders by the Fund is summarized as follows:
  Years Ended December 31,
  2021 2020
Distributions from ordinary income* $  6,391,312 $  5,574,246
Distributions from long-term capital gains $ 24,078,720 $ 34,707,721
* For tax purposes, short-term capital gain distributions are considered ordinary income distributions.
Contingencies. In the normal course of business, the Fund may enter into contracts with service providers that contain general indemnification clauses. The Fund’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet been made. However, based on experience, the Fund expects the risk of loss to be remote.
Expenses. Expenses of the Trust arising in connection with a specific fund are allocated to that fund. Other Trust expenses which cannot be directly attributed to a fund are apportioned among the funds in the Trust based upon the relative net assets or other appropriate measures.
Real Estate Investment Trusts. The Fund at its fiscal year end recharacterizes distributions received from a Real Estate Investment Trust (“REIT”) investment based on information provided by the REIT into the following categories: ordinary income, long-term and short-term capital gains, and return of capital. If information is not available timely from a REIT, the recharacterization will be estimated for financial reporting purposes and a recharacterization will be made to the accounting records in the following year when such information becomes available. Distributions received from REITs in excess of income are recorded as either a reduction of cost of investments or realized gains.
Other. Investment transactions are accounted for on a trade date plus one basis for daily net asset value calculations. However, for financial reporting purposes, investment transactions are reported on trade date. Interest income is recorded on the accrual basis. Dividend income is recorded on the ex-dividend date net of foreign withholding taxes. Realized gains and losses from investment transactions are recorded on an identified cost basis. Proceeds from litigation payments, if any, are included in net realized gain (loss) from investments.
B. Derivative Instruments
A futures contract is an agreement between a buyer or seller and an established futures exchange or its clearinghouse in which the buyer or seller agrees to take or make a delivery of a specific amount of a financial instrument at a specified price on a specific date (settlement date). For the year ended December 31, 2021, the Fund invested in futures to keep cash on hand to meet shareholder redemptions or other needs while maintaining exposure to the stock market.
Upon entering into a futures contract, the Fund is required to deposit with a financial intermediary cash or securities (“initial margin”) in an amount equal to a certain percentage of the face value indicated in the
38 | DWS Small Cap Index VIP

futures contract. Subsequent payments (“variation margin”) are made or received by the Fund dependent upon the daily fluctuations in the value and are recorded for financial reporting purposes as unrealized gains or losses by the Fund. Gains or losses are realized when the contract expires or is closed. Since all futures contracts are exchange-traded, counterparty risk is minimized as the exchange’s clearinghouse acts as the counterparty, and guarantees the futures against default.
Certain risks may arise upon entering into futures contracts, including the risk that an illiquid market will limit the Fund's ability to close out a futures contract prior to the settlement date and the risk that the futures contract is not well correlated with the security, index or currency to which it relates. Risk of loss may exceed amounts recognized in the Statement of Assets and Liabilities.
A summary of the open futures contracts as of December 31, 2021, is included in a table following the Fund’s Investment Portfolio. For the year ended December 31, 2021, the investment in futures contracts purchased had a total notional value generally indicative of a range from approximately $3,752,000 to $14,855,000.
The following tables summarize the value of the Fund's derivative instruments held as of December 31, 2021 and the related location in the accompanying Statement of Assets and Liabilities, presented by primary underlying risk exposure:
Assets Derivative Futures
Contracts
Equity Contracts (a) $ 153,915
The above derivative is located in the following Statement of Assets and Liabilities account:
(a) Includes cumulative appreciation of futures contracts as disclosed in the Investment Portfolio. Unsettled variation margin is disclosed separately within the Statement of Assets and Liabilities.
Additionally, the amount of unrealized and realized gains and losses on derivative instruments recognized in Fund earnings during the year ended December 31, 2021 and the related location in the accompanying Statement of Operations is summarized in the following tables by primary underlying risk exposure:
Realized Gain (Loss) Futures
Contracts
Equity Contracts (a) $ (59,141)
The above derivative is located in the following Statement of Operations account:
(a) Net realized gain (loss) from futures
Change in Net Unrealized Appreciation (Depreciation) Futures
Contracts
Equity Contracts (a) $ 88,310
The above derivative is located in the following Statement of Operations account:
(a) Change in net unrealized appreciation (depreciation) on futures
C. Purchases and Sales of Securities
During the year ended December 31, 2021, purchases and sales of investment securities (excluding short-term investments) aggregated $118,358,979 and $139,367,306, respectively.
D. Related Parties
Management Agreement. Under the Investment Management Agreement with DWS Investment Management Americas, Inc. (“DIMA” or the “Advisor”), an indirect, wholly owned subsidiary of DWS Group GmbH & Co. KGaA (“DWS Group”), the Advisor determines the securities, instruments and other contracts relating to investments to be purchased, sold or entered into by the Fund or delegates such responsibility to the Fund’s subadvisor. Northern Trust Investments, Inc. (“NTI”) serves as subadvisor. As a subadvisor to the Fund, NTI makes investment decisions and buys and sells securities for the Fund. NTI is paid by the Advisor for the services NTI provides to the Fund.
Prior to Octorber 1, 2021, under the Investment Management Agreement with the Advisor, the Fund paid the Advisor an annual fee based on the average daily net assets of the Fund, computed and accrued daily and payable monthly at the annual rate (exclusive of any applicable waivers/reimbursements) of 0.35%.
DWS Small Cap Index VIP |39

Effective October 1, 2021, under the Investment Management Agreement with the Advisor, the Fund pays a monthly management fee based on the average daily net assets of the Fund, computed and accrued daily and payable monthly at the annual rate (exclusive of any applicable waivers/reimbursements) of 0.28%.
For the period from January 1, 2021 through September 30, 2022 (through April 30, 2022 for Class B shares), the Advisor has contractually agreed to waive its fees and/or reimburse certain operating expenses of the Fund to the extent necessary to maintain the total annual operating expenses (excluding certain expenses such as extraordinary expenses, taxes, brokerage and interest expense) of each class as follows:
Class A .39%
Class B .67%
For the year ended December 31, 2021, fees waived and/or expenses reimbursed for each class are as follows:
Class A $ 329,940
Class B 38,093
  $ 368,033
Administration Fee. Pursuant to an Administrative Services Agreement, DIMA provides most administrative services to the Fund. For all services provided under the Administrative Services Agreement, the Fund pays the Advisor an annual fee (“Administration Fee”) of 0.097% of the Fund’s average daily net assets, computed and accrued daily and payable monthly. For the year ended December 31, 2021, the Administration Fee was $450,572, of which $37,904 is unpaid.
Distribution Service Agreement. DWS Distributors, Inc. (“DDI”), an affiliate of the Advisor, is the Fund’s distributor. In accordance with the Distribution Plan, DDI receives 12b-1 fees of up to 0.25% of the average daily net assets of Class B shares. For the year ended December 31, 2021, the Distribution Service Fee was as follows:
Distribution Service Fee Total
Aggregated
Unpaid at
December 31, 2021
Class B $ 105,471 $ 9,058
Service Provider Fees. DWS Service Company (“DSC”), an affiliate of the Advisor, is the transfer agent, dividend-paying agent and shareholder service agent for the Fund. Pursuant to a sub-transfer agency agreement between DSC and DST Systems, Inc. (“DST”), DSC has delegated certain transfer agent, dividend-paying agent and shareholder service agent functions to DST. DSC compensates DST out of the shareholder servicing fee it receives from the Fund. For the year ended December 31, 2021, the amounts charged to the Fund by DSC were as follows:
Services to Shareholders Total
Aggregated
Unpaid at
December 31, 2021
Class A $ 1,445 $ 246
Class B 283 48
  $ 1,728 $ 294
Other Service Fees. Under an agreement with the Fund, DIMA is compensated for providing regulatory filing services to the Fund. For the year ended December 31, 2021, the amount charged to the Fund by DIMA included in the Statement of Operations under “Reports to shareholders” aggregated $5,840, of which $367 is unpaid.
Trustees’ Fees and Expenses. The Fund paid retainer fees to each Trustee not affiliated with the Advisor, plus specified amounts to the Board Chairperson and to each committee Chairperson.
Affiliated Cash Management Vehicles. The Fund may invest uninvested cash balances in DWS Central Cash Management Government Fund and DWS ESG Liquidity Fund, affiliated money market funds which are managed by the Advisor. Each affiliated money market fund is managed in accordance with Rule 2a-7 under the 1940 Act, which governs the quality, maturity, diversity and liquidity of instruments in which a money market fund may invest. DWS Central Cash Management Government Fund seeks to maintain a stable net asset value, and DWS ESG Liquidity Fund maintains a floating net asset value. The Fund indirectly bears its
40 | DWS Small Cap Index VIP

proportionate share of the expenses of each affiliated money market fund in which it invests. DWS Central Cash Management Government Fund does not pay the Advisor an investment management fee. To the extent that DWS ESG Liquidity Fund pays an investment management fee to the Advisor, the Advisor will waive an amount of the investment management fee payable to the Advisor by the Fund equal to the amount of the investment management fee payable on the Fund’s assets invested in DWS ESG Liquidity Fund.
E. Ownership of the Fund
At December 31, 2021, four participating insurance companies were owners of record of 10% or more of the total outstanding Class A shares of the Fund, each owning 36%, 15%, 12% and 10%, respectively. Four participating insurance companies were owners of record of 10% or more of the total outstanding Class B shares of the Fund, each owning 36%, 20%, 19% and 13%, respectively.
F. Line of Credit
The Fund and other affiliated funds (the “Participants”) share in a $350 million revolving credit facility provided by a syndication of banks. The Fund may borrow for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities. The Participants are charged an annual commitment fee, which is allocated based on net assets, among each of the Participants. Interest is calculated at a daily fluctuating rate per annum equal to the sum of 0.10% plus the higher of the Federal Funds Effective Rate and the Overnight Bank Funding Rate, plus 1.25%. The Fund may borrow up to a maximum of 33 percent of its net assets under the agreement. The Fund had no outstanding loans at December 31, 2021.
G. Other COVID-19 Pandemic
A novel coronavirus known as COVID-19, declared a pandemic by the World Health Organization, has caused significant uncertainty, market volatility, decreased economic and other activity, increased government activity, including economic stimulus measures, and supply chain interruptions. The full effects, duration and costs of the COVID-19 pandemic are impossible to predict, and the circumstances surrounding the COVID-19 pandemic will continue to evolve, including the risk of future increased rates of infection due to low vaccination rates and/or the lack of effectiveness of current vaccines against new variants. The pandemic has affected and may continue to affect certain countries, industries, economic sectors, companies and investment products more than others, may exacerbate existing economic, political, or social tensions and may increase the probability of an economic recession or depression. The Fund and its investments may be adversely affected by the effects of the COVID-19 pandemic, and the pandemic may result in the Fund and its service providers experiencing operational difficulties in coordinating a remote workforce and implementing their business continuity plans, among others. Management will continue to monitor the impact COVID-19 has on the Fund and reflect the consequences as appropriate in the Fund's accounting and financial reporting.
DWS Small Cap Index VIP |41

Report of Independent Registered Public Accounting Firm
To the Board of Trustees of Deutsche DWS Investments VIT Funds and Shareholders of DWS Small Cap Index VIP:
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities of DWS Small Cap Index VIP (the “Fund”) (one of the funds constituting Deutsche DWS Investments VIT Funds) (the “Trust”), including the investment portfolio, as of December 31, 2021, and the related statement of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, the financial highlights for each of the three years in the period then ended and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund (one of the funds constituting Deutsche DWS Investments VIT Funds) at December 31, 2021, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period then ended and its financial highlights for each of the three years in the period then ended, in conformity with U.S. generally accepted accounting principles.
The financial highlights for the years ended December 31, 2017 and December 31, 2018, were audited by another independent registered public accounting firm whose report, dated February 14, 2019, expressed an unqualified opinion on those financial highlights.
Basis for Opinion
These financial statements are the responsibility of the Trust’s management. Our responsibility is to express an opinion on the Fund’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Trust in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Trust is not required to have, nor were we engaged to perform, an audit of the Trust’s internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Trust’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of December 31, 2021, by correspondence with the custodian and others or by other appropriate auditing procedures where replies from others were not received. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
We have served as the auditor of one or more investment companies in the DWS family of funds since at least 1979, but we are unable to determine the specific year.
Boston, Massachusetts
February 15, 2022
42 | DWS Small Cap Index VIP

Information About Your Fund’s Expenses (Unaudited)
As an investor of the Fund, you incur two types of costs: ongoing expenses and transaction costs. Ongoing expenses include management fees, distribution and service (12b-1) fees and other Fund expenses. Examples of transaction costs include contract charges, which are not shown in this section. The following tables are intended to help you understand your ongoing expenses (in dollars) of investing in the Fund and to help you compare these expenses with the ongoing expenses of investing in other mutual funds. In the most recent six-month period, the Fund limited these expenses; had it not done so, expenses would have been higher. The example in the table is based on an investment of $1,000 invested at the beginning of the six-month period and held for the entire period (July 1, 2021 to December 31, 2021).
The tables illustrate your Fund’s expenses in two ways:
—  Actual Fund Return. This helps you estimate the actual dollar amount of ongoing expenses (but not transaction costs) paid on a $1,000 investment in the Fund using the Fund’s actual return during the period. To estimate the expenses you paid over the period, simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the “Expenses Paid per $1,000” line under the share class you hold.
—  Hypothetical 5% Fund Return. This helps you to compare your Fund’s ongoing expenses (but not transaction costs) with those of other mutual funds using the Fund’s actual expense ratio and a hypothetical rate of return of 5% per year before expenses. Examples using a 5% hypothetical fund return may be found in the shareholder reports of other mutual funds. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period.
Please note that the expenses shown in these tables are meant to highlight your ongoing expenses only and do not reflect any transaction costs. The “Expenses Paid per $1,000” line of the tables is useful in comparing ongoing expenses only and will not help you determine the relative total expense of owning different funds. If these transaction costs had been included, your costs would have been higher.
Expenses and Value of a $1,000 Investment for the six months ended December 31, 2021

Actual Fund Return Class A Class B
Beginning Account Value 7/1/21 $ 1,000.00 $ 1,000.00
Ending Account Value 12/31/21 $  974.90 $  973.90
Expenses Paid per $1,000* $  1.94 $  3.33
Hypothetical 5% Fund Return Class A Class B
Beginning Account Value 7/1/21 $ 1,000.00 $ 1,000.00
Ending Account Value 12/31/21 $ 1,023.24 $ 1,021.83
Expenses Paid per $1,000* $  1.99 $  3.41
* Expenses are equal to the Fund's annualized expense ratio for each share class, multiplied by the average account value over the period, multiplied by 184 (the number of days in the most recent six-month period), then divided by 365.
Annualized Expense Ratios Class A Class B
DWS Small Cap Index VIP .39% .67%
For more information, please refer to the Fund’s prospectus.
These tables do not reflect charges and fees (“contract charges”) associated with the separate account that invests in the Fund or any variable life insurance policy or variable annuity contract for which the Fund is an investment option.
For an analysis of the fees associated with an investment in the Fund or similar funds, please refer to the current and hypothetical expense calculators for Variable Insurance Products which can be found at dws.com/calculators.
DWS Small Cap Index VIP |43

Tax Information (Unaudited)
The Fund paid distributions of $1.03 per share from net long-term capital gains during its year ended December 31, 2021.
Pursuant to Section 852 of the Internal Revenue Code, the Fund designates $64,099,000 as capital gain dividends for its year ended December 31, 2021.
For corporate shareholders, 47% of the ordinary dividends (i.e., income dividends plus short-term capital gains) paid during the Fund’s fiscal year ended December 31, 2021, qualified for the dividends received deduction.
Please consult a tax advisor if you have questions about federal or state income tax laws, or on how to prepare your tax returns. If you have specific questions about your account, please contact your insurance provider.
Proxy Voting
The Fund's policies and procedures for voting proxies for portfolio securities and information about how the Fund voted proxies related to its portfolio securities during the most recent 12-month period ended June 30 are available on our Web site — dws.com/en-us/resources/proxy-voting — or on the SEC’s Web site — sec.gov. To obtain a written copy of the Fund's policies and procedures without charge, upon request, call us toll free at (800) 728-3337.
44 | DWS Small Cap Index VIP

Advisory Agreement Board Considerations and Fee Evaluation
The Board of Trustees (hereinafter referred to as the “Board” or “Trustees”) approved the renewal of DWS Small Cap Index VIP's (the “Fund”) investment management agreement (the “Agreement”) with DWS Investment Management Americas, Inc. (“DIMA”) and sub-advisory agreement (the “Sub-Advisory Agreement” and together with the Agreement, the “Agreements”) between DIMA and Northern Trust Investments, Inc. (“NTI”) in September 2021.
In terms of the process that the Board followed prior to approving the Agreements, shareholders should know that:
—  During the entire process, all of the Fund's Trustees were independent of DIMA and its affiliates (the “Independent Trustees”).
—  The Board met frequently during the past year to discuss fund matters and dedicated a substantial amount of time to contract review matters. Over the course of several months, the Board reviewed extensive materials received from DIMA, independent third parties and independent counsel. These materials included an analysis of the Fund’s performance, fees and expenses, and profitability from a fee consultant retained by the Fund’s Independent Trustees (the “Fee Consultant”).
—  The Board also received extensive information throughout the year regarding performance of the Fund.
—  The Independent Trustees regularly met privately with counsel to discuss contract review and other matters. In addition, the Independent Trustees were advised by the Fee Consultant in the course of their review of the Fund's contractual arrangements and considered a comprehensive report prepared by the Fee Consultant in connection with their deliberations.
—  In connection with reviewing the Agreements, the Board also reviewed the terms of the Fund's Rule 12b-1 plan, distribution agreement, administrative services agreement, transfer agency agreement and other material service agreements.
In connection with the contract review process, the Board considered the factors discussed below, among others. The Board also considered that DIMA and its predecessors have managed the Fund since its inception, and the Board believes that a long-term relationship with a capable, conscientious advisor is in the best interests of the Fund. The Board considered, generally, that shareholders chose to invest or remain invested in the Fund knowing that DIMA managed the Fund. DIMA is part of DWS Group GmbH & Co. KGaA (“DWS Group”). DWS Group is a global asset management business that offers a wide range of investing expertise and resources, including research capabilities in many countries throughout the world. In 2018, approximately 20% of DWS Group’s shares were sold in an initial public offering, with Deutsche Bank AG owning the remaining shares.
As part of the contract review process, the Board carefully considered the fees and expenses of each DWS fund overseen by the Board in light of the fund’s performance. In many cases, this led to the negotiation and implementation of expense caps.
While shareholders may focus primarily on fund performance and fees, the Fund’s Board considers these and many other factors, including the quality and integrity of DIMA’s and NTI’s personnel and administrative support services provided by DIMA, such as back-office operations, fund valuations, and compliance policies and procedures.
Nature, Quality and Extent of Services. The Board considered the terms of the Agreements, including the scope of advisory services provided under the Agreements. The Board noted that, under the Agreements, DIMA and NTI provide portfolio management services to the Fund and that, pursuant to a separate administrative services agreement, DIMA provides administrative services to the Fund. The Board considered the experience and skills of senior management and investment personnel and the resources made available to such personnel. The Board also considered the risks to DIMA in sponsoring or managing the Fund, including financial, operational and reputational risks, the potential economic impact to DIMA from such risks and DIMA’s approach to addressing such risks. Throughout the course of the year, the Board also received information regarding DIMA’s oversight of fund sub-advisors, including NTI. The Board reviewed the Fund’s performance over short-term and long-term periods and compared those returns to various agreed-upon performance measures, including market index(es) and a peer universe compiled using information supplied by Morningstar Direct (“Morningstar”), an independent fund data service. The Board also noted that it has put into place a process of identifying “Funds in Review” (e.g., funds performing poorly relative to a peer universe), and receives additional reporting from DIMA regarding such funds and, where appropriate, DIMA’s plans to address underperformance. The Board believes this process is an effective manner of identifying and addressing underperforming funds. Based on the information provided, the Board noted that,
DWS Small Cap Index VIP |45

for the one-, three- and five-year periods ended December 31, 2020, the Fund’s performance (Class A shares) was in the 2nd quartile, 2nd quartile and 1st quartile, respectively, of the applicable Morningstar universe (the 1st quartile being the best performers and the 4th quartile being the worst performers).
Fees and Expenses. The Board considered the Fund’s investment management fee schedule, sub-advisory fee schedule, operating expenses and total expense ratios, and comparative information provided by Broadridge Financial Solutions, Inc. (“Broadridge”) and the Fee Consultant regarding investment management fee rates paid to other investment advisors by similar funds (1st quartile being the most favorable and 4th quartile being the least favorable). With respect to management fees paid to other investment advisors by similar funds, the Board noted that the contractual fee rates paid by the Fund, which include a 0.097% fee paid to DIMA under the Fund’s administrative services agreement, were higher than the median (4th quartile) of the applicable Broadridge peer group (based on Broadridge data provided as of December 31, 2020). The Board noted that, effective October 1, 2021, in connection with the 2021 contract renewal process, DIMA agreed to reduce the Fund’s contractual management fee by 0.07%. With respect to the sub-advisory fee paid to NTI, the Board noted that the fee is paid by DIMA out of its fee and not directly by the Fund. The Board noted that the Fund’s Class A shares total (net) operating expenses were expected to be higher than the median (3rd quartile) of the applicable Broadridge expense universe (based on Broadridge data provided as of December 31, 2020, and analyzing Broadridge expense universe Class A (net) expenses less any applicable 12b-1 fees) (“Broadridge Universe Expenses”). The Board also reviewed data comparing each other operational share class’s total (net) operating expenses to the applicable Broadridge Universe Expenses. The Board noted that the expense limitations agreed to by DIMA were expected to help the Fund’s total (net) operating expenses remain competitive. The Board considered the Fund’s management fee rate as compared to fees charged by DIMA to comparable DWS U.S. registered funds (“DWS Funds”) and considered differences between the Fund and the comparable DWS Funds. The information requested by the Board as part of its review of fees and expenses also included information about institutional accounts (including any sub-advised funds and accounts) and funds offered primarily to European investors (“DWS Europe Funds”) managed by DWS Group. The Board noted that DIMA indicated that DWS Group does not manage any institutional accounts or DWS Europe Funds comparable to the Fund.
On the basis of the information provided, the Board concluded that management fees were reasonable and appropriate in light of the nature, quality and extent of services provided by DIMA and NTI.
Profitability. The Board reviewed detailed information regarding revenues received by DIMA under the Agreement. The Board considered the estimated costs to DIMA, and pre-tax profits realized by DIMA, from advising the DWS Funds, as well as estimates of the pre-tax profits attributable to managing the Fund in particular. The Board also received information regarding the estimated enterprise-wide profitability of DIMA and its affiliates with respect to all fund services in totality and by fund. The Board and the Fee Consultant reviewed DIMA’s methodology in allocating its costs to the management of the Fund. Based on the information provided, the Board concluded that the pre-tax profits realized by DIMA in connection with the management of the Fund were not unreasonable. The Board also reviewed certain publicly available information regarding the profitability of certain similar investment management firms. The Board noted that, while information regarding the profitability of such firms is limited (and in some cases is not necessarily prepared on a comparable basis), DIMA and its affiliates’ overall profitability with respect to the DWS Funds (after taking into account distribution and other services provided to the funds by DIMA and its affiliates) was lower than the overall profitability levels of most comparable firms for which such data was available. The Board did not consider the profitability of NTI with respect to the Fund. The Board noted that DIMA pays NTI’s fee out of its management fee, and its understanding that the Fund’s sub-advisory fee schedule was the product of an arm’s length negotiation with DIMA.
Economies of Scale. The Board considered whether there are economies of scale with respect to the management of the Fund and whether the Fund benefits from any economies of scale. In this regard, the Board observed that while the Fund’s current investment management fee schedule does not include breakpoints, the Fund’s fee schedule represents an appropriate sharing between the Fund and DIMA of such economies of scale as may exist in the management of the Fund at current asset levels.
Other Benefits to DIMA and NTI and Their Affiliates. The Board also considered the character and amount of other incidental or “fall-out” benefits received by DIMA and NTI and their affiliates, including any fees received by DIMA for administrative services provided to the Fund, any fees received by an affiliate of DIMA for transfer agency services provided to the Fund and any fees received by an affiliate of DIMA for distribution services. The Board also considered benefits to DIMA related to brokerage and soft-dollar allocations, including allocating brokerage to pay for research generated by parties other than the executing broker dealers, which pertain primarily to funds investing in equity securities. In addition, the Board
46 | DWS Small Cap Index VIP

considered the incidental public relations benefits to DIMA related to DWS Funds advertising and cross-selling opportunities among DIMA products and services. The Board considered these benefits in reaching its conclusion that the Fund’s management fees were reasonable.
Compliance. The Board considered the significant attention and resources dedicated by DIMA to its compliance processes in recent years. The Board noted in particular (i) the experience, seniority and time commitment of the individuals serving as DIMA’s and the Fund’s chief compliance officers and (ii) the substantial commitment of resources by DIMA and its affiliates to compliance matters, including the retention of compliance personnel. The Board also considered the attention and resources dedicated by DIMA to the oversight of the investment sub-advisor’s compliance program and compliance with the applicable fund policies and procedures.
Based on all of the information considered and the conclusions reached, the Board determined that the continuation of the Agreements is in the best interests of the Fund. In making this determination, the Board did not give particular weight to any single factor identified above. The Board considered these factors over the course of numerous meetings, certain of which were in executive session with only the Independent Trustees and counsel present. It is possible that individual Independent Trustees may have weighed these factors differently in reaching their individual decisions to approve the continuation of the Agreements.
DWS Small Cap Index VIP |47

Board Members and Officers
The following table presents certain information regarding the Board Members and Officers of the Trust/Corporation. Each Board Member’s year of birth is set forth in parentheses after his or her name. Unless otherwise noted, (i) each Board Member has engaged in the principal occupation(s) noted in the table for at least the most recent five years, although not necessarily in the same capacity; and (ii) the address of each Independent Board Member is c/o Keith R. Fox, DWS Funds Board Chair, c/o Thomas R. Hiller, Ropes & Gray LLP, Prudential Tower, 800 Boylston Street, Boston, MA 02199-3600. Except as otherwise noted below, the term of office for each Board Member is until the election and qualification of a successor, or until such Board Member sooner dies, resigns, is removed or as otherwise provided in the governing documents of the Trust/Corporation. Because the Fund does not hold an annual meeting of shareholders, each Board Member will hold office for an indeterminate period.
The Board Members may also serve in similar capacities with other funds in the fund complex. The number of funds in the DWS fund complex shown in the table below includes all registered open- and closed-end funds (including all of their portfolios) advised by the Advisor and any registered funds that have an investment advisor that is an affiliated person of the Advisor.
Independent Board Members/Independent Advisory Board Members

Name, Year of
Birth, Position
with the Trust/
Corporation
and Length of
Time Served1
Business Experience and Directorships
During the Past Five Years
Number of
Funds in
DWS Fund
Complex
Overseen
Other
Directorships
Held by Board
Member
Keith R. Fox, CFA (1954)
Chairperson since 2017, and Board Member since 1996
Managing General Partner, Exeter Capital Partners (a series of private investment funds) (since 1986). Directorships: Progressive International Corporation (kitchen goods importer and distributor); former Chairman, National Association of Small Business Investment Companies; Former Directorships: ICI Mutual Insurance Company; BoxTop Media Inc. (advertising); Sun Capital Advisers Trust (mutual funds) 70
John W. Ballantine (1946)
Board Member since 1999
Retired; formerly, Executive Vice President and Chief Risk Management Officer, First Chicago NBD Corporation/The First National Bank of Chicago (1996–1998); Executive Vice President and Head of International Banking (1995–1996); Not-for-Profit Directorships: Palm Beach Civic Assn.; Window to the World Communications (public media); Life Director of Harris Theater for Music and Dance (Chicago); Life Director of Hubbard Street Dance Chicago; Former Directorships: Director and Chairman of the Board, Healthways, Inc.2 (population wellbeing and wellness services) (2003–2014); Stockwell Capital Investments PLC (private equity); Enron Corporation; FNB Corporation; Tokheim Corporation; First Oak Brook Bancshares, Inc.; Oak Brook Bank; Portland General Electric2 (utility company (2003–2021); and Prisma Energy International; Former Not-for-Profit Directorships: Public Radio International 70
Dawn-Marie Driscoll (1946)
Board Member since 1987
Advisory Board and former Executive Fellow, Hoffman Center for Business Ethics, Bentley University; formerly: Partner, Palmer & Dodge (law firm) (1988–1990); Vice President of Corporate Affairs and General Counsel, Filene’s (retail) (1978–1988); Directorships: Trustee and former Chairman of the Board, Southwest Florida Community Foundation (charitable organization); Former Directorships: ICI Mutual Insurance Company (2007–2015); Sun Capital Advisers Trust (mutual funds) (2007–2012), Investment Company Institute (audit, executive, nominating committees) and Independent Directors Council (governance, executive committees) 70
Richard J. Herring (1946)
Board Member since 1990
Jacob Safra Professor of International Banking and Professor of Finance, The Wharton School, University of Pennsylvania (since July 1972); Director, The Wharton Financial Institutions Center (1994–2020); formerly: Vice Dean and Director, Wharton Undergraduate Division (1995–2000) and Director, The Lauder Institute of International Management Studies (2000–2006); Member FDIC Systemic Risk Advisory Committee since 2011, member Systemic Risk Council since 2012 and member of the Advisory Board at the Yale Program on Financial Stability since 2013; Former Directorships: Co-Chair of the Shadow Financial Regulatory Committee (2003–2015), Executive Director of The Financial Economists Roundtable (2008–2015), Director of The Thai Capital Fund (2007–2013), Director of The Aberdeen Singapore Fund (2007–2018), and Nonexecutive Director of Barclays Bank DE (2010–2018) 70 Director, Aberdeen Japan Fund (since 2007)
William McClayton (1944)
Board Member since 2004
Private equity investor (since October 2009); formerly: Managing Director, Diamond Management & Technology Consultants, Inc. (global consulting firm) (2001–2009); Senior Partner, Arthur Andersen LLP (accounting) (1966–2001); Former Directorships: Board of Managers, YMCA of Metropolitan Chicago; Trustee, Ravinia Festival 70
48 | DWS Small Cap Index VIP

Name, Year of
Birth, Position
with the Trust/
Corporation
and Length of
Time Served1
Business Experience and Directorships
During the Past Five Years
Number of
Funds in
DWS Fund
Complex
Overseen
Other
Directorships
Held by Board
Member
Chad D. Perry (1972)
Board Member or Advisory Board Member since 20213
Executive Vice President, General Counsel and Secretary, Tanger Factory Outlet Centers, Inc.2 (since 2011); formerly Executive Vice President and Deputy General Counsel, LPL Financial Holdings Inc.2 (2006–2011); Senior Corporate Counsel, EMC Corporation (2005–2006); Associate, Ropes & Gray LLP (1997–2005) 21 4
Rebecca W. Rimel (1951)
Board Member since 1995
Senior Advisor, The Pew Charitable Trusts (charitable organization) (since July 2020); Director, The Bridgespan Group (nonprofit organization) (since October 2020); formerly: Executive Vice President, The Glenmede Trust Company (investment trust and wealth management) (1983–2004); Board Member, Investor Education (charitable organization) (2004–2005); Former Directorships: Trustee, Executive Committee, Philadelphia Chamber of Commerce (2001–2007); Director, Viasys Health Care2 (January 2007–June 2007); Trustee, Thomas Jefferson Foundation (charitable organization) (1994–2012); President, Chief Executive Officer and Director, The Pew Charitable Trusts (charitable organization) (1994–2020); Director, BioTelemetry Inc.2 (acquired by Royal Philips in 2021) (healthcare) (2009–2021) 70 Director, Becton Dickinson and Company2 (medical technology company)
(2012–present)
Catherine Schrand (1964)
Board Member or Advisory Board Member since 20213
Celia Z. Moh Professor of Accounting (since 2016) and Professor of Accounting (since 1994), The Wharton School, University of Pennsylvania; formerly Vice Dean, Wharton Doctoral Programs (2016–2019) 21 4
William N. Searcy, Jr. (1946)
Board Member since 1993
Private investor since October 2003; formerly: Pension & Savings Trust Officer, Sprint Corporation2 (telecommunications) (November 1989–September 2003); Former Directorships: Trustee, Sun Capital Advisers Trust (mutual funds) (1998–2012) 70
Officers5

Name, Year of Birth, Position
with the Trust/Corporation
and Length of Time Served6
Business Experience and Directorships During the
Past Five Years
Hepsen Uzcan7 (1974)
President and Chief Executive Officer, 2017–present
Fund Administration (Head since 2017), DWS; Secretary, DWS USA Corporation (2018–present); Assistant Secretary, DWS Distributors, Inc. (2018–present); Director and Vice President, DWS Service Company (2018–present); Assistant Secretary, DWS Investment Management Americas, Inc. (2018–present); Director and President, DB Investment Managers, Inc. (2018–present); President and Chief Executive Officer, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2017–present); formerly: Vice President for the Deutsche funds (2016–2017); Assistant Secretary for the DWS funds (2013–2019); Assistant Secretary, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2013–2020); Directorships: Interested Director, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (since June 25, 2020); ICI Mutual Insurance Company (since October 16, 2020); and Episcopalian Charities of New York (2018–present)
John Millette8 (1962)
Vice President and Secretary, 1999–present
Legal (Associate General Counsel), DWS; Chief Legal Officer, DWS Investment Management Americas, Inc. (2015–present); Director and Vice President, DWS Trust Company (2016–present); Secretary, DBX ETF Trust (2020–present); Vice President, DBX Advisors LLC (2021–present); Secretary, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. 2011–present); formerly: Secretary, Deutsche Investment Management Americas Inc. (2015–2017); and Assistant Secretary, DBX ETF Trust (2019–2020)
Ciara Crawford9 (1984)
Assistant Secretary, (2019–present)
Fund Administration (Specialist), DWS (2015–present); formerly, Legal Assistant at Accelerated Tax Solutions.
Diane Kenneally8 (1966)
Chief Financial Officer and Treasurer, 2018–present
Fund Administration Treasurer's Office (Co-Head since 2018), DWS; Treasurer, Chief Financial Officer and Controller, DBX ETF Trust (2019–present); Treasurer and Chief Financial Officer, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2018–present); formerly: Assistant Treasurer for the DWS funds (2007–2018)
Paul Antosca8 (1957)
Assistant Treasurer, 2007–present
Fund Administration Tax (Head), DWS; and Assistant Treasurer, DBX ETF Trust (2019–present)
Sheila Cadogan8 (1966)
Assistant Treasurer, 2017–present
Fund Administration Treasurer's Office (Co-Head since 2018), DWS; Director and Vice President, DWS Trust Company (2018–present); Assistant Treasurer, DBX ETF Trust (2019–present); Assistant Treasurer, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2018–present)
Scott D. Hogan8 (1970)
Chief Compliance Officer, 2016–present
Anti-Financial Crime & Compliance US (Senior Team Lead), DWS; Chief Compliance Officer, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2016–present)
DWS Small Cap Index VIP |49

Name, Year of Birth, Position
with the Trust/Corporation
and Length of Time Served6
Business Experience and Directorships During the
Past Five Years
Caroline Pearson8 (1962)
Chief Legal Officer, 2010–present
Legal (Senior Team Lead), DWS; Assistant Secretary, DBX ETF Trust (2020–present); Chief Legal Officer, DBX Advisors LLC (2020–present); Chief Legal Officer, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (2012–present); formerly: Secretary, Deutsche AM Distributors, Inc. (2002–2017); Secretary, Deutsche AM Service Company (2010–2017); and Chief Legal Officer, DBX Strategic Advisors LLC (2020–2021)
Christian Rijs7 (1980)
Anti-Money Laundering
Compliance Officer,
since October 6, 2021
DWS Americas Head of Anti-Financial Crime and AML Officer, DWS; AML Officer, DWS Trust Company (since October 6, 2021); AML Officer, DBX ETF Trust (since October 6, 2021); AML Officer, The European Equity Fund, Inc., The New Germany Fund, Inc. and The Central and Eastern Europe Fund, Inc. (since October 6, 2021); formerly: DWS UK & Ireland Head of Anti-Financial Crime and MLRO
1 The length of time served represents the year in which the Board Member joined the board of one or more DWS funds currently overseen by the Board.
2 A publicly held company with securities registered pursuant to Section 12 of the Securities Exchange Act of 1934.
3 Mr. Perry and Ms. Schrand are Advisory Board Members of Deutsche DWS Asset Allocation Trust, Deutsche DWS Equity 500 Index Portfolio, Deutsche DWS Global/International Fund, Inc., Deutsche DWS Income Trust, Deutsche DWS Institutional Funds, Deutsche DWS International Fund, Inc., Deutsche DWS Investment Trust, Deutsche DWS Investments VIT Funds, Deutsche DWS Money Market Trust, Deutsche DWS Municipal Trust, Deutsche DWS Portfolio Trust, Deutsche DWS Securities Trust, Deutsche DWS Tax Free Trust, Deutsche DWS Variable Series I and Government Cash Management Portfolio. Mr. Perry and Ms. Schrand are Board Members of each other Trust.
4 Mr. Perry and Ms. Schrand oversee 21 funds in the DWS Fund Complex as Board Members of various Trusts. Mr. Perry and Ms. Schrand are Advisory Board Members of various Trusts/Corporations comprised of 49 funds in the DWS Fund Complex.
5 As a result of their respective positions held with the Advisor or its affiliates, these individuals are considered “interested persons” of the Advisor within the meaning of the 1940 Act. Interested persons receive no compensation from the Fund.
6 The length of time served represents the year in which the officer was first elected in such capacity for one or more DWS funds.
7 Address: 875 Third Avenue, New York, NY 10022.
8 Address: 100 Summer Street, Boston, MA 02110.
9 Address: 5201 Gate Parkway, Jacksonville, FL 32256.
Certain officers hold similar positions for other investment companies for which DIMA or an affiliate serves as the Advisor.
The Fund’s Statement of Additional Information (“SAI”) includes additional information about the Board Members. The SAI is available, without charge, upon request. If you would like to request a copy of the SAI, you may do so by calling the following toll-free number: (800) 728-3337.
50 | DWS Small Cap Index VIP

Notes

vit-scif-2 (R-025818-11 2/22)

   
  (b) Not applicable
   
ITEM 2. CODE OF ETHICS
   
 

As of the end of the period covered by this report, the registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR that applies to its Principal Executive Officer and Principal Financial Officer.

 

There have been no amendments to, or waivers from, a provision of the code of ethics during the period covered by this report that would require disclosure under Item 2.

 

A copy of the code of ethics is filed as an exhibit to this Form N-CSR.

   
ITEM 3. AUDIT COMMITTEE FINANCIAL EXPERT
   
  The fund’s audit committee is comprised solely of trustees who are "independent" (as such term has been defined by the Securities and Exchange Commission ("SEC") in regulations implementing Section 407 of the Sarbanes-Oxley Act (the "Regulations")). The fund’s Board of Trustees has determined that there are several "audit committee financial experts" (as such term has been defined by the Regulations) serving on the fund’s audit committee including Mr. William McClayton, the chair of the fund’s audit committee.  An “audit committee financial expert” is not an “expert” for any purpose, including for purposes of Section 11 of the Securities Act of 1933 and the designation or identification of a person as an “audit committee financial expert” does not impose on such person any duties, obligations or liability that are greater than the duties, obligations and liability imposed on such person as a member of the audit committee and board of directors in the absence of such designation or identification.
   
ITEM 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES
   

DWS Small Cap INdex VIP

form n-csr disclosure re: AUDIT FEES

The following table shows the amount of fees that Ernst & Young LLP (“EY”), the Fund’s Independent Registered Public Accounting Firm, billed to the Fund during the Fund’s last two fiscal years. The Audit Committee approved in advance all audit services and non-audit services that EY provided to the Fund.

Services that the Fund’s Independent Registered Public Accounting Firm Billed to the Fund

Fiscal Year
Ended
December 31,
Audit Fees Billed to Fund Audit-Related
Fees Billed to Fund
Tax Fees Billed to Fund All
Other Fees Billed to Fund
2021 $38,433 $0 $8,316 $0
2020 $38,433 $0 $8,316 $0

 

The above “Tax Fees” were billed for professional services rendered for tax preparation.

Services that the Fund’s Independent Registered Public Accounting Firm Billed to the Adviser and Affiliated Fund Service Providers

The following table shows the amount of fees billed by EY to DWS Investment Management Americas, Inc. (“DIMA” or the “Adviser”), and any entity controlling, controlled by or under common control with DIMA (“Control Affiliate”) that provides ongoing services to the Fund (“Affiliated Fund Service Provider”), for engagements directly related to the Fund’s operations and financial reporting, during the Fund’s last two fiscal years.

Fiscal Year
Ended
December 31,
Audit-Related
Fees Billed to Adviser and Affiliated Fund Service Providers
Tax Fees Billed to Adviser and Affiliated Fund Service Providers All
Other Fees Billed to Adviser and Affiliated Fund Service Providers
2021 $0 $461,717 $0
2020 $0 $650,763 $0

The above “Tax Fees” were billed in connection with tax compliance services and agreed upon procedures.

Non-Audit Services

The following table shows the amount of fees that EY billed during the Fund’s last two fiscal years for non-audit services. The Audit Committee pre-approved all non-audit services that EY provided to the Adviser and any Affiliated Fund Service Provider that related directly to the Fund’s operations and financial reporting. The Audit Committee requested and received information from EY about any non-audit services that EY rendered during the Fund’s last fiscal year to the Adviser and any Affiliated Fund Service Provider. The Committee considered this information in evaluating EY’s independence.

Fiscal Year
Ended
December 31,
Total
Non-Audit Fees Billed to Fund
(A)
Total Non-Audit Fees billed to Adviser and Affiliated Fund Service Providers (engagements related directly to the operations and financial reporting of the Fund)
(B)
Total Non-Audit Fees billed to Adviser and Affiliated Fund Service Providers (all other engagements)
(C)
Total of
(A), (B) and (C)
2021 $8,316 $461,717 $0 $470,033
2020 $8,316 $650,763 $0 $659,079

All other engagement fees were billed for services in connection with agreed upon procedures and tax compliance for DIMA and other related entities.

Audit Committee Pre-Approval Policies and Procedures. Generally, each Fund’s Audit Committee must pre approve (i) all services to be performed for a Fund by a Fund’s Independent Registered Public Accounting Firm and (ii) all non-audit services to be performed by a Fund’s Independent Registered Public Accounting Firm for the DIMA Entities with respect to operations and financial reporting of the Fund, except that the Chairperson or Vice Chairperson of each Fund’s Audit Committee may grant the pre-approval for non-audit services described in items (i) and (ii) above for non-prohibited services for engagements of less than $100,000. All such delegated pre approvals shall be presented to each Fund’s Audit Committee no later than the next Audit Committee meeting.

There were no amounts that were approved by the Audit Committee pursuant to the de minimis exception under Rule 2-01 of Regulation S-X.

According to the registrant’s principal Independent Registered Public Accounting Firm, substantially all of the principal Independent Registered Public Accounting Firm's hours spent on auditing the registrant's financial statements were attributed to work performed by full-time permanent employees of the principal Independent Registered Public Accounting Firm.

***

In connection with the audit of the 2020 and 2021 financial statements, the Fund entered into an engagement letter with EY. The terms of the engagement letter required by EY, and agreed to by the Audit Committee, include a provision mandating the use of mediation and arbitration to resolve any controversy or claim between the parties arising out of or relating to the engagement letter or services provided thereunder.

***

Pursuant to PCAOB Rule 3526, EY is required to describe in writing to the Fund’s Audit Committee, on at least an annual basis, all relationships between EY, or any of its affiliates, and the DWS Funds, including the Fund, or persons in financial reporting oversight roles at the DWS Funds that, as of the date of the communication, may reasonably be thought to bear on EY’s independence. Pursuant to PCAOB Rule 3526, EY has reported the matters set forth below that may reasonably be thought to bear on EY’s independence. With respect to each reported matter in the aggregate, EY advised the Audit Committee that, after careful consideration of the facts and circumstances and the applicable independence rules, it concluded that the matters do not and will not impair EY’s ability to exercise objective and impartial judgement in connection with the audits of the financial statements for the Fund and a reasonable investor with knowledge of all relevant facts and circumstances would conclude that EY has been and is capable of exercising objective and impartial judgment on all issues encompassed within EY’s audit engagements. EY also confirmed to the Audit Committee that it can continue to act as the Independent Registered Public Accounting Firm for the Fund.

·EY advised the Fund’s Audit Committee that various covered persons within EY and EY’s affiliates held investments in, or had other financial relationships with, entities within the DWS Funds “investment company complex” (as defined in Regulation S-X) (the “DWS Funds Complex”). EY informed the Audit Committee that these investments and financial relationships were inconsistent with Rule 2-01(c)(1) of Regulation S-X. EY reported that all breaches have been resolved and that none of the breaches involved any professionals who were part of the audit engagement team for the Fund or in the position to influence the audit engagement team for the Fund.

 

   
ITEM 5. AUDIT COMMITTEE OF LISTED REGISTRANTS
   
  Not applicable
   
ITEM 6. SCHEDULE OF INVESTMENTS
   
  Not applicable
   
ITEM 7. DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES
   
  Not applicable
   
ITEM 8. PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES
   
  Not applicable
   
ITEM 9. PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS
   
  Not applicable
   
ITEM 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
   
  There were no material changes to the procedures by which shareholders may recommend nominees to the Fund’s Board. The primary function of the Nominating and Governance Committee is to identify and recommend individuals for membership on the Board and oversee the administration of the Board Governance Guidelines. Shareholders may recommend candidates for Board positions by forwarding their correspondence by U.S. mail or courier service to Keith R. Fox, DWS Funds Board Chair, c/o Thomas R. Hiller, Ropes & Gray LLP, Prudential Tower, 800 Boylston Street, Boston, MA 02199-3600.
   
ITEM 11. CONTROLS AND PROCEDURES
   
  (a) The Chief Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on the evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.
   
  (b) There have been no changes in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting.
   
ITEM 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies
   
  Not applicable
   
ITEM 13. EXHIBITS
   
  (a)(1) Code of Ethics pursuant to Item 2 of Form N-CSR is filed and attached hereto as EX-99.CODE ETH.
   
  (a)(2) Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.
   
  (b) Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) is furnished and attached hereto as Exhibit 99.906CERT.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Registrant: DWS Small Cap Index VIP, a series of Deutsche DWS Investments VIT Funds
   
   
By:

/s/Hepsen Uzcan

Hepsen Uzcan

President

   
Date: 2/15/2022

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

 

By:

/s/Hepsen Uzcan

Hepsen Uzcan

President

   
Date: 2/15/2022
   
   
   
By:

/s/Diane Kenneally

Diane Kenneally

Chief Financial Officer and Treasurer

   
Date: 2/15/2022
   

 

EX-99.CODE ETH 2 codeofethics.htm CODE OF ETHICS

DWS

Principal Executive and Principal Financial Officer Code of Ethics

 

For the Registered Management Investment Companies Listed on Appendix A

 

 

Effective Date

January 31, 2005

 

Date Last Reviewed

April 14, 2021

 

Table of Contents

I.   Overview 3
II.   Purposes of the Officer Code 3
III.   Responsibilities of Covered Officers 4
A.   Honest and Ethical Conduct 4
B.   Conflicts of Interest 4
C.   Use of Personal Fund Shareholder Information 6
D.   Public Communications 6
E.   Compliance with Applicable Laws, Rules and Regulations 7
IV.   Violation Reporting 7
A.   Overview 7
B.   How to Report 8
C.   Process for Violation Reporting to the Fund Board 8
D.   Sanctions for Code Violations 8
V.   Waivers from the Officer Code 8
VI.   Amendments to the Code 9
VII.   Acknowledgement and Certification of Adherence to the Officer Code 9
VIII.   Scope of Responsibilities 9
IX.   Recordkeeping 9
X.   Confidentiality 9
Appendices 11
Appendix A: List of Officers Covered under the Code, by Board 11
Appendix B: Acknowledgement and Certification 12
Appendix C:  Definitions 14

 

I.Overview

 

This Principal Executive Officer and Principal Financial Officer Code of Ethics (“Officer Code”) sets forth the policies, practices, and values expected to be exhibited in the conduct of the Principal Executive Officers and Principal Financial Officers of the investment companies (each a “Fund” and together, the “Funds”) they serve (“Covered Officers”). A list of Covered Officers and Funds is included on Appendix A.

 

The Boards of the Funds listed on Appendix A have elected to implement the Officer Code, pursuant to Section 406 of the Sarbanes-Oxley Act of 2002 and the SEC’s rules thereunder, to promote and demonstrate honest and ethical conduct in their Covered Officers.

 

DWS represents the asset management activities conducted by DWS Investment Management Americas, Inc., DWS International GmbH or their affiliates that may serve as investment adviser to each Fund. All Covered Officers are also employees of DWS. Thus, in addition to adhering to the Officer Code, these individuals must comply with DWS policies and procedures, such as the DWS Code of Ethics governing personal trading activities, as adopted pursuant to Rule 17j-1 under the Investment Company Act of 1940.[1] In addition, such individuals also must comply with other applicable Fund policies and procedures.

 

The DWS Compliance Officer, who shall not be a Covered Officer and who shall serve as such subject to the approval of the Fund’s Board (or committee thereof), is primarily responsible for implementing and enforcing this Code. The DWS Compliance Officer has the authority to interpret this Officer Code and its applicability to particular circumstances. Any questions about the Officer Code should be directed to the DWS Compliance Officer.

 

The DWS Compliance Officer and his or her contact information can be found in Appendix A.

 

II.Purposes of the Officer Code

 

The purposes of the Officer Code are to deter wrongdoing and to:

 

·promote honest and ethical conduct among Covered Officers, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

 

·promote full, fair, accurate, timely and understandable disclosures in reports and documents that the Funds file with or submit to the SEC (and in other public communications from the Funds) and that are within the Covered Officer’s responsibilities;

 

·promote compliance with applicable laws, rules and regulations;

 

·encourage the prompt internal reporting of violations of the Officer Code to the DWS Compliance Officer; and

 

·establish accountability for adherence to the Officer Code.

 

Any questions about the Officer Code should be referred to the DWS Compliance Officer.

 

III.Responsibilities of Covered Officers

A.        Honest and Ethical Conduct

 

It is the duty of every Covered Officer to encourage and demonstrate honest and ethical conduct, as well as adhere to and require adherence to the Officer Code and any other applicable policies and procedures designed to promote this behavior. Covered Officers must at all times conduct themselves with integrity and distinction, putting first the interests of the Fund(s) they serve. Covered Officers must be honest and candid while maintaining confidentiality of information where required by law, DWS policy or Fund policy.

 

Covered Officers also must, at all times, act in good faith, responsibly and with due care, competence and diligence, without misrepresenting or being misleading about material facts or allowing their independent judgment to be subordinated. Covered Officers also should maintain skills appropriate and necessary for the performance of their duties for the Fund(s). Covered Officers also must responsibly use and control all Fund assets and resources entrusted to them.

 

Covered Officers may not retaliate against others for, or otherwise discourage the reporting of, actual or apparent violations of the Officer Code or applicable laws or regulations. Covered Officers should create an environment that encourages the exchange of information, including concerns of the type that this Code is designed to address.

 

B.        Conflicts of Interest

 

A “conflict of interest” occurs when a Covered Officer’s personal interests interfere with the interests of the Fund for which he or she serves as an officer. Covered Officers may not improperly use their position with a Fund for personal or private gain to themselves, their family, or any other person. Similarly, Covered Officers may not use their personal influence or personal relationships to influence decisions or other Fund business or operational matters where they would benefit personally at the Fund’s expense or to the Fund’s detriment. Covered Officers may not cause the Fund to take action, or refrain from taking action, for their personal benefit at the Fund’s expense or to the Fund’s detriment. Some examples of conflicts of interest follow (this is not an all-inclusive list): being in the position of supervising, reviewing or having any influence on the job evaluation, pay or benefit of any immediate family member who is an employee of a Fund service provider or is otherwise associated with the Fund; or having an ownership interest in, or having any consulting or employment relationship with, any Fund service provider other than DWS or its affiliates.

 

Certain conflicts of interest covered by this Code arise out of the relationships between Covered Officers and the Fund that already are subject to conflict of interest provisions in the Investment Company Act and the Investment Advisers Act. For example, Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property) with the Fund because of their status as “affiliated persons” of the Fund. Covered Officers must comply with applicable laws and regulations. Therefore, any violations of existing statutory and regulatory prohibitions on individual behavior could be considered a violation of this Code.

 

As to conflicts arising from, or as a result of the advisory relationship (or any other relationships) between the Fund and DWS, of which the Covered Officers are also officers or employees, it is recognized by the Board that, subject to DWS’s fiduciary duties to the Fund, the Covered Officers will in the normal course of their duties (whether formally for the Fund or for DWS, or for both) be involved in establishing policies and implementing decisions which will have different effects on DWS and the Fund. The Board recognizes that the participation of the Covered Officers in such activities is inherent in the contract relationship between the Fund and DWS, and is consistent with the expectation of the Board of the performance by the Covered Officers of their duties as officers of the Fund.

 

Covered Officers should avoid actual conflicts of interest, and appearances of conflicts of interest, between the Covered Officer’s duties to the Fund and his or her personal interests beyond those contemplated or anticipated by applicable regulatory schemes. If a Covered Officer suspects or knows of a conflict or an appearance of one, the Covered Officer must immediately report the matter to the DWS Compliance Officer. If a Covered Officer, in lieu of reporting such a matter to the DWS Compliance Officer, may report the matter directly to the Fund’s Board (or committee thereof), as appropriate (e.g., if the conflict involves the DWS Compliance Officer or the Covered Officer reasonably believes it would be futile to report the matter to the DWS Compliance Officer).

 

When actual, apparent or suspected conflicts of interest arise in connection with a Covered Officer, DWS personnel aware of the matter should promptly contact the DWS Compliance Officer. There will be no reprisal or retaliation against the person reporting the matter.

 

Upon receipt of a report of a possible conflict, the DWS Compliance Officer will take steps to determine whether a conflict exists. In so doing, the DWS Compliance Officer may take any actions he or she determines to be appropriate in his or her sole discretion and may use all reasonable resources, including retaining or engaging legal counsel, accounting firms or other consultants, subject to applicable law.[2] The costs associated with such actions may be borne by the Fund, if appropriate, after consultation with the Fund’s Board (or committee thereof). Otherwise, such costs will be borne by DWS or other appropriate Fund service provider.

 

After full review of a report of a possible conflict of interest, the DWS Compliance Officer may determine that no conflict or reasonable appearance of a conflict exists. If, however, the DWS Compliance Officer determines that an actual conflict exists, the Compliance Officer will resolve the conflict solely in the interests of the Fund, and will report the conflict and its resolution to the Fund’s Board (or committee thereof). If the DWS Compliance Officer determines that the appearance of a conflict exists, the DWS Compliance Officer will take appropriate steps to remedy such appearance. In lieu of determining whether a conflict exists and/or resolving a conflict, the DWS Compliance Officer instead may refer the matter to the Fund’s Board (or committee thereof), as appropriate. However, the DWS Compliance Officer must refer the matter to the Fund’s Board (or committee thereof) if the DWS Compliance Officer is directly involved in the conflict or under similar appropriate circumstances.

 

After responding to a report of a possible conflict of interest, the DWS Compliance Officer will discuss the matter with the person reporting it (and with the Covered Officer at issue, if different) for purposes of educating those involved on conflicts of interests (including how to detect and avoid them, if appropriate).

 

Appropriate resolution of conflicts may restrict the personal activities of the Covered Officer and/or his family, friends or other persons.

 

Solely because a conflict is disclosed to the DWS Compliance Officer (and/or the Board or Committee thereof) and/or resolved by the DWS Compliance Officer does not mean that the conflict or its resolution constitutes a waiver from the Code’s requirements.

 

Any questions about conflicts of interests, including whether a particular situation might be a conflict or an appearance of one, should be directed to the DWS Compliance Officer.

 

C.        Use of Personal Fund Shareholder Information

 

A Covered Officer may not use or disclose personal information about Fund shareholders, except in the performance of his or her duties for the Fund. Each Covered Officer also must abide by the Funds’ and DWS’s privacy policies under SEC Regulation S-P.

 

D.        Public Communications

 

In connection with his or her responsibilities for or involvement with a Fund’s public communications and disclosure documents (e.g., shareholder reports, registration statements, press releases), each Covered Officer must provide information to Fund service providers (within the DWS organization or otherwise) and to the Fund’s Board (and any committees thereof), independent auditors, government regulators and self-regulatory organizations that is fair, accurate, complete, objective, relevant, timely and understandable.

 

Further, within the scope of their duties, Covered Officers having direct or supervisory authority over Fund disclosure documents or other public Fund communications will, to the extent appropriate within their area of responsibility, endeavor to ensure full, fair, timely, accurate and understandable disclosure in Fund disclosure documents. Such Covered Officers will oversee, or appoint others to oversee, processes for the timely and accurate creation and review of all public reports and regulatory filings. Within the scope of his or her responsibilities as a Covered Officer, each Covered Officer also will familiarize himself or herself with the disclosure requirements applicable to the Fund, as well as the business and financial operations of the Fund. Each Covered Officer also will adhere to, and will promote adherence to, applicable disclosure controls, processes and procedures, including DWS’s Disclosure Controls and Procedures, which govern the process by which Fund disclosure documents are created and reviewed.

 

To the extent that Covered Officers participate in the creation of a Fund’s books or records, they must do so in a way that promotes the accuracy, fairness and timeliness of those records.

 

E.        Compliance with Applicable Laws, Rules and Regulations

 

In connection with his or her duties and within the scope of his or her responsibilities as a Covered Officer, each Covered Officer must comply with governmental laws, rules and regulations, accounting standards, and Fund policies/procedures that apply to his or her role, responsibilities and duties with respect to the Funds (“Applicable Laws”). These requirements do not impose on Covered Officers any additional substantive duties. Additionally, Covered Officers should promote compliance with Applicable Laws.

 

If a Covered Officer knows of any material violations of Applicable Laws or suspects that such a violation may have occurred, the Covered Officer is expected to promptly report the matter to the DWS Compliance Officer.

 

IV.Violation Reporting

A.        Overview

Each Covered Officer must promptly report to the DWS Compliance Officer, and promote the reporting of, any known or suspected violations of the Officer Code. Failure to report a violation may be a violation of the Officer Code.

 

Examples of violations of the Officer Code include, but are not limited to, the following:

·Unethical or dishonest behavior
·Obvious lack of adherence to policies surrounding review and approval of public communications and regulatory filings
·Failure to report violations of the Officer Code
·Known or obvious deviations from Applicable Laws
·Failure to acknowledge and certify adherence to the Officer Code

 

The DWS Compliance Officer has the authority to take any and all action he or she considers appropriate in his or her sole discretion to investigate known or suspected Code violations, including consulting with the Fund’s Board, the independent Board members, a Board committee, the Fund’s legal counsel and/or counsel to the independent Board members. The Compliance Officer also has the authority to use all reasonable resources to investigate violations, including retaining or engaging legal counsel, accounting firms or other consultants, subject to applicable law.[3] The costs associated with such actions may be borne by the Fund, if appropriate, after consultation with the Fund’s Board (or committee thereof). Otherwise, such costs will be borne by DWS.

 

B.How to Report

Any known or suspected violations of the Officer Code must be promptly reported to the DWS Compliance Officer.

 

C.Process for Violation Reporting to the Fund Board

 

The DWS Compliance Officer will promptly report any violations of the Code to the Fund’s Board (or committee thereof).

 

D.Sanctions for Code Violations

 

Violations of the Code will be taken seriously. In response to reported or otherwise known violations, DWS and the relevant Fund’s Board may impose sanctions within the scope of their respective authority over the Covered Officer at issue. Sanctions imposed by DWS could include termination of employment. Sanctions imposed by a Fund’s Board could include termination of association with the Fund.

 

V.Waivers from the Officer Code

 

A Covered Officer may request a waiver from the Officer Code by transmitting a written request for a waiver to the DWS Compliance Officer.[4] The request must include the rationale for the request and must explain how the waiver would be in furtherance of the standards of conduct described in and underlying purposes of the Officer Code. The DWS Compliance Officer will present this information to the Fund’s Board (or committee thereof). The Board (or committee) will determine whether to grant the requested waiver. If the Board (or committee) grants the requested waiver, the DWS Compliance Officer thereafter will monitor the activities subject to the waiver, as appropriate, and will promptly report to the Fund’s Board (or committee thereof) regarding such activities, as appropriate.

 

The DWS Compliance Officer will coordinate and facilitate any required public disclosures of any waivers granted or any implicit waivers.

 

VI.Amendments to the Code

 

The DWS Compliance Officer will review the Officer Code from time to time for its continued appropriateness and will propose any amendments to the Fund’s Board (or committee thereof) on a timely basis. In addition, the Board (or committee thereof) will review the Officer Code at least annually for its continued appropriateness and may amend the Code as necessary or appropriate.

 

The DWS Compliance Officer will coordinate and facilitate any required public disclosures of Code amendments.

 

VII.Acknowledgement and Certification of Adherence to the Officer Code

 

Each Covered Officer must sign a statement upon appointment as a Covered Officer and annually thereafter acknowledging that he or she has received and read the Officer Code, as amended or updated, and confirming that he or she has complied with it (see Appendix B: Acknowledgement and Certification of Obligations Under the Officer Code).

 

Understanding and complying with the Officer Code and truthfully completing the Acknowledgement and Certification Form is each Covered Officer’s obligation.

 

The DWS Compliance Officer will maintain such Acknowledgements in the Fund’s books and records.

 

VIII.Scope of Responsibilities

 

A Covered Officer’s responsibilities under the Officer Code are limited to:

 

(1)Fund matters over which the Officer has direct responsibility or control, matters in which the Officer routinely participates, and matters with which the Officer is otherwise involved (i.e., matters within the scope of the Covered Officer’s responsibilities as a Fund officer); and
(2)Fund matters of which the Officer has actual knowledge.

 

IX.Recordkeeping

 

The DWS Compliance Officer will create and maintain appropriate records regarding the implementation and operation of the Officer Code, including records relating to conflicts of interest determinations and investigations of possible Code violations.

 

X.Confidentiality

 

All reports and records prepared or maintained pursuant to this Officer Code shall be considered confidential and shall be maintained and protected accordingly. Except as otherwise required by law or this Officer Code, such matters shall not be disclosed to anyone other than the DWS Compliance Officer, the Fund’s Board (or committee thereof), legal counsel, independent auditors, and any consultants engaged by the Compliance Officer.

Appendices

Appendix A: List of Officers Covered under the Code, by Board

 

 

Fund Board Principal Executive Officer Principal Financial Officer Treasurer
DWS Funds Hepsen Uzcan Diane Kenneally Diane Kenneally
Germany Funds* Hepsen Uzcan Diane Kenneally Diane Kenneally

 

*The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc. and

The New Germany Fund, Inc.

 

DWS Compliance Officer:

 

Scott Hogan

Chief Compliance Officer of the DWS Funds/Germany Funds

Phone: (617) 295-3986

Email: scott-d.hogan@dws.com

 

As of: April 14, 2021

Appendix B: Acknowledgement and Certification

 

 

Initial Acknowledgement and Certification

of Obligations Under the Officer Code

 

 

 

Print Name Department Location Telephone

 

 

1.I acknowledge and certify that I am a Covered Officer under the DWS Principal Executive and Financial Officer Code of Ethics (“Officer Code”), and therefore subject to all of its requirements and provisions.
2.I have received and read the Officer Code and I understand the requirements and provisions set forth in the Officer Code.
3.I have disclosed any conflicts of interest of which I am aware to the DWS Compliance Officer.
4.I will act in the best interest of the Funds for which I serve as an officer and have maintained the confidentiality of personal information about Fund shareholders.
5.I will report any known or suspected violations of the Officer Code in a timely manner to the DWS Compliance Officer.

 

______________________________ ____________________

Signature Date

 

Annual Acknowledgement and Certification

of Obligations Under the Officer Code

 

 

 

Print Name Department Location Telephone

 

 

 

 

1.I acknowledge and certify that I am a Covered Officer under the DWS Principal Executive and Financial Officer Code of Ethics (“Officer Code”), and therefore subject to all of its requirements and provisions.
2.I have received and read the Officer Code, and I understand the requirements and provisions set forth in the Officer Code.
3.I have adhered to the Officer Code.
4.I have not knowingly been a party to any conflict of interest, nor have I had actual knowledge about actual or apparent conflicts of interest that I did not report to the DWS Compliance Officer in accordance with the Officer Code’s requirements.
5.I have acted in the best interest of the Funds for which I serve as an officer and have maintained the confidentiality of personal information about Fund shareholders.
6.With respect to the duties I perform for the Fund as a Fund officer, I believe that effective processes are in place to create and file public reports and documents in accordance with applicable regulations.
7.With respect to the duties I perform for the Fund as a Fund officer, I have complied to the best of my knowledge with all Applicable Laws (as that term is defined in the Officer Code) and have appropriately monitored those persons under my supervision for compliance with Applicable Laws.
8.I have reported any known or suspected violations of the Officer Code in a timely manner to the DWS Compliance Officer.

 

 

 

 

 

 

 

 

______________________________ ____________________

Signature Date

Appendix C: Definitions

 

Principal Executive Officer

Individual holding the office of President of the Fund or series of Funds, or a person performing a similar function.

 

Principal Financial Officer

Individual holding the office of Treasurer of the Fund or series of Funds, or a person performing a similar function.

 

Registered Investment Management Investment Company

Registered investment companies other than a face-amount certificate company or a unit investment trust.

 

Waiver

A waiver is an approval of an exemption from a Code requirement.

 

Implicit Waiver

An implicit waiver is the failure to take action within a reasonable period of time regarding a material departure from a requirement or provision of the Officer Code that has been made known to the DWS Compliance Officer or the Fund’s Board (or committee thereof).


[1] The obligations imposed by the Officer Code are separate from, and in addition to, any obligations imposed under codes of ethics adopted pursuant to Rule 17j-1 under the Investment Company Act of 1940, and any other code of conduct applicable to Covered Officers in whatever capacity they serve. The Officer Code does not incorporate any of those other codes and, accordingly, violations of those codes will not necessarily be considered violations of the Officer Code and waivers granted under those codes would not necessarily require a waiver to be granted under this Code. Sanctions imposed under those codes may be considered in determining appropriate sanctions for any violation of this Code.

[2] For example, retaining a Fund’s independent accounting firm may require pre-approval by the Fund’s audit committee.

[3] For example, retaining a Fund’s independent accounting firm may require pre-approval by the Fund’s audit committee.

[4] Of course, it is not a waiver of the Officer Code if the Fund’s Board (or committee thereof) determines that a matter is not a deviation from the Officer Code’s requirements or is otherwise not covered by the Code.

EX-99.CERT 3 ex99cert.htm CERTIFICATION

President

Form N-CSR Certification under Sarbanes Oxley Act

 

I, Hepsen Uzcan, certify that:

 

1) I have reviewed this report, filed on behalf of DWS Small Cap Index VIP, a series of Deutsche DWS Investments VIT Funds, on Form N-CSR;
     
2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
     
4) The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
     
  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
     
  d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
     
5) The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
     
  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting
       

 

2/15/2022 /s/Hepsen Uzcan
  Hepsen Uzcan
  President

 

 

Chief Financial Officer and Treasurer

Form N-CSR Certification under Sarbanes Oxley Act

 

I, Diane Kenneally, certify that:

 

1) I have reviewed this report, filed on behalf of DWS Small Cap Index VIP, a series of Deutsche DWS Investments VIT Funds, on Form N-CSR;
     
2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
     
4) The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
     
  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
     
  d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
     
5) The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
     
  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting
       

 

2/15/2022 /s/Diane Kenneally
  Diane Kenneally
  Chief Financial Officer and Treasurer

 

EX-99.906 CERT 4 ex99906cert.htm 906 CERTIFICATION

President

Section 906 Certification under Sarbanes Oxley Act

 

 

 

I, Hepsen Uzcan, certify that:

 

1. I have reviewed this report, filed on behalf of DWS Small Cap Index VIP, a series of Deutsche DWS Investments VIT Funds, on Form N-CSR;
   
2. Based on my knowledge and pursuant to 18 U.S.C. § 1350, the periodic report on Form N-CSR (the “Report”) fully complies with the requirements of § 13 (a) or § 15 (d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

2/15/2022 /s/Hepsen Uzcan
  Hepsen Uzcan
  President

 

 

 

Chief Financial Officer and Treasurer

Section 906 Certification under Sarbanes Oxley Act

 

 

I, Diane Kenneally, certify that:

 

1. I have reviewed this report, filed on behalf of DWS Small Cap Index VIP, a series of Deutsche DWS Investments VIT Funds, on Form N-CSR;
   
2. Based on my knowledge and pursuant to 18 U.S.C. § 1350, the periodic report on Form N-CSR (the “Report”) fully complies with the requirements of § 13 (a) or § 15 (d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

2/15/2022 /s/Diane Kenneally
  Diane Kenneally
  Chief Financial Officer and Treasurer

 

GRAPHIC 5 g614358img0c3f12c42.jpg GRAPHIC begin 644 g614358img0c3f12c42.jpg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end GRAPHIC 6 g614358img124236441.jpg GRAPHIC begin 644 g614358img124236441.jpg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end GRAPHIC 7 g614358img15c460723.jpg GRAPHIC begin 644 g614358img15c460723.jpg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